FKnol.com

Financial Knowledge & Information Portal

Healthcare Stocks Performance of 2020

Updated Jul 7, 2020
Healthcare industry is a big business across the globe. With individuals having longer life-spans and increasing population, the need for healthcare has consistently increased many-folds in the last few decades. Also termed as the medical industry, the health business, or the health economy, the healthcare industry is essentially a combination of several sub-sectors, each of which aims to provide products as well as services for treating patients through curative, preventive, rehabilitative, and comforting care and services.
The typical sub-sectors within the larger healthcare sector include Pharmaceuticals, Biotech, Biological Products, Medical Specialties, Dental, Nursing Services, Hospital and Nursing Management, Medical Electronics, Diagnostics, Ophthalmic services, Precision Instruments, Drug Delivery, Drug Manufacturing, Health Care Equipment & Services, Medical Products, and Drug Development.
Since healthcare services are a common need across the globe, a wide variety of big and small, local and multinational healthcare companies exist and operate worldwide. A large number of such healthcare companies are listed on the leading stock exchanges.
As of writing, the following stocks exist in the FKnol.com records which qualify for Healthcare theme based investments. See the List of Top 10 Healthcare Stocks of 2020. Alternatively, one can also explore the List of Top Healthcare ETFs.

This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.

Top Performing Healthcare StocksAll Healthcare StocksAll Healthcare ETFsTop Dividend-paying Healthcare StocksTop Healthcare Stocks for Q3 2020

Performance of Healthcare Stocks

No.Company (Ticker)
Market Cap
%YTD Gains
Company DescriptionStock Price
52-wk Low52-wk High
Sorted by Market Cap. Click on the arrow buttons to sort the table as per the desired column
1.Johnson and Johnson (JNJ)$376.6 billion-2.07%Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharma...See Company Profile ...Dividend History ...Candlestick Patterns ...List of ETFs holding JNJ$142.85$109.16$157
2.United Health (UNH)$281.34 billion0.91%UnitedHealth Group Incorporated, incorporated on July 1, 2015, is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations ...See Company Profile ...Dividend History ...Candlestick Patterns ...List of ETFs holding UNH$296.65$187.72$315.84
3.Novartis AG (NVS)$200.63 billion-7.28%Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company's Innovative Medicines segment offers patented prescription medicines for patients and healthcare...See Company Profile ...Dividend History ...List of ETFs holding NVS$87.8$69.18$99.84
4.Merck (MRK)$198.7 billion-13.45%Merck & Co., Inc., incorporated in 1970, is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates ...See Company Profile ...Dividend History ...Candlestick Patterns ...List of ETFs holding MRK$78.72$65.25$92.64
5.Pfizer (PFE)$189.03 billion-13.14%Pfizer Inc. (Pfizer), incorporated on June 2, 1942, is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio ...See Company Profile ...Dividend History ...Candlestick Patterns ...List of ETFs holding PFE$34.03$27.88$44.11
6.AbbVie (ABBV)$175.09 billion12.21%AbbVie Inc. (AbbVie), incorporated on April 10, 2012, is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. ...See Company Profile ...Dividend History ...Candlestick Patterns ...List of ETFs holding ABBV$99.35$62.55$100.69
7.Abbott Labs (ABT)$163.55 billion6.45%Abbott Laboratories, incorporated on March 6, 1900, is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical ...See Company Profile ...Dividend History ...Candlestick Patterns ...List of ETFs holding ABT$92.46$61.61$100
8.Eli Lilly (LLY)$159.49 billion26.87%Eli Lilly and Company, incorporated on January 17, 1901, is engaged in drug manufacturing business. The Company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and ...See Company Profile ...Dividend History ...List of ETFs holding LLY$166.75$101.36$168.92
9.Novo Nordisk (NVO)$151.71 billion12.4%Novo Nordisk A S, a healthcare company, engages in the development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes Care and Obesity, and Bi...See Company Profile ...Dividend History ...List of ETFs holding NVO$65.06$47.25$68.72
10.Thermo Fisher Scientific (TMO)$150.18 billion17.05%Thermo Fisher Scientific Inc., incorporated on October 11, 1960, develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for ...See Company Profile ...Dividend History ...List of ETFs holding TMO$380.25$250.21$386.57
11.Amgen (AMGN)$148.92 billion5.01%Amgen Inc., incorporated on October 31, 1986, is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. The Company operates in the human therapeutics segment. The ...See Company Profile ...Dividend History ...List of ETFs holding AMGN$253.15$173.12$264.97
12.Astrazeneca (AZN)$140.11 billion7.24%AstraZeneca PLC (AstraZeneca), incorporated on June 17, 1992, is a biopharmaceutical company. The Company focuses on discovery and development of products, which are then manufactured, marketed and sold. The Company ...See Company Profile ...Dividend History ...List of ETFs holding AZN$53.47$36.15$57.44
13.Bristol-Myers Squibb (BMY)$136.42 billion-6.08%Bristol-Myers Squibb Company, incorporated on August 11, 1933, is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Companys pharmaceutical products include chemically synthesized ...See Company Profile ...Dividend History ...Candlestick Patterns ...List of ETFs holding BMY$60.29$42.48$68.34
14.Sanofi (SNY)$128.73 billion2.45%Sanofi, incorporated on May 11, 1994, is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. The Companys segments are ...See Company Profile ...Dividend History ...List of ETFs holding SNY$51.43$37.62$52.94
15.Danaher (DHR)$128.71 billion18.61%Danaher Corporation (Danaher), incorporated on October 3, 1986, designs, manufactures and markets professional, medical, industrial and commercial products and services. As of December 31, 2016, the Companys research and development, ...See Company Profile ...Dividend History ...Candlestick Patterns ...List of ETFs holding DHR$182.04$119.6$184.73
16.Medtronic (MDT)$122.96 billion-19.2%Medtronic Public Limited Company (Medtronic), incorporated on June 12, 2014, is a medical technology, services and solutions company. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive ...See Company Profile ...Dividend History ...Candlestick Patterns ...List of ETFs holding MDT$91.67$72.13$122.15
17.GlaxoSmithKline (GSK)$101.71 billion-14.07%GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of vaccines, over-the-counter medicines, and health-related consumer products worldwide. It operates through four ...See Company Profile ...Dividend History ...List of ETFs holding GSK$40.38$31.43$48.25
18.Gilead Sciences (GILD)$95.86 billion17.61%Gilead Sciences, Inc., incorporated on June 22, 1987, is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Companys portfolio of products ...See Company Profile ...Dividend History ...Candlestick Patterns ...List of ETFs holding GILD$76.42$60.89$85.97
19.CVS Health (CVS)$83.55 billion-13.96%CVS Health Corporation, incorporated on August 22, 1996, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. ...See Company Profile ...Dividend History ...Candlestick Patterns ...List of ETFs holding CVS$63.92$52.04$77.03
20.Vertex Pharma (VRTX)$77.54 billion36.59%Vertex Pharmaceuticals Incorporated, incorporated on January 4, 1989, is engaged in discovering, developing, manufacturing and commercializing medicines for serious diseases. The Company is focused on developing and commercializing therapies for ...See Company Profile ...Dividend History ...List of ETFs holding VRTX$299.06$165.23$306.08
21.Becton Dickinson and (BDX)$74.13 billion-7.57%Becton, Dickinson and Company (BD), incorporated in November 1906, is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory ...See Company Profile ...Dividend History ...List of ETFs holding BDX$251.38$197.75$286.72
22.Stryker (SYK)$67.7 billion-14.1%Stryker Corporation (Stryker), incorporated on February 20, 1946, is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine ...See Company Profile ...Dividend History ...List of ETFs holding SYK$180.34$124.54$226.3
23.CIGNA (CI)$67.17 billion-10.97%Cigna Corporation (Cigna), incorporated on November 3, 1981, together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products ...See Company Profile ...Dividend History ...List of ETFs holding CI$182.05$118.5$224.64
24.Intuitive Surgical (ISRG)$67.17 billion-2.67%Intuitive Surgical, Inc. (Intuitive), incorporated on November 9, 1995, designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Companys da Vinci Surgical System consists of ...See Company Profile ...Dividend History ...List of ETFs holding ISRG$575.34$360.5$619
25.Anthem (ANTM)$66.78 billion-12.3%Anthem, Inc., incorporated on July 17, 2001, is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a full ...See Company Profile ...Dividend History ...List of ETFs holding ANTM$264.89$171.03$312.48
26.Regeneron Pharma (REGN)$65.75 billion70.68%Regeneron Pharmaceuticals, Inc., incorporated on January 11, 1988, is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. The Company commercializes ...See Company Profile ...Dividend History ...List of ETFs holding REGN$640.88$271.37$653.49
27.Zoetis (ZTS)$65.75 billion4.6%Zoetis Inc., incorporated on July 25, 2012, is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion ...See Company Profile ...Dividend History ...List of ETFs holding ZTS$138.44$90.14$146.26
28.Allergan (AGN)$63.66 billion0.97%Allergan plc, incorporated on May 16, 2013, is a specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of brand name pharmaceutical products, medical aesthetics, ...See Company Profile ...Dividend History ...List of ETFs holding AGN$193.02$156.06$202.21
29.Takeda Pharmaceutical Company (TAK)$54.93 billion-11.35%Takeda Pharmaceutical Company Limited, together with its subsidiaries, engages in the research, development, manufacturing, and marketing of pharmaceutical products, over-the-counter medicines and quasi-drug co...See Company Profile ...Dividend History ...List of ETFs holding TAK$17.49$12.43$20.93
30.Illumina (ILMN)$54.7 billion12.17%Illumina, Inc. (Illumina), incorporated on May 16, 2000, is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated ...See Company Profile ...Dividend History ...List of ETFs holding ILMN$372.12$196.78$384.21
31.Humana (HUM)$51.79 billion6.87%Humana Inc. (Humana), incorporated on July 27, 1964, is a health and well-being company. The Companys segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of ...See Company Profile ...Dividend History ...List of ETFs holding HUM$391.7$208.25$412.7
32.Boston Scientific (BSX)$49.49 billion-23.4%Boston Scientific Corporation, incorporated on June 22, 1979, is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers ...See Company Profile ...Dividend History ...Candlestick Patterns ...List of ETFs holding BSX$34.64$24.1$46.62
33.Biogen (BIIB)$43.79 billion-9.56%Biogen Inc., incorporated on April 1, 1997, is a biopharmaceutical company. The Company focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune ...See Company Profile ...Dividend History ...List of ETFs holding BIIB$268.35$215.78$374.99
34.Edwards Lifesciences (EW)$43.61 billion-70.61%Edwards Lifesciences Corporation, incorporated on September 10, 1999, is a manufacturer of heart valve systems and repair products used to replace or repair a patients diseased or defective heart valve. ...See Company Profile ...Dividend History ...List of ETFs holding EW$68.57$51.51$82.55
35.Baxter International (BAX)$43.51 billion2.25%Baxter International Inc., incorporated on October 19, 1931, through its subsidiaries, provides a portfolio of essential renal and hospital products, including acute and chronic dialysis; sterile intravenous (IV) solutions; infusion ...See Company Profile ...Dividend History ...List of ETFs holding BAX$85.5$69.1$95.19
36.Koninklijke Philips (PHG)$42.35 billion-1.91%Koninklijke Philips N.V., incorporated on November 14, 2000, is a health technology company. The Companys segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care & Health Informatics businesses, ...See Company Profile ...Dividend History ...List of ETFs holding PHG$47.87$30.5$50.78
37.DexCom (DXCM)$40.16 billion94.69%Dexcom, Inc. (Dexcom), incorporated on May 13, 1999, is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory ...See Company Profile ...Dividend History ...List of ETFs holding DXCM$425.86$138.28$439.47
38.Centene (CNC)$38.12 billion4.71%Centene Corporation, incorporated on September 26, 2001, is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The ...See Company Profile ...Dividend History ...List of ETFs holding CNC$65.83$41.62$74.7
39.Hoya Corp (ADR) (HOCPY)$37.42 billion4.55%HOYA Corporation engages in the life care and information technology businesses. The company offers healthcare products, including eyeglass and contact lenses; and medical products, such as medical endoscopes, ...See Company Profile ...Dividend History ...List of ETFs holding HOCPY$100.79$70.36$102.36
40.Walgreens Boots Alliance (WBA)$37.04 billion-28.39%Walgreens Boots Alliance, Inc., incorporated on September 2, 2014, is a holding company. The Company is a pharmacy-led health and wellbeing company. The Company operates through three segments: Retail Pharmacy ...See Company Profile ...Dividend History ...Candlestick Patterns ...List of ETFs holding WBA$42.22$36.65$64.5
41.HCA (HCA)$32.49 billion-34.89%HCA Holdings, Inc., incorporated on October 19, 2010, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, ...See Company Profile ...Dividend History ...List of ETFs holding HCA$96.24$58.38$151.97
42.Seattle Genetics (SGEN)$30.49 billion54.16%Seattle Genetics, Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company markets ADCETRIS, an antibody-d...See Company Profile ...Dividend History ...List of ETFs holding SGEN$176.14$63.02$180.18
43.IDEXX Laboratories (IDXX)$28.65 billion29.17%IDEXX Laboratories, Inc., incorporated on December 19, 1983, develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing markets. ...See Company Profile ...Dividend History ...List of ETFs holding IDXX$337.3$168.65$344.81
44.ResMed (RMD)$27.7 billion23.55%ResMed Inc., incorporated on March 31, 1994, is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that ...See Company Profile ...Dividend History ...List of ETFs holding RMD$191.47$108.85$197.38
45.Agilent (A)$27.55 billion4.57%Agilent Technologies, Inc., incorporated on May 4, 1999, provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, ...See Company Profile ...Dividend History ...List of ETFs holding A$89.21$61.13$93.04
46.IQVIA Holdings (IQV)$27.11 billion-8.14%IQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., incorporated on October 3, 2016, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. ...List of ETFs holding IQV$141.94$81.79$169.14
47.Fresenius Medical Care (FMS)$25.61 billion18.52%Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offe...See Company Profile ...Dividend History ...List of ETFs holding FMS$43.65$29.17$44.47
48.Alexion Pharma (ALXN)$24.83 billion3.99%Alexion Pharmaceuticals, Inc., incorporated on January 28, 1992, is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic products. The Companys products include Soliris (eculizumab), ...See Company Profile ...Dividend History ...List of ETFs holding ALXN$112.46$72.67$127.74
49.Zimmer Biomet (ZBH)$24.2 billion-21.83%Zimmer Biomet Holdings, Inc., incorporated on January 12, 2001, is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, ...See Company Profile ...Dividend History ...List of ETFs holding ZBH$117$74.37$161.11
50.McKesson (MCK)$23.64 billion5.41%McKesson Corporation (McKesson), incorporated on July 7, 1994, is a pharmaceutical distribution services and information technology company. The Company delivers an offering of pharmaceuticals and medical supplies. The Company operates ...See Company Profile ...Dividend History ...List of ETFs holding MCK$145.8$112.6$172.18
51.Incyte (INCY)$23.62 billion24.43%Incyte Corporation, incorporated on April 8, 1991, is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutics. The Companys portfolio includes compounds in various ...See Company Profile ...Dividend History ...List of ETFs holding INCY$108.65$62.48$110.36
52.BioMarin Pharmaceutical (BMRN)$23.14 billion51.37%BioMarin Pharmaceutical Inc., incorporated on October 25, 1996, is a biotechnology company. The Company develops and commercializes pharmaceuticals for various diseases and medical conditions. As of December 31, 2016, the ...See Company Profile ...Dividend History ...List of ETFs holding BMRN$127.98$62.88$129.89
53.Moderna (MRNA)$22.68 billion212.32%Moderna, Inc. develops medicines based on messenger RNA (mRNA). Its pipeline includes development candidates for mRNA-based vaccines and therapies for use in various therapeutic areas comprising prophylactic va...See Company Profile ...Dividend History ...List of ETFs holding MRNA$61.09$11.54$87
54.Genmab AS (GMAB)$22.35 billion53.96%Genmab Au002FS, a biotechnology company, develops antibody therapeutics for the treatment of cancer primarily in Denmark. The company markets DARZALEX, a human IgG1k monoclonal antibody for the treatment of patients with multiple myeloma (MM); and Arzerra, a human IgG1k monoclonal antibody for the treatment of chronic lymphocytic leukemia (CLL). Its products under development include Ofatumumab to trea...See Company Profile ...Dividend History ...List of ETFs holding GMAB$34.38$16.24$34.76
55.Align Technology (ALGN)$21.64 billion-1.55%Align Technology, Inc., incorporated on April 3, 1997, designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, ...See Company Profile ...Dividend History ...List of ETFs holding ALGN$274.71$127.88$301.65
56.AmerisourceBergen (ABC)$20 billion15.62%AmerisourceBergen Corporation, incorporated on March 16, 2001, is a pharmaceutical sourcing and distribution services company. The Companys segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, ...See Company Profile ...Dividend History ...List of ETFs holding ABC$98.3$72.06$103.37
57.Mettler Toledo (MTD)$19.58 billion3.25%Mettler-Toledo International Inc., incorporated on December 6, 1991, is a supplier of precision instruments and services. The Company operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese ...See Company Profile ...Dividend History ...List of ETFs holding MTD$819.06$579.4$867.94
58.Alnylam Pharma (ALNY)$18.37 billion38.93%Alnylam Pharmaceuticals, Inc., incorporated on May 8, 2003, is a biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of ribonucleic acid (RNA) interference (RNAi) therapeutics. The ...See Company Profile ...Dividend History ...List of ETFs holding ALNY$160$69.11$164.09
59.Teladoc (TDOC)$17.95 billion159.51%Teladoc, Inc. is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Companys solution connects its Members, ...See Company Profile ...Dividend History ...List of ETFs holding TDOC$217.26$54.58$223.73
60.WellCare Health Plans (WCG)$17.7 billion5.97%WellCare Health Plans, Inc., incorporated on February 5, 2004, is a managed care company. The Company focuses on government-sponsored managed care services, primarily through Medicaid, Medicare Advantage (MA) and Medicare ...See Company Profile ...Dividend History ...List of ETFs holding WCG$349.92$254.08$350.17
61.Grifols (GRFS)$17.69 billion-19.71%Grifols SA is a Spain-based company engaged in the biopharmaceuticals manufacture. The Company?ÇÖs activities are divided into four business segments: Bioscience, Hospital, Diagnostic and Raw materials. The Bioscience division focuses ...See Company Profile ...Dividend History ...List of ETFs holding GRFS$18.7$13.4$25.73
62.Smith and Nephew SNATS (SNN)$17.42 billion-17.95%Smith & Nephew plc, incorporated on February 17, 1937, is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products ...See Company Profile ...Dividend History ...List of ETFs holding SNN$39.44$26.07$52.26
63.West Pharmaceutical (WST)$16.99 billion53.54%West Pharmaceutical Services, Inc., incorporated on July 27, 1923, is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Companys products include vial containment ...See Company Profile ...Dividend History ...List of ETFs holding WST$230.82$120.12$236.54
64.Laboratory of America (LH)$16.83 billion2.33%Laboratory Corporation of America Holdings, incorporated on March 8, 1994, is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. ...See Company Profile ...Dividend History ...List of ETFs holding LH$173.12$98.02$196.36
65.Teleflex (TFX)$16.75 billion-4.18%Teleflex Incorporated, incorporated on June 25, 1943, is a provider of medical technology products. The Company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare ...See Company Profile ...Dividend History ...List of ETFs holding TFX$360.69$221.27$398.65
66.Biontech SE (BNTX)$15.73 billion104.66%BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other diseases. The company is involved in developing FixVac product candidates, including BNT111, which is in Phase I clinical trial for advance melanoma; BNT112 for prostate cancer; BNT113 that is in Phase I clinical trial to treat HPV+ head and neck cancers; BNT114, which is in Phase I clinical trial for...See Company Profile ...Dividend History ...List of ETFs holding BNTX$69.34$12.52$105
67.Quest Diagnostics (DGX)$15.69 billion9.85%Quest Diagnostics Incorporated, incorporated on September 20, 1996, is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information ...See Company Profile ...Dividend History ...List of ETFs holding DGX$117.31$73.02$125
68.BeiGene (BGNE)$15.64 billion18.6%BeiGene, Ltd. is a clinical-stage biopharmaceutical company. The Company is focused in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. The Company had ...See Company Profile ...Dividend History ...List of ETFs holding BGNE$196.59$114.41$210.35
69.Cooper Companies (COO)$15.05 billion-12.15%The Cooper Companies, Inc., incorporated on March 4, 1980, is a global medical device company. The Company operates through two business units: CooperVision, Inc. and CooperSurgical, Inc. CooperVision offers soft ...See Company Profile ...Dividend History ...List of ETFs holding COO$282.26$236.68$365.68
70.Hologic (HOLX)$14.68 billion8.89%Hologic, Inc., incorporated on January 18, 1990, is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on womens health. The Company ...See Company Profile ...Dividend History ...List of ETFs holding HOLX$56.85$26.49$59.14
71.Cardinal Health (CAH)$14.66 billion-0.71%Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter ...See Company Profile ...Dividend History ...List of ETFs holding CAH$50.22$39.05$60.69
72.Bio-Rad Laboratories (BIO)$13.74 billion26.57%Bio-Rad Laboratories, Inc. (Bio-Rad), incorporated on March 10, 1975, is a manufacturer and distributor of its life science research and clinical diagnostics products. The Company operates through two segments: Life ...See Company Profile ...Dividend History ...List of ETFs holding BIO$468.34$303.82$497.42
73.Insulet (PODD)$13.49 billion20.4%Insulet Corporation, incorporated on July 20, 2000, is engaged in the development, manufacturing and sale of the OmniPod Insulin Management System (the OmniPod System), an insulin delivery system for people ...See Company Profile ...Dividend History ...List of ETFs holding PODD$206.13$115.56$228.79
74.Galapagos NV (GLPG)$13.17 billion-2.35%Galapagos NV, a clinical-stage biotechnology company, discovers, develops, and commercializes novel medicines. Its clinical stage programs include filgotinib, which is in Phase III clinical trials for...See Company Profile ...Dividend History ...List of ETFs holding GLPG$201.97$112$274.03
75.Exact Sciences (EXAS)$12.94 billion-6.68%Exact Sciences Corporation, incorporated on February 10, 1995, is a molecular diagnostics company. The Company focuses on the early detection and prevention of some forms of cancer. The Company offers ...See Company Profile ...Dividend History ...List of ETFs holding EXAS$86.3$35.25$123.99
76.STERIS (STE)$12.89 billion-0.42%STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including ...See Company Profile ...Dividend History ...List of ETFs holding STE$151.78$105.69$168.98
77.Sarepta Therapeutics (SRPT)$12.78 billion27.01%Sarepta Therapeutics, Inc., incorporated on June 5, 2013, is a biopharmaceutical company. The Company focuses on the discovery and development of ribose nucleic acid (RNA)-targeted therapeutics for the treatment of ...See Company Profile ...Dividend History ...List of ETFs holding SRPT$163.89$72.05$172.7
78.Masimo (MASI)$12.66 billion47.98%Masimo Corporation, incorporated on May 7, 1996, is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Companys business is Measure-through Motion ...See Company Profile ...Dividend History ...List of ETFs holding MASI$233.89$139.36$258
79.Teva Pharma (TEVA)$12.44 billion14.39%Teva Pharmaceutical Industries Limited, incorporated on February 13, 1944, is a pharmaceutical company. The Company is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. ...See Company Profile ...Dividend History ...Candlestick Patterns ...List of ETFs holding TEVA$11.21$6.07$13.76
80.Catalent (CTLT)$12.08 billion30.96%Catalent, Inc., incorporated on March 14, 2007, is a provider of delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. The Companys segments include Softgel ...See Company Profile ...Dividend History ...List of ETFs holding CTLT$73.73$31.04$80.52
81.ABIOMED (ABMD)$11.92 billion55.1%ABIOMED, Inc., incorporated on June 4, 1987, is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Company operates in the ...See Company Profile ...Dividend History ...List of ETFs holding ABMD$264.59$119.01$285.77
82.Neurocrine Biosciences (NBIX)$11.88 billion19.04%Neurocrine Biosciences, Inc., incorporated on March 20, 1996, is engaged in discovering and developing pharmaceuticals, in diseases with unmet medical needs, through its research and development (R&D) platform, focused on ...See Company Profile ...Dividend History ...List of ETFs holding NBIX$127.96$72.14$131
83.argenx SE (ARGX)$11.59 billion52.88%argenx SE, a clinical-stage biopharmaceutical company, focuses on developing antibody-based therapies for the treatment of autoimmune diseases and cancer. The company's lead product candidates include ARGX-113 ...See Company Profile ...Dividend History ...List of ETFs holding ARGX$245.4$103.75$247.16
84.Waters Corp. (WAT)$11.47 billion-20.68%Waters Corporation, incorporated on December 6, 1991, is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. The Company designs, manufactures, sells and services high performance ...See Company Profile ...Dividend History ...List of ETFs holding WAT$185.34$154.39$245.68
85.Horizon Pharma (HZNP)$11.23 billion58.26%Horizon Pharma Public Limited Company, a biopharmaceutical company, focuses on researching, developing, and commercializing medicines that address unmet treatment needs for rare and rheumatic diseases...See Company Profile ...Dividend History ...List of ETFs holding HZNP$57.29$22.81$59.19
86.PerkinElmer (PKI)$11.1 billion2.63%PerkinElmer, Inc., incorporated on November 13, 1947, is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two ...See Company Profile ...Dividend History ...List of ETFs holding PKI$99.65$62.91$105.7
87.Varian Medical (VAR)$10.92 billion-15.37%Varian Medical Systems, Inc., incorporated on January 22, 1976, is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and ...See Company Profile ...Dividend History ...List of ETFs holding VAR$120.19$89.62$150.06
88.Molina Healthcare (MOH)$10.8 billion34.44%Molina Healthcare, Inc., incorporated on July 24, 2002, offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates ...See Company Profile ...Dividend History ...List of ETFs holding MOH$182.42$102.85$196.52
89.Bio-Techne (TECH)$10.2 billion21.52%Bio-Techne Corporation, incorporated on July 17, 1981, develops, manufactures and sells biotechnology reagents and instruments for the research and clinical diagnostic markets. The Company operates through three segments: Biotechnology, Clinical ...See Company Profile ...Dividend History ...List of ETFs holding TECH$266.75$155.17$282.52
90.DaVita (DVA)$9.99 billion9.28%DaVita Inc., formerly DaVita HealthCare Partners Inc., incorporated on April 4, 1994, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists ...See Company Profile ...Dividend History ...List of ETFs holding DVA$81.99$50.68$90.15
91.Qiagen (QGEN)$9.85 billion27.78%QIAGEN N.V. (QIAGEN), incorporated on April 29, 1996, is a holding company. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its ...See Company Profile ...Dividend History ...List of ETFs holding QGEN$43.19$25.04$44.41
92.Immunomedics (IMMU)$9.5 billion94.52%Immunomedics, Inc., incorporated on July 6, 1982, is a clinical-stage biopharmaceutical company, which is engaged in researching, developing, manufacturing and marketing biopharmaceutical products. It develops monoclonal antibody-based products for the ...See Company Profile ...Dividend History ...List of ETFs holding IMMU$41.16$8.8$41.67
93.Dentsply Sirona (XRAY)$9.5 billion-23.36%DENTSPLY SIRONA Inc., incorporated on February 15, 1983, is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health ...See Company Profile ...Dividend History ...List of ETFs holding XRAY$43.37$31.58$60.87
94.Quidel (QDEL)$9.45 billion199.85%Quidel Corporation, incorporated on July 14, 1987, is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: immunoassays, ...See Company Profile ...Dividend History ...List of ETFs holding QDEL$224.98$52.49$236.76
95.Livongo Health (LVGO)$9.17 billion274.14%Livongo Health, Inc. provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates acce...See Company Profile ...Dividend History ...List of ETFs holding LVGO$93.76$15.12$94.11
96.ICON (ICLR)$9.03 billion-0.2%ICON public limited company, incorporated on May 31, 1989, is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device ...See Company Profile ...Dividend History ...List of ETFs holding ICLR$171.88$104.28$178.99
97.Charles River Laboratories International (CRL)$8.98 billion18.75%Charles River Laboratories International, Inc., incorporated on February 3, 1994, is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and ...See Company Profile ...Dividend History ...List of ETFs holding CRL$181.41$95.58$189.85
98.ACADIA Pharma (ACAD)$8.88 billion33.24%ACADIA Pharmaceuticals Inc., incorporated on January 16, 1997, is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for central nervous system (CNS) disorders. The ...See Company Profile ...Dividend History ...List of ETFs holding ACAD$57$21.56$58.69
99.10X Genomics (TXG)$8.72 billion16.28%10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems. It offers chromium instruments, enzymes, reagents, microfluidic chips, and other consumable products, as well as software for analyzing biological systems. The company serves researchers in approximately 40 countries. Its customers include a range of academi...See Company Profile ...Dividend History ...List of ETFs holding TXG$88.66$45.11$108.36
100.Elanco Animal Health (ELAN)$8.6 billion-26.83%Elanco Animal Health Incorporated, an animal health company, develops, manufactures, and markets products for companion and food animals in the United States and internationally. It offers companion animal dise...See Company Profile ...Dividend History ...List of ETFs holding ELAN$21.55$15.17$35.23
101.Ionis Pharma (IONS)$8.55 billion1.62%Ionis Pharmaceuticals, Inc., incorporated on March 25, 1991, is engaged in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The Company, using its drug discovery platform, has developed a pipeline of ...See Company Profile ...Dividend History ...List of ETFs holding IONS$61.39$39.32$73.09
102.Dr. Reddy's Laboratories (RDY)$8.49 billion26.79%Dr. Reddys Laboratories Limited, incorporated on February 24, 1984, is a pharmaceutical company that is engaged in providing medicines. The Company operates in three segments: Global Generics, Pharmaceutical Services and ...See Company Profile ...Dividend History ...List of ETFs holding RDY$51.45$33.33$55.19
103.Guardant Health (GH)$8.43 billion9.14%Guardant Health, Inc., a precision oncology company, provides non-invasive cancer diagnostics. It offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that meas...See Company Profile ...Dividend History ...List of ETFs holding GH$85.28$55.9$112.22
104.Henry Schein (HSIC)$8.35 billion-12.31%Henry Schein, Inc., incorporated on December 23, 1992, is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two ...See Company Profile ...Dividend History ...List of ETFs holding HSIC$58.51$41.85$73.99
105.Mylan (MYL)$8.33 billion-19.85%Mylan N.V., incorporated on July 7, 2014, is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic, brand name and over-the-counter (OTC) products in a range ...See Company Profile ...Dividend History ...List of ETFs holding MYL$16.11$12.75$23.11
106.Universal Health (UHS)$7.74 billion-36.45%Universal Health Services, Inc., incorporated on January 8, 1979, is a holding company. The Companys principal business is owning and operating, through its subsidiaries, acute care hospitals and outpatient facilities, ...See Company Profile ...Dividend History ...List of ETFs holding UHS$91.17$65.2$157.79
107.Perrigo (PRGO)$7.52 billion6.85%Perrigo Company plc (Perrigo), formerly Perrigo Company Limited, incorporated on June 28, 2013, is an over-the-counter (OTC) consumer goods and specialty pharmaceutical company. The Companys segments include Consumer Healthcare (CHC), ...See Company Profile ...Dividend History ...List of ETFs holding PRGO$55.2$40.01$63.86
108.Chemed (CHE)$7.49 billion7.36%Chemed Corporation, incorporated on April 2, 1970, purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter ...See Company Profile ...Dividend History ...List of ETFs holding CHE$471.59$330.01$513.75
109.Hill-Rom (HRC)$7.4 billion-2.07%Hill-Rom Holdings, Inc., incorporated on August 7, 1969, is a global medical technology company. The Company partners with healthcare providers by focusing on patient care solutions that improve clinical and ...See Company Profile ...Dividend History ...List of ETFs holding HRC$111.18$72.29$117.5
110.Exelixis (EXEL)$7.17 billion32.63%Exelixis, Inc., incorporated on November 15, 1994, is a biopharmaceutical company. The Company is focused on discovery, development and commercialization of new medicines to manage care and outcomes for people ...See Company Profile ...Dividend History ...List of ETFs holding EXEL$23.37$13.67$27.8
111.Ascendis Pharma AS (ASND)$7.13 billion6.1%Ascendis Pharma A/S, incorporated on September 21, 2006, is a clinical-stage biopharmaceutical company. The Company is engaged in applying its TransCon technology to develop sustained release prodrug therapies with several ...See Company Profile ...Dividend History ...List of ETFs holding ASND$147.6$90.06$158.93
112.The Medicines (MDCO)$6.79 billion-0.05%The Medicines Company, incorporated on July 31, 1996, is a global biopharmaceutical company. The Company is focused on advancing the treatment of acute and intensive care patients through the delivery ...See Company Profile ...Dividend History ...List of ETFs holding MDCO$84.9$28.22$84.98
113.Penumbra (PEN)$6.71 billion16.38%Penumbra, Inc., incorporated on June 21, 2004, is a healthcare company focused on interventional therapies. The Company designs, develops, manufactures and markets medical devices. The Company has a portfolio of ...See Company Profile ...Dividend History ...List of ETFs holding PEN$191.17$121.8$194.93
114.Bausch Health Companies (BHC)$6.53 billion-38.4%Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter products primarily in the therapeutic areas of eye health, gastroenterology, and ...See Company Profile ...Dividend History ...List of ETFs holding BHC$18.43$11.15$31.97
115.Amedisys (AMED)$6.5 billion20.33%Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. The Home Health segment ...See Company Profile ...Dividend History ...List of ETFs holding AMED$200.86$118.79$218.44
116.Repligen (RGEN)$6.49 billion34.21%Repligen Corporation, incorporated on May 29, 1981, is a bioprocessing company. The Company is focused on the development, manufacture and commercialization of products used to improve the interconnected phases of ...See Company Profile ...Dividend History ...List of ETFs holding RGEN$124.14$72.32$143.93
117.Bruker (BRKR)$6.31 billion-19.7%Bruker Corporation, incorporated on February 4, 2000, is a developer, manufacturer and distributor of scientific instruments and analytical and diagnostic solutions that enable its customers to explore life and materials ...See Company Profile ...Dividend History ...List of ETFs holding BRKR$40.93$30.78$54.49
118.Herbalife (HLF)$6.29 billion-4.17%Herbalife Ltd., incorporated on April 4, 2002, is a global nutrition company. The Company develops and sells weight management, healthy meals and snacks, sports and fitness, energy and targeted nutritional ...See Company Profile ...Dividend History ...List of ETFs holding HLF$45.68$20.73$48.82
119.Zai Lab (ZLAB)$6.18 billion99.11%Zai Lab Limited, a biopharmaceutical company, engages in discovering or licensing, developing, and commercializing proprietary therapeutics that address medical needs in the fields of oncology, and autoimmune and infectious disease therapies in the People's Republic of China. Its drug candidates include ZL-2306, a poly ADP ribose polymerase 1 002F2 inhibitor, ...See Company Profile ...Dividend History ...List of ETFs holding ZLAB$82.81$29.43$86.21
120.Encompass Health (EHC)$6.17 billion-10.41%Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and ...See Company Profile ...Dividend History ...List of ETFs holding EHC$62.06$48.01$83.3
121.Novavax (NVAX)$6.14 billion2527.14%Novavax, Inc. (Novavax), incorporated on June 18, 1987, is a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants. The Company operates through ...See Company Profile ...Dividend History ...List of ETFs holding NVAX$104.56$3.54$111.77
122.Tandem Diabetes Care (TNDM)$6.13 billion71.08%Tandem Diabetes Care, Inc., incorporated on January 7, 2008, is a medical device company. The Company is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The ...See Company Profile ...Dividend History ...List of ETFs holding TNDM$101.98$43.69$106.18
123.Canopy Growth (CGC)$6.12 billion-21.76%Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel ca...See Company Profile ...Dividend History ...List of ETFs holding CGC$16.5$9$39.67
124.Allogene Therapeutics (ALLO)$6.12 billion69.67%Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, engages in the research, development, and commercialization of genetically engineered allogeneic T cell therapies for the treatment of canc...See Company Profile ...Dividend History ...List of ETFs holding ALLO$44.08$17.43$55
125.PRA Health Sciences (PRAH)$6.1 billion-13.94%PRA Health Sciences, Inc., incorporated on June 21, 2013, is a contract research organization (CRO). The Company provides outsourced clinical development services to the biotechnology and pharmaceutical industries. The Company ...See Company Profile ...Dividend History ...List of ETFs holding PRAH$95.66$58.67$113.32
126.Jazz Pharma (JAZZ)$6.02 billion-27.13%Jazz Pharmaceuticals Public Limited Company, incorporated on March 15, 2005, is a biopharmaceutical company. The Company is focused on developing and commercializing products that address unmet medical needs. The Company ...See Company Profile ...Dividend History ...List of ETFs holding JAZZ$108.78$86.88$154.24
127.NovoCure (NVCR)$5.98 billion-29.3%NovoCure Limited, incorporated on February 11, 2000, is a commercial-stage oncology company. The Company is engaged in developing a cancer treatment centered on a therapy called TTFields, the use of ...See Company Profile ...Dividend History ...List of ETFs holding NVCR$59.58$53.4$98.84
128.Syneos Health (SYNH)$5.98 billion-3.48%Syneos Health, Inc. operates as an integrated biopharmaceutical solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinic...See Company Profile ...Dividend History ...List of ETFs holding SYNH$57.4$30.02$74.25
129.Adaptive Biotechnologies (ADPT)$5.91 billion55.58%Adaptive Biotechnologies Corporation develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ research service and kit that is used to answer research questions that inform current and future clinical trials, as well as to discover new prognostic and diagnostic signals. It also provides clonoSEQ diagnostic tests, which include immunosequenci...See Company Profile ...Dividend History ...List of ETFs holding ADPT$46.55$15.19$55.12
130.CRISPR Therapeutics AG (CRSP)$5.69 billion50.1%Crispr Therapeutics AG is a Switzerland-based gene-editing company. The Company focuses on the development of transformative gene-based medicines for serious diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 ...See Company Profile ...Dividend History ...List of ETFs holding CRSP$91.41$32.3$93.99
131.LHC (LHCG)$5.62 billion29.05%LHC Group, Inc., incorporated on January 20, 2005, is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies ...See Company Profile ...Dividend History ...List of ETFs holding LHCG$177.78$100$181.49
132.Acceleron Pharma (XLRN)$5.54 billion93.96%Acceleron Pharma Inc., incorporated on June 13, 2003, is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutics to treat serious and rare ...See Company Profile ...Dividend History ...List of ETFs holding XLRN$102.84$37.6$110.49
133.Ultragenyx Pharmaceutical (RARE)$5.25 billion105.76%Ultragenyx Pharmaceutical Inc., incorporated on June 13, 2011, is a clinical-stage biopharmaceutical company. The Company is focused on the identification, acquisition, development, and commercialization of products for the treatment of ...See Company Profile ...Dividend History ...List of ETFs holding RARE$87.88$31.99$90.98
134.Vir Biotechnology (VIR)$5.23 billion252.54%Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products for the treatment and prevention of serious infectious diseases. It develops VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; VIR-1111 for the prevention of human immunodeficiency virus, and VIR-2020 for the prevention of tuberculosis. The company ha...See Company Profile ...Dividend History ...List of ETFs holding VIR$44.35$11.65$75
135.Reata Pharma (RETA)$5.23 billion-23.87%Reata Pharmaceuticals, Inc., incorporated on March 11, 2002, is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing product candidates that modulate the activity of regulatory ...See Company Profile ...Dividend History ...List of ETFs holding RETA$155.64$70$257.96
136.United Therapeutics (UTHR)$5.22 billion34.65%United Therapeutics Corporation, incorporated on June 26, 1996, is a biotechnology company. The Company is focused on the development and commercialization of products for the treatment of chronic and life-threatening ...See Company Profile ...Dividend History ...List of ETFs holding UTHR$118.6$74.31$127.79
137.Mirati Therapeutics (MRTX)$5.12 billion-8.91%Mirati Therapeutics, Inc., incorporated on April 29, 2013, is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of targeted oncology products. The Companys clinical pipeline consists ...See Company Profile ...Dividend History ...List of ETFs holding MRTX$117.38$66.01$132.59
138.1Life Healthcare (ONEM)$4.75 billion70.68%1Life Healthcare, Inc. operates a membership-based primary care platform. The company develops a healthcare membership model based on direct consumer enrollment, as well as employer sponsorship. It also provides medical services in-office and virtually. As of September 30, 2019, the company had approximately 397,000 members in 9 markets in the United States; 6,000 enterprise clients; and health network...See Company Profile ...Dividend History ...List of ETFs holding ONEM$37.67$15$42
139.Emergent Biosolutions (EBS)$4.69 billion65.84%Emergent BioSolutions Inc., incorporated on December 19, 2003, is a life sciences company. The Company focuses on protecting and enhancing life by providing specialty products for civilian and military populations ...See Company Profile ...Dividend History ...List of ETFs holding EBS$89.47$39.11$93.58
140.Forty Seven (FTSV)$4.6 billion142.6%Forty Seven Inc., a clinical-stage immuno-oncology company, focuses on developing therapies to activate macrophages for the treatment of cancer. It is developing 5F9, a humanized IgG4 subclass monoclonal antibo...See Company Profile ...Dividend History ...List of ETFs holding FTSV$95.51$5.53$95.51
141.Haemonetics (HAE)$4.59 billion-20.7%Haemonetics Corporation (Haemonetics), incorporated on August 29, 1985, is a healthcare company. The Company provides various products to customers involved in the processing, handling and analysis of blood. The Companys ...See Company Profile ...Dividend History ...List of ETFs holding HAE$91.12$63.41$140.36
142.Arrowhead Pharma (ARWR)$4.5 billion-30.25%Arrowhead Pharmaceuticals, Inc., formerly Arrowhead Research Corporation, incorporated on February 13, 2001, develops medicines that treat intractable diseases by silencing the genes that cause them. Using a portfolio of ribonucleic ...See Company Profile ...Dividend History ...List of ETFs holding ARWR$44.24$19.51$73.72
143.Globus Medical (GMED)$4.41 billion-23.13%Globus Medical, Inc., a medical device company, focuses on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. The company...See Company Profile ...Dividend History ...List of ETFs holding GMED$45.26$33.41$60.15
144.MyoKardia (MYOK)$4.39 billion29.02%MyoKardia, Inc., incorporated on June 8, 2012, is a clinical-stage biopharmaceutical company. The Company focuses on the treatment of heritable cardiomyopathies, a group of rare, genetically-driven forms of heart failure ...See Company Profile ...Dividend History ...List of ETFs holding MYOK$94.04$42.65$126.3
145.Iovance Biotherapeutics (IOVA)$4.38 billion8.16%Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate canc...See Company Profile ...Dividend History ...List of ETFs holding IOVA$29.94$17.67$41.49
146.MSA Safety (MSA)$4.3 billion-12.44%MSA Safety Incorporated develops, manufactures, and supplies safety products that protect people and facility infrastructures in the oil, gas, petrochemical, fire service, construction, utilities, and mining in...See Company Profile ...Dividend History ...List of ETFs holding MSA$110.64$83.57$142.34
147.Nektar Therapeutics (NKTR)$4.3 billion11.86%Nektar Therapeutics, incorporated on June 3, 1998, is a biopharmaceutical company that discovers and develops medicines in areas of high unmet medical need. The Companys research and development pipeline of ...See Company Profile ...Dividend History ...List of ETFs holding NKTR$24.14$13.63$35.03
148.MorphoSys AG (MOR)$4.29 billion-7.49%MorphoSys AG, together with its subsidiaries, engages in the research, development, and optimization of therapeutic antibody drug candidates in partnership with pharmaceutical and biotechnology companies. The c...See Company Profile ...Dividend History ...List of ETFs holding MOR$33$18.21$37.96
149.Biohaven Pharmaceutical Holding Company (BHVN)$4.22 billion32.4%Biohaven Pharmaceutical Holding Company Ltd., a clinical-stage biopharmaceutical company, develops product candidates to treat neurological diseases, including rare disorders. Its lead product candidate is rime...See Company Profile ...Dividend History ...List of ETFs holding BHVN$72.08$26.56$76.4
150.Blueprint Medicines (BPMC)$4.18 billion-3.64%Blueprint Medicines Corporation, incorporated on October 14, 2008, is a biopharmaceutical company. The Company focuses on patients with genomically defined diseases driven by abnormal kinase activation. The Company focuses on ...See Company Profile ...Dividend History ...List of ETFs holding BPMC$77.19$43.29$102.98
151.Invitae (NVTA)$4.15 billion105.95%Invitae Corporation, incorporated on January 13, 2010, utilizes an integrated portfolio of laboratory processes, software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic ...See Company Profile ...Dividend History ...List of ETFs holding NVTA$33.22$7.41$34.7
152.China Biologic Products (CBPO)$4.12 billion-8.1%China Biologic Products, Inc. (China Biologic), incorporated on January 10, 2007, is a biopharmaceutical company. The Company is principally engaged in the research, development, manufacturing and sales of human plasma-based ...See Company Profile ...Dividend History ...List of ETFs holding CBPO$106.95$92.22$119.44
153.Neogen (NEOG)$4.1 billion18.79%Neogen Corporation, incorporated on June 30, 1981, develops, manufactures and markets a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food ...See Company Profile ...Dividend History ...List of ETFs holding NEOG$77.52$48.91$79.9
154.Amicus Therapeutics (FOLD)$4.09 billion63.14%Amicus Therapeutics, Inc., incorporated on February 4, 2002, is a biotechnology company. The Company is engaged in the discovery, development and commercialization of a set of treatments for patients living ...See Company Profile ...Dividend History ...List of ETFs holding FOLD$15.89$6.25$15.91
155.Global Blood Therapeutics (GBT)$4.08 billion-15.84%Global Blood Therapeutics, Inc., incorporated on February 04, 2011, is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing therapeutics to treat blood-based disorders. The Company ...See Company Profile ...Dividend History ...List of ETFs holding GBT$66.9$39.95$87.54
156.Hutchison China MediTech (HCM)$3.99 billion15.6%Hutchison China MediTech Limited, a biopharmaceutical company, engages in the research, development, manufacture, and sale of pharmaceuticals and healthcare products primarily in the People's Republic of China ...See Company Profile ...Dividend History ...List of ETFs holding HCM$28.98$14.74$29.92
157.ChemoCentryx (CCXI)$3.99 billion48.67%ChemoCentryx, Inc., incorporated on November 8, 1996, is a biopharmaceutical company. The Company is engaged in developing new medications targeted at inflammatory disorders, autoimmune diseases and cancer. Each of the ...See Company Profile ...Dividend History ...List of ETFs holding CCXI$58.8$6.16$65.43
158.Integra LifeSciences (IART)$3.97 billion-19.65%Integra LifeSciences Holdings Corporation, incorporated on June 19, 1989, is a medical technology company. The Company focuses on the development, manufacturing, and marketing of surgical implants and medical instruments. The ...See Company Profile ...Dividend History ...List of ETFs holding IART$46.83$34.21$65.09
159.Momenta Pharma (MNTA)$3.97 billion71.11%Momenta Pharmaceuticals, Inc., incorporated on May 17, 2001, is a biotechnology company. The Company is focused on developing generic versions of drugs, biosimilars and therapeutics for oncology and autoimmune disease. ...See Company Profile ...Dividend History ...List of ETFs holding MNTA$33.76$9.51$39.88
160.Nevro (NVRO)$3.93 billion-1.55%Nevro Corp., a medical device company, provides products for the patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal...See Company Profile ...Dividend History ...List of ETFs holding NVRO$115.72$60.51$148.05
161.ICU Medical (ICUI)$3.9 billion0.09%ICU Medical, Inc., incorporated on January 9, 1992, is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Companys ...See Company Profile ...Dividend History ...List of ETFs holding ICUI$187.29$148.89$259.72
162.NeoGenomics (NEO)$3.88 billion20.96%NeoGenomics, Inc., incorporated on October 29, 1998, is an operator of a network of cancer-focused genetic testing laboratories. The Company operates in Laboratory Testing Segment. This segment delivers testing services ...See Company Profile ...Dividend History ...List of ETFs holding NEO$35.38$18.52$35.92
163.GW Pharma (GWPH)$3.86 billion23.97%GW Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing therapeutics from its cannabinoid product platform in a range of disease areas. The Companys lead cannabinoid product candidate ...See Company Profile ...Dividend History ...List of ETFs holding GWPH$129.62$67.98$180.75
164.Wright Medical (WMGI)$3.84 billion-2.36%Wright Medical Group N.V. is a medical device company. The Company is focused on extremities and biologics products. The Companys segments include U.S. Lower Extremities & Biologics, U.S. Upper Extremities ...See Company Profile ...Dividend History ...List of ETFs holding WMGI$29.76$19.04$30.66
165.Inovio Pharma (INO)$3.81 billion630%Inovio Pharmaceuticals, Inc. (Inovio), incorporated on June 15, 2001, is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing ...See Company Profile ...Dividend History ...List of ETFs holding INO$24.09$1.92$33.79
166.Halozyme Therapeutics (HALO)$3.77 billion56.74%Halozyme Therapeutics, Inc., incorporated on August 23, 2007, is a biotechnology company focused on developing and commercializing oncology therapies. The Company operates in research, development and commercialization of human enzymes ...See Company Profile ...Dividend History ...List of ETFs holding HALO$27.79$12.71$29.34
167.Agios Pharma (AGIO)$3.74 billion13.78%Agios Pharmaceuticals, Inc., incorporated on August 7, 2007, is a clinical-stage biopharmaceutical company. The Companys therapeutic areas of focus are cancer and rare genetic metabolic disorders, which are a group ...See Company Profile ...Dividend History ...List of ETFs holding AGIO$54.33$27.77$56.75
168.FibroGen (FGEN)$3.71 billion-2.84%FibroGen, Inc., incorporated on September 29, 1993, is a science-based biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of therapeutics to treat serious unmet medical needs. ...See Company Profile ...Dividend History ...List of ETFs holding FGEN$41.67$22.65$48.95
169.Natera (NTRA)$3.71 billion39.92%Natera, Inc., incorporated on January 26, 2007, is a diagnostics company. The Company is engaged in the discovery, development and commercialization of genetic testing services. The Company operates a laboratory ...See Company Profile ...Dividend History ...List of ETFs holding NTRA$47.14$16.87$50.57
170.Bridgebio Pharma (BBIO)$3.69 billion-13.21%BridgeBio Pharma, Inc. finds, develops, and delivers various medicines for genetic diseases. The company has a pipeline of 15 development programs that include product candidates ranging from early discovery to late-stage development in various therapeutic areas, including genetic dermatology, oncology, cardiology, neurology, endocrinology, renal disease, and ophthalmology. Its principal products in de...See Company Profile ...Dividend History ...List of ETFs holding BBIO$30.42$14.23$48.36
171.Arena Pharma (ARNA)$3.62 billion40.47%Arena Pharmaceuticals, Inc., incorporated on April 14, 1997, is a biopharmaceutical company. The Company is focused on developing small molecule drugs across a range of therapeutic areas. The Company has ...See Company Profile ...Dividend History ...List of ETFs holding ARNA$63.8$32.95$69.75
172.bluebird bio (BLUE)$3.58 billion-26.76%bluebird bio, Inc., incorporated on April 16, 1992, is a clinical-stage biotechnology company. The Company is focused on developing gene therapies for severe diseases and cancer. With its lentiviral-based gene ...See Company Profile ...Dividend History ...List of ETFs holding BLUE$64.27$38.95$143.98
173.Medpace (MEDP)$3.47 billion16.55%Medpace Holdings, Inc., incorporated on February 18, 2014, is a clinical contract research organization. The Company provides clinical research-based drug and medical device development services. The Company partners with pharmaceutical, ...See Company Profile ...Dividend History ...List of ETFs holding MEDP$97.97$58.72$109.09
174.PTC Therapeutics (PTCT)$3.45 billion14.53%PTC Therapeutics, Inc., incorporated on March 31, 1998, is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of medicines using its expertise in ribonucleic acid ...See Company Profile ...Dividend History ...List of ETFs holding PTCT$55.01$30.79$59.89
175.Envista (NVST)$3.35 billion-28.95%Envista Holdings Corporation manufactures and sells dental products in the United States and internationally. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics, and dental eye loupes to oral surgeons, prosthodontists, and periodontists under the brands, including Nobel Biocare, Alpha ...See Company Profile ...Dividend History ...List of ETFs holding NVST$21.06$10.08$33.3
176.Allakos (ALLK)$3.29 billion-29.31%Allakos Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutic antibodies targeting allergic, inflammatory, and proliferative diseases. The company is developing AK002 for the treat...See Company Profile ...Dividend History ...List of ETFs holding ALLK$67.41$30.32$139.99
177.Intrexon (XON)$3.24 billion247.99%Intrexon Corporation (Intrexon), incorporated on May 21, 2014, forms collaborations to create biologically-based products and processes using synthetic biology. The Companys domestic operations are in California, Florida, Maryland, and Virginia, ...See Company Profile ...Dividend History ...List of ETFs holding XON$19.07$1.26$8.77
178.Change Healthcare (CHNG)$3.21 billion-35.39%Change Healthcare Inc., an independent healthcare technology platform, provides data and analytics-driven solutions to improve clinical, financial, and patient engagement outcomes in the United States healthcare system. It operates in three segments: Software and Analytics, Network Solutions, and Technology-Enabled Services. The Software and Analytics segment provides software and analytics solutions f...See Company Profile ...Dividend History ...List of ETFs holding CHNG$10.59$6.18$17.57
179.Alkermes (ALKS)$3.19 billion-1.52%Alkermes plc, incorporated on May 4, 2011, is a biopharmaceutical company. The Company is engaged in the researching, developing and commercializing pharmaceutical products that are designed to address medical needs ...See Company Profile ...Dividend History ...List of ETFs holding ALKS$20.09$11.98$25.35
180.Fate Therapeutics (FATE)$3.18 billion91.72%Fate Therapeutics, Inc. (Fate Therapeutics), incorporated on April 27, 2007, is a clinical-stage biopharmaceutical company. The Company is engaged in development of programmed cellular immunotherapies for cancer and immune disorders. ...See Company Profile ...Dividend History ...List of ETFs holding FATE$37.52$12.59$38.52
181.Smiledirectclub (SDC)$3.16 billion-6.06%SmileDirectClub, Inc. operates a teledentistry platform that provides member's with a customized clear aligner therapy treatment in the United States and internationally. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a doctor, and monitoring through completion of their treatment proprietary with a network of approximately 250 affil...See Company Profile ...Dividend History ...List of ETFs holding SDC$8.21$3.64$21.1
182.Axsome Therapeutics (AXSM)$3.11 billion-18.85%Axsome Therapeutics, Inc., incorporated on January 12, 2012, is a clinical-stage biopharmaceutical company. The Company is engaged in developing therapies for the management of central nervous system (CNS) disorders, including ...See Company Profile ...Dividend History ...List of ETFs holding AXSM$83.88$13.64$109.94
183.Deciphera Pharmaceuticals (DCPH)$3.06 billion-11.79%Deciphera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durabi...See Company Profile ...Dividend History ...List of ETFs holding DCPH$54.9$19.88$71.11
184.iRhythm (IRTC)$3.04 billion64.91%iRhythm Technologies, Inc. is a United States-based digital health company. The Company develops and commercializes solutions that integrate biosensor technology, patient data, analytics and medical expertise. The Company offers flagship ...See Company Profile ...Dividend History ...List of ETFs holding IRTC$112.29$56.24$136.55
185.BioScrip (BIOS)$2.95 billion12.06%BioScrip, Inc., incorporated on March 22, 1996, is engaged in providing infusion solutions. The Company partners with physicians, hospital systems, skilled nursing facilities, healthcare payors and pharmaceutical manufacturers to provide ...See Company Profile ...Dividend History ...List of ETFs holding BIOS$4.18$4.14$18.21
186.Denali Therapeutics (DNLI)$2.81 billion52.87%Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. The company offers leucine-rich repeat kinase 2 (LRRK2) ...See Company Profile ...Dividend History ...List of ETFs holding DNLI$26.63$12.39$30.41
187.Insmed (INSM)$2.79 billion15.79%Insmed Incorporated, incorporated on March 21, 2013, is a biopharmaceutical company. The Company operates through development and commercialization of therapies for patients with rare diseases segment. The Companys lead product ...See Company Profile ...Dividend History ...List of ETFs holding INSM$27.65$12.09$34.94
188.Audentes Therapeutics (BOLD)$2.75 billion0.22%Audentes Therapeutics, Inc., incorporated on November 13, 2012, is an early-stage biotechnology company. The Company is focused on developing and commercializing gene therapy products for patients suffering from serious, life-threatening ...See Company Profile ...Dividend History ...List of ETFs holding BOLD$59.97$25.41$60
189.NuVasive (NUVA)$2.71 billion-31.69%Nuvasive, Inc., incorporated on July 21, 1997, is a medical device company. The Company focuses on developing minimally-disruptive surgical products and procedurally-integrated solutions for the spine surgery. The Companys product ...See Company Profile ...Dividend History ...List of ETFs holding NUVA$52.83$28.55$81.91
190.STAAR Surgical (STAA)$2.64 billion64.77%STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The...See Company Profile ...Dividend History ...List of ETFs holding STAA$57.95$23.2$62.51
191.Karuna Therapeutics (KRTX)$2.62 billion32.97%Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, primarily focuses on developing novel therapies to address disabling neuropsychiatric conditions characterized by significant unmet medical needs. The company's lead product candidate is KarXT, an oral modulator that is in Phase II clinical trial for the treatment of acute psychosis in patients with schizophrenia, as well as in Phas...See Company Profile ...Dividend History ...List of ETFs holding KRTX$100.18$11.24$152
192.Amarin (AMRN)$2.6 billion-68.56%Amarin Corporation plc, incorporated on March 1, 1989, is a biopharmaceutical company with operations in lipid science focused on the commercialization and development of therapeutics for cardiovascular health. The Company ...See Company Profile ...Dividend History ...List of ETFs holding AMRN$6.74$3.95$26.12
193.TG Therapeutics (TGTX)$2.6 billion103.78%TG Therapeutics, Inc. (TG), incorporated on May 18, 1993, is a biopharmaceutical company focused on the acquisition, development and commercialization of treatments for B-cell malignancies and autoimmune diseases. As of ...See Company Profile ...Dividend History ...List of ETFs holding TGTX$22.62$4.95$22.78
194.Opko Health (OPK)$2.57 billion160.54%OPKO Health, Inc., incorporated on November 18, 1991, is a diversified healthcare company. The Companys segments include Pharmaceutical, Diagnostics and Corporate. The pharmaceutical segment consists of the pharmaceutical operations in ...See Company Profile ...Dividend History ...List of ETFs holding OPK$3.83$1.12$4.04
195.Taro Pharmaceutical Industries (TARO)$2.56 billion-23.86%Taro Pharmaceutical Industries Ltd. (Taro), incorporated on June 3, 1959, is a science-based pharmaceutical company. The Company develops, manufactures and markets prescription (Rx) and over-the-counter (OTC) pharmaceutical products, primarily in ...See Company Profile ...Dividend History ...List of ETFs holding TARO$66.95$56.07$99.69
196.Turning Point Therapeutics (TPTX)$2.56 billion-0.71%Turning Point Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in designing and developing novel small molecule targeted oncology therapies. It develops a pipeline of tyrosine kinase inhibitors (TKIs) that targets genetic drivers of cancer and TKI-pretreated patients. The company's lead drug candidate repotrectinib (TPX-0005) is being evaluated in an ongoing Phase...See Company Profile ...Dividend History ...List of ETFs holding TPTX$61.85$31.3$72.03
197.LivaNova (LIVN)$2.54 billion-30.78%LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Companys segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac ...See Company Profile ...Dividend History ...List of ETFs holding LIVN$52.21$33.4$87.45
198.ArQule (ARQL)$2.42 billion0.2%ArQule, Inc., a biopharmaceutical company, researches and develops therapeutics for the treatment of cancer and rare diseases in the United States. It offers Derazantinib (ARQ 087), a multi-kinase inh...See Company Profile ...Dividend History ...List of ETFs holding ARQL$20$6.79$20.45
199.Merit Medical (MMSI)$2.41 billion39.56%Merit Medical Systems, Inc., incorporated on July 28, 1987, is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The ...See Company Profile ...Dividend History ...List of ETFs holding MMSI$43.57$19.5$58.56
200.Inspire Medical Systems (INSP)$2.38 billion20.13%Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire s...See Company Profile ...Dividend History ...List of ETFs holding INSP$89.15$40.53$99.26
201.Apellis Pharmaceuticals (APLS)$2.34 billion1.14%Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapeutic compounds for autoimmune and inflammatory diseases. Its lead product candidate is APL-2...See Company Profile ...Dividend History ...List of ETFs holding APLS$30.97$16.85$45.04
202.Nu Skin Enterprises (NUS)$2.3 billion8.15%Nu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care system...See Company Profile ...Dividend History ...List of ETFs holding NUS$44.32$12.31$48.61
203.Pacira Pharma (PCRX)$2.28 billion19.58%Pacira Pharmaceuticals, Inc., incorporated on December 22, 2006, is a holding company. The Company is a pharmaceutical company focused on the development, manufacture and commercialization of pharmaceutical products, based on ...See Company Profile ...Dividend History ...List of ETFs holding PCRX$54.17$27.46$56.23
204.Ra Pharma (RARX)$2.27 billion2.26%Ra Pharmaceuticals, Inc. is a United States-based clinical-stage biopharmaceutical company. The Company focuses on the development of therapeutics for diseases of complement dysregulation and a range of orphan indications. It ...See Company Profile ...Dividend History ...List of ETFs holding RARX$47.99$22.25$48.02
205.Integer (ITGR)$2.27 billion-14.15%Integer Holdings Corporation, formerly Greatbatch, Inc., incorporated on June 13, 1997, is a medical device outsource manufacturing company. The Companys segments include Medical and Non-Medical. It serves the cardiac, neuromodulation, ...See Company Profile ...Dividend History ...List of ETFs holding ITGR$69.05$46.01$99.95
206.Benitec Biopharma (BNTC)$2.25 billion37.25%Benitec Biopharma Limited is a biotechnology company. The Company is engaged in progressing programs through the clinic; the commercialization of its Intellectual Property (IP); development of its therapeutic pipeline and ...See Company Profile ...Dividend History ...List of ETFs holding BNTC$7$4.14$19.8
207.Acadia Healthcare (ACHC)$2.24 billion-24.17%Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare fac...See Company Profile ...Dividend History ...List of ETFs holding ACHC$25.19$11.09$35.3
208.Kodiak Sciences (KOD)$2.24 billion-30.17%Kodiak Sciences Inc., a clinical stage biopharmaceutical company, provides novel therapeutics to treat ophthalmic diseases. The company's lead product candidate is KSI-301, a vascular endothelial growth factor ...See Company Profile ...Dividend History ...List of ETFs holding KOD$50.24$9.47$82.75
209.The Ensign (ENSG)$2.22 billion-8.9%The Ensign Group, Inc., incorporated on May 27, 1999, through its operating subsidiaries, provides healthcare services across the post-acute care continuum, as well as other ancillary businesses located in Arizona, ...See Company Profile ...Dividend History ...List of ETFs holding ENSG$41.33$24.06$58.93
210.Progyny (PGNY)$2.21 billion-5.5%Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution th...See Company Profile ...Dividend History ...List of ETFs holding PGNY$25.94$13.29$36.5
211.Synthorx (THOR)$2.21 billion-2.72%Synthorx, Inc., a biotechnology company, discovers and develops protein therapeutics. The company's lead product candidate is THOR-707, a variant of IL-2 that is in development in various tumor types as a singl...See Company Profile ...Dividend History ...List of ETFs holding THOR$67.99$11.05$71.9
212.Patterson Companies (PDCO)$2.18 billion11.08%Patterson Companies, Inc., incorporated on June 15, 1992, is a distributor serving the dental, veterinary and rehabilitation supply markets. The Company operates through three segments: dental supply, veterinary supply and ...See Company Profile ...Dividend History ...List of ETFs holding PDCO$22.75$12.93$25.7
213.Cronos Group (CRON)$2.18 billion-18.25%Cronos Group Inc is a Canada-based globally diversified and vertically integrated cannabis company with a worldwide presence. The Company operates through its subsidiaries and licensed producers: Peace Naturals Project Inc, which was the non-incumbent medical cannabis license...See Company Profile ...Dividend History ...List of ETFs holding CRON$6.27$4$15.85
214.Sage Therapeutics (SAGE)$2.18 billion-41.88%SAGE Therapeutics, Inc., incorporated on April 16, 2010, is a clinical-stage biopharmaceutical company. The Company is engaged in developing and commercializing medicines to treat central nervous system (CNS) disorders. The ...See Company Profile ...Dividend History ...List of ETFs holding SAGE$41.96$25.01$193.56
215.Twist Bioscience (TWST)$2.17 billion132.43%Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, ...See Company Profile ...Dividend History ...List of ETFs holding TWST$48.81$18.52$49.06
216.Igm Biosciences (IGMS)$2.17 billion85.22%IGM Biosciences, Inc., a biotechnology company, engages in the research and development of engineered Immunoglobulin M (IgM) antibodies for the treatment of cancer patients. The company's lead product candidate is IGM-2323, a bispecific T cell engaging IgM antibody that completed preclinical trials for targeting CD20 and CD3 proteins for the treatment of relapsedu002Frefractory B cell Non-Hodgkin's lym...See Company Profile ...Dividend History ...List of ETFs holding IGMS$70.68$16.1$80.55
217.Viela Bio (VIE)$2.16 billion55.76%Viela Bio, Inc., a clinical-stage biotechnology company, engages in the research and development of treatments for severe inflammation and autoimmune diseases in the United States. The company is developing inebilizumab, a humanized monoclonal antibody for neuromyelitis optica spectrum disorder; kidney transplant desensitization; myasthenia gravis; and IgG4-related diseases. It is also developing VIB49...See Company Profile ...Dividend History ...List of ETFs holding VIE$42.29$18.2$70.66
218.AMN Healthcare (AMN)$2.05 billion-30.12%AMN Healthcare Services, Inc., incorporated on November 10, 1997, provides healthcare workforce solutions and staffing services at acute and sub-acute care hospitals and other healthcare facilities throughout the United States. ...See Company Profile ...Dividend History ...List of ETFs holding AMN$43.54$36.65$89.22
219.uniQure (QURE)$2.03 billion-36.17%uniQure N.V. (uniQure) is a gene therapy company. The Company is engaged in developing single treatments with curative results for patients suffering from genetic and other severe diseases. The Company ...See Company Profile ...Dividend History ...List of ETFs holding QURE$45.74$36.2$76.69
220.CONMED (CNMD)$2.02 billion-36.67%CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures in the Americas, Europe, the Middle East, A...See Company Profile ...Dividend History ...List of ETFs holding CNMD$70.82$37.66$116.81
221.Editas Medicine (EDIT)$2 billion8.65%Editas Medicine, Inc., incorporated on September 3, 2013, is a genome editing company. The Company is engaged in treating patients with genetically defined diseases by correcting their disease-causing genes. The ...See Company Profile ...Dividend History ...List of ETFs holding EDIT$32.17$14.01$36.78
222.Eidos Therapeutics (EIDX)$1.92 billion-13.33%Eidos Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on developing drugs to treat diseases caused by transthyretin (TTR) amyloidosis (ATTR). It is developing AG10, an orally-administere...See Company Profile ...Dividend History ...List of ETFs holding EIDX$49.74$28$66.56
223.Dicerna Pharma (DRNA)$1.9 billion16.84%Dicerna Pharmaceuticals, Inc., incorporated on October 24, 2006, is a ribonucleic acid (RNA) interference-based biopharmaceutical company. The Company operates in the segment of discovery, research and development of treatments based ...See Company Profile ...Dividend History ...List of ETFs holding DRNA$25.74$11.75$27.68
224.Corcept Therapeutics (CORT)$1.9 billion37.11%Corcept Therapeutics Incorporated, incorporated on May 13, 1998, is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic ...See Company Profile ...Dividend History ...List of ETFs holding CORT$16.59$9.7$18.52
225.Select Medical (SEM)$1.9 billion-39.33%Select Medical Holdings Corporation, incorporated on October 14, 2004, is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Companys segments include ...See Company Profile ...Dividend History ...List of ETFs holding SEM$14.16$10$28.61
226.Principia Biopharma (PRNB)$1.88 billion3.72%Principia Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on developing novel oral therapies for immunology and oncology in the United States. It is developing PRN1008, an inhibitor that is ...See Company Profile ...Dividend History ...List of ETFs holding PRNB$56.82$25.35$75.65
227.Akebia Therapeutics (AKBA)$1.86 billion106.17%Akebia Therapeutics, Inc., incorporated on February 27, 2007, is a biopharmaceutical company. The Company focuses on the development and commercialization of therapeutics based on hypoxia-inducible factor (HIF) biology. The Companys ...See Company Profile ...Dividend History ...List of ETFs holding AKBA$13.03$2.99$13.7
228.Tenet Healthcare (THC)$1.86 billion-53.3%Tenet Healthcare Corporation (Tenet), incorporated on November 7, 1975, is a healthcare services company. The Company operates regionally focused, integrated healthcare delivery networks in large urban and suburban markets in ...See Company Profile ...Dividend History ...List of ETFs holding THC$17.76$10$39.37
229.Alector (ALEC)$1.86 billion36.45%Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its product includes AL001, a humanized recombinant monoclonal antibody, which is in phase II clinical trial for the treatment of frontotemporal dementia disease; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's ...See Company Profile ...Dividend History ...List of ETFs holding ALEC$23.51$13.64$35.93
230.Xencor (XNCR)$1.86 billion-5.26%Xencor, Inc., incorporated on June 8, 2004, is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing engineered monoclonal antibodies to treat severe and life threatening diseases. ...See Company Profile ...Dividend History ...List of ETFs holding XNCR$32.58$19.35$46.33
231.Cantel Medical (CMD)$1.85 billion-38.21%Cantel Medical Corp., incorporated on August 16, 1963, is a provider of infection prevention products and services in the healthcare market. The Companys operating segments include Endoscopy; Water Purification and ...See Company Profile ...Dividend History ...List of ETFs holding CMD$43.81$20.81$93.87
232.Prestige Brand (PBH)$1.84 billion-9.7%Prestige Brands Holdings, Inc., incorporated on June 24, 2004, is engaged in the marketing, sales and distribution of over-the-counter healthcare and household cleaning products to mass merchandisers, drug stores, supermarkets, ...See Company Profile ...Dividend History ...List of ETFs holding PBH$36.57$27.4$46.12
233.Magellan Health (MGLN)$1.8 billion-7.82%Magellan Health, Inc., incorporated on August 11, 1969, is engaged in the healthcare management business. The Companys segments include Healthcare, Pharmacy Management and Corporate. The Company is focused on managing ...See Company Profile ...Dividend History ...List of ETFs holding MGLN$72.13$30.6$81.04
234.Ligand Pharma (LGND)$1.76 billion5.27%Ligand Pharmaceuticals Incorporated (Ligand), incorporated on September 28, 1987, is a biopharmaceutical company that focuses on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines. The Company ...See Company Profile ...Dividend History ...List of ETFs holding LGND$109.79$57.24$124.97
235.Zymeworks (ZYME)$1.76 billion-15.05%Zymeworks Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer in Canada. The company's lead product candidate is ZW25, a novel bispecific antibody that is in Phase I clinical trial for the treatment of breast and gastric cancer. It is ...See Company Profile ...Dividend History ...List of ETFs holding ZYME$38.62$20.33$52.75
236.AtriCure (ATRC)$1.73 billion33.04%AtriCure, Inc., incorporated on October 31, 2000, is an atrial fibrillation (Afib) solutions company. The Company develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue ...See Company Profile ...Dividend History ...List of ETFs holding ATRC$43.25$22.57$51.76
237.Aurinia Pharma (AUPH)$1.73 billion-24.58%Aurinia Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company operating in the field of nephrology and autoimmunity. The Companys primary business is the development of a therapeutic drug to treat ...See Company Profile ...Dividend History ...List of ETFs holding AUPH$15.28$3.52$21.93
238.Myovant Sciences (MYOV)$1.72 billion23.52%Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for women?ÇÖs health diseases and other endocrine-related disorders. Its main product candidate is Relugolix. Relugolix is ...See Company Profile ...Dividend History ...List of ETFs holding MYOV$19.17$4.14$22.07
239.I-Mab (IMAB)$1.7 billion135.6%I-Mab, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel or highly differentiated biologics to treat diseases with unmet medical needs, primarily cancers and autoimmune disorders worldwide. It is developing TJ202, a CD38 antibody in Phase III clinical trials to treat multiple myeloma and autoimmune diseases; TJ101, a long-acting human grow...See Company Profile ...Dividend History ...List of ETFs holding IMAB$29.45$9.3$32.89
240.Healthcare (HCSG)$1.67 billion-7.48%Healthcare Services Group, Inc., incorporated on November 22, 1976, provides management, administrative and operating services to the housekeeping, laundry, linen, facility maintenance and dietary service departments of the healthcare industry, ...See Company Profile ...Dividend History ...List of ETFs holding HCSG$22.5$15.8$31.84
241.Madrigal Pharma (MDGL)$1.67 billion19.05%Madrigal Pharmaceuticals, Inc., formerly Synta Pharmaceuticals Corp., incorporated on March 10, 2000, is a clinical-stage biopharmaceutical company. The Company focuses on the development and commercialization of therapeutic candidates for the ...See Company Profile ...Dividend History ...List of ETFs holding MDGL$108.47$56.82$127.25
242.Bavarian Nordic ADR (BVNRY)$1.67 billion3.12%Bavarian Nordic A S, a biotechnology company, develops, manufactures, and commercializes a portfolio of novel vaccines for the prevention and treatment of life-threatening infectious diseases and cancer. T...See Company Profile ...Dividend History ...List of ETFs holding BVNRY$8.6$5.04$12.25
243.Y-mAbs Therapeutics (YMAB)$1.65 billion33.12%Y-mAbs Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody therapeutic products for cancer treatment in the United States. It is developing naxitamab for the treatment of pediatric patients with relapsed or refractory, high-risk neuroblastoma, as well as other GD2 positive tumors; and omburtamab ...See Company Profile ...Dividend History ...List of ETFs holding YMAB$41.6$14.16$50.49
244.CareDx (CDNA)$1.65 billion58.92%CareDx, Inc., incorporated on December 21, 1998, is a molecular diagnostics company. The Company is focused on the discovery, development and commercialization of clinically differentiated diagnostic surveillance solutions for transplant ...See Company Profile ...Dividend History ...List of ETFs holding CDNA$34.28$13.04$41.27
245.Glaukos (GKOS)$1.65 billion-31.65%Glaukos Corporation, incorporated on July 14, 1998, is an ophthalmic medical technology company. The Company focuses on the development and commercialization of products and procedures for the treatment of glaucoma. ...See Company Profile ...Dividend History ...List of ETFs holding GKOS$37.23$23.31$84.65
246.Adverum Biotechnologies (ADVM)$1.64 billion77.78%Adverum Biotechnologies, Inc., formerly Avalanche Biotechnologies, Inc., incorporated on July 17, 2006, is a gene therapy company. The Company is engaged in discovering and developing medicines to patients suffering from ...See Company Profile ...Dividend History ...List of ETFs holding ADVM$20.48$4.96$26.98
247.Springworks Therapeutics (SWTX)$1.64 billion-0.94%SpringWorks Therapeutics, Inc., a clinical-stage biopharmaceutical company, acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its advanced product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase 3 clinical trials for the treatment of desmoid tumors. The company is also developing mir...See Company Profile ...Dividend History ...List of ETFs holding SWTX$38.13$17.02$49.79
248.Epizyme (EPZM)$1.63 billion-34.43%Epizyme, Inc., incorporated on November 1, 2007, is a clinical-stage biopharmaceutical company. The Company discovers, develops and plans to commercialize epigenetic therapies for cancer patients. The Company is engaged in ...See Company Profile ...Dividend History ...List of ETFs holding EPZM$16.13$9.74$27.82
249.Ironwood Pharma (IRWD)$1.62 billion-23.67%Ironwood Pharmaceuticals, Inc., incorporated on January 5, 1998, is a biotechnology company. The Company is advancing product opportunities in areas of unmet need, including irritable bowel syndrome with constipation (IBS ...See Company Profile ...Dividend History ...List of ETFs holding IRWD$10.16$7.91$14.1
250.Intra-Cellular Therapies (ITCI)$1.61 billion-29.2%Intra-Cellular Therapies, Inc. (ITI), incorporated on August 29, 2012, is a biopharmaceutical company. The Company is focused on the discovery and clinical development of small molecule drugs that address underserved ...See Company Profile ...Dividend History ...List of ETFs holding ITCI$24.29$6.75$43.56
251.Shockwave Medical (SWAV)$1.61 billion8.56%ShockWave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters or treating bel...See Company Profile ...Dividend History ...List of ETFs holding SWAV$47.68$22.01$54.51
252.Mersana Therapeutics (MRSN)$1.59 billion307.16%Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company focusing on the development of oncology therapeutics in the United States and Canada. The company develops Dolaflexin, an antibody drug con...See Company Profile ...Dividend History ...List of ETFs holding MRSN$23.33$1.32$24.07
253.Cytokinetics (CYTK)$1.55 billion145.43%Cytokinetics, Incorporated, incorporated on August 5, 1997, is a late-stage biopharmaceutical company. The Company is focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases ...See Company Profile ...Dividend History ...List of ETFs holding CYTK$26.04$7.73$27
254.Sorrento Therapeutics (SRNE)$1.55 billion118.34%Sorrento Therapeutics, Inc., incorporated on December 4, 2009, is a biopharmaceutical company. The Company is engaged in the discovery, acquisition, development and commercialization of drug therapeutics. Its primary therapeutic focus ...See Company Profile ...Dividend History ...List of ETFs holding SRNE$7.38$1.39$10
255.Axonics Modulation (AXNX)$1.55 billion42.51%Axonics Modulation Technologies, Inc., a medical technology company, focuses on the design, development, and commercialization of sacral neuromodulation solutions (SNM) solutions. The SNM therapy is primarily u...See Company Profile ...Dividend History ...List of ETFs holding AXNX$39.49$15.25$41.37
256.Trupanion (TRUP)$1.54 billion17.06%Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through ...See Company Profile ...Dividend History ...List of ETFs holding TRUP$43.85$20.84$45.88
257.Zogenix (ZGNX)$1.53 billion-47.09%Zogenix, Inc., incorporated on May 11, 2006, is a pharmaceutical company engaged in developing and commercializing central nervous system (CNS) therapies that address specific clinical needs for people living with ...See Company Profile ...Dividend History ...List of ETFs holding ZGNX$27.58$16.65$57.22
258.So-Young International (SY)$1.5 billion15.47%So-Young International Inc. operates an online platform for discovering, evaluating, and reserving medical aesthetic services. The company facilitates research for treatments, read reviews about them, and book appointments on the platform and blog under the name Beauty Diaries. Its platform enables users to discover content and share their own experience on medical aesthetics procedures, and leads user...See Company Profile ...Dividend History ...List of ETFs holding SY$14.11$8.03$17.18
259.Mednax (MD)$1.5 billion-36.96%MEDNAX, Inc., incorporated on October 10, 2007, is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. As of December 31, 2016, ...See Company Profile ...Dividend History ...List of ETFs holding MD$17.52$7.37$28.66
260.Intercept Pharma (ICPT)$1.5 billion-63.39%Intercept Pharmaceuticals, Inc., incorporated on September 4, 2002, is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics to treat non-viral, progressive liver diseases. The ...See Company Profile ...Dividend History ...List of ETFs holding ICPT$45.37$44.5$125
261.MacroGenics (MGNX)$1.49 billion179.04%MacroGenics, Inc., incorporated on August 14, 2000, is a clinical-stage biopharmaceutical company focused on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune ...See Company Profile ...Dividend History ...List of ETFs holding MGNX$30.36$4.04$30.75
262.Adaptimmune Therapeutics (ADAP)$1.49 billion706.67%Adaptimmune Therapeutics plc, incorporated on December 03, 2014, is a clinical-stage biopharmaceutical company. The Company is focused on cancer immunotherapy products based on its Specific Peptide Enhanced Affinity Receptor (SPEAR) ...See Company Profile ...Dividend History ...List of ETFs holding ADAP$9.68$0.71$13.4
263.Luminex (LMNX)$1.48 billion39.77%Luminex Corporation, incorporated on June 19, 1998, develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Companys products are focused on ...See Company Profile ...Dividend History ...List of ETFs holding LMNX$32.37$17.35$40.21
264.Sangamo Therapeutics (SGMO)$1.48 billion25.69%Sangamo Therapeutics, Inc., formerly Sangamo BioSciences, Inc., incorporated on June 22, 1995, is a clinical-stage biotechnology company. The Company is focused on translating science into genomic therapies that transform patients ...See Company Profile ...Dividend History ...List of ETFs holding SGMO$10.52$4.81$12.49
265.Revance Therapeutics (RVNC)$1.46 billion57.55%Revance Therapeutics, Inc., incorporated on August 10, 1999, is a clinical-stage biotechnology company. The Company is focused on the development, manufacturing and commercialization of botulinum toxin products for multiple aesthetic ...See Company Profile ...Dividend History ...List of ETFs holding RVNC$25.57$9.88$27.97
266.Mesoblast (MESO)$1.46 billion72.86%Mesoblast Limited is engaged in developing cell-based medicines. The Company has leveraged its technology platform, which is based on specialized cells known as mesenchymal lineage adult stem cells, to establish ...See Company Profile ...Dividend History ...List of ETFs holding MESO$12.74$3.12$20.57
267.Silk Road Medical (SILK)$1.44 billion6.49%Silk Road Medical, Inc. operates as a medical device company in the United States. It offers ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent with clinical data regarding lasting safety outcomes; ENHANCE Transcarotid Peripheral Access ...See Company Profile ...Dividend History ...List of ETFs holding SILK$43$20.84$48.44
268.Constellation Pharmaceuticals (CNST)$1.43 billion-35.89%Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapeutics that address serious unmet medical needs in patients with cancers associated w...See Company Profile ...Dividend History ...List of ETFs holding CNST$30.2$6.01$59.49
269.National Research (NRC)$1.43 billion-13.98%National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-ba...See Company Profile ...Dividend History ...List of ETFs holding NRC$56.72$34$71.35
270.Veracyte (VCYT)$1.43 billion2.08%Veracyte, Inc., incorporated on August 15, 2006, is a genomic diagnostics company. The Company uses genomic technology to resolve diagnostic ambiguity. The Company targets diseases in which patients undergo invasive ...See Company Profile ...Dividend History ...List of ETFs holding VCYT$28.5$13.9$31.18
271.Akcea Therapeutics (AKCA)$1.43 billion-17.06%Akcea Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing drugs to treat patients with cardiometabolic diseases caused by lipid disorders in the United States a...See Company Profile ...Dividend History ...List of ETFs holding AKCA$14.05$8$25.66
272.Zealand Pharma (ZEAL)$1.42 billion9.94%Zealand Pharma A 002FS, a biotechnology company, engages in the discovery, design, and development of peptide therapeutics-based medicines in Denmark. It has a portfolio of proprietary medicines in late-stage clinical development focusing on gastrointestinal and metabolic diseases. The company markets lixisenatide for the treatment of type 2 diabetes under the ...See Company Profile ...Dividend History ...List of ETFs holding ZEAL$36.5$18.75$44.6
273.Addus HomeCare (ADUS)$1.42 billion-6.33%Addus HomeCare Corporation, incorporated on July 27, 2006, is a provider of personal care services, which are provided primarily in the home. The Companys personal care services include assistance with ...See Company Profile ...Dividend History ...List of ETFs holding ADUS$91.07$43.13$104.56
274.Portola Pharma (PTLA)$1.42 billion-24.5%Portola Pharmaceuticals, Inc., incorporated on September 2, 2003, is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics in the areas of thrombosis, other hematologic ...See Company Profile ...Dividend History ...List of ETFs holding PTLA$18.03$5.31$31.73
275.Amneal Pharmaceuticals (AMRX)$1.42 billion-5.81%Amneal Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and distributes generic pharmaceutical products for various dosage forms and therapeutic areas. It operates thr...See Company Profile ...Dividend History ...List of ETFs holding AMRX$4.54$2.27$6.89
276.Esperion Therapeutics (ESPR)$1.41 billion-14.42%Esperion Therapeutics, Inc., incorporated on January 22, 2008, is a lipid management company. The Company is a late-stage pharmaceutical company focused on developing and commercializing once-daily, oral therapies for the ...See Company Profile ...Dividend History ...List of ETFs holding ESPR$51.03$24.82$76.98
277.Intellia Therapeutics (NTLA)$1.41 billion63.8%Intellia Therapeutics, Inc., incorporated on May 7, 2014, is a genome editing company. The Company is focused on developing therapeutics utilizing a biological tool known as CRISPR/Cas9. The CRISPR/Cas9 genome ...See Company Profile ...Dividend History ...List of ETFs holding NTLA$24.03$9.18$24.51
278.Avanos Medical (AVNS)$1.41 billion-12.52%Avanos Medical, Inc. operates as a medical technology company that focuses on eliminating pain, speeding recovery, and preventing infection for healthcare providers and patients worldwide. Its Medical Devices s...See Company Profile ...Dividend History ...List of ETFs holding AVNS$29.48$19.46$48.07
279.REGENXBIO (RGNX)$1.4 billion-7.96%REGENXBIO Inc., incorporated on July 16, 2008, is a clinical-stage biotechnology company. The Companys gene therapy product candidates are designed to deliver genes to cells to address genetic defects or ...See Company Profile ...Dividend History ...List of ETFs holding RGNX$37.71$20.03$54.97
280.Aurora Cannabis (ACB)$1.4 billion-48.76%Aurora Cannabis Inc. produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering a...See Company Profile ...Dividend History ...List of ETFs holding ACB$12.42$5.3$89.76
281.Karyopharm Therapeutics (KPTI)$1.4 billion-0.42%Karyopharm Therapeutics Inc., incorporated on December 22, 2008, is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development and commercialization of drugs directed against nuclear transport and ...See Company Profile ...Dividend History ...List of ETFs holding KPTI$19.09$7.31$29.61
282.BioTelemetry (BEAT)$1.39 billion-11.86%BioTelemetry, Inc., incorporated on April 12, 2013, provides monitoring services and digital population health management in a healthcare setting, medical device manufacturing and centralized laboratory services for clinical research. The ...See Company Profile ...Dividend History ...List of ETFs holding BEAT$40.81$27.35$55.85
283.NanoString (NSTG)$1.39 billion32.49%NanoString Technologies, Inc., incorporated on June 20, 2003, develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company ...See Company Profile ...Dividend History ...List of ETFs holding NSTG$36.86$13.85$38.4
284.Kiniksa Pharmaceuticals (KNSA)$1.39 billion106.6%Kiniksa Pharmaceuticals, Ltd., a clinical-stage biopharmaceutical company, focuses on the discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating d...See Company Profile ...Dividend History ...List of ETFs holding KNSA$22.85$5.01$28.67
285.Innoviva (INVA)$1.38 billion-3.88%Innoviva, Inc., formerly Theravance, Inc., incorporated on November 19, 1996, focuses on bringing new medicines to patients in areas of unmet need. The Company is engaged in the development, commercialization ...See Company Profile ...Dividend History ...List of ETFs holding INVA$13.61$7.58$15.62
286.Heron Therapeutics (HRTX)$1.36 billion-36.13%Heron Therapeutics, Inc., incorporated on February 5, 1987, is a biotechnology company. The Company is engaged in developing pharmaceutical products for patients suffering from cancer or pain. The Companys product ...See Company Profile ...Dividend History ...List of ETFs holding HRTX$15.01$9.6$26.81
287.NGM Biopharma (NGM)$1.36 billion8%NGM Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of novel therapeutics for the treatment of cardio-metabolic, liver, oncologic, and ophthalmic diseases. The company's product candidates include NGM282, an engineered variant of the FGF19 human hormone in Phase 2 clinical trials for the treatment of non-alcoholic steatohepatitis (NASH); NG...See Company Profile ...Dividend History ...List of ETFs holding NGM$19.97$8.81$23.95
288.Cortexyme (CRTX)$1.36 billion-17.63%Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's disease and other degenerative disorders. Its lead drug candidate is COR388, an orally-administered brain-penetrating small molecule gingipain inhibitor, which has completed Phase 1a and Phase 1b clinical trials for use in patients with mild to moderate Alzheimer's disease. The company was in...See Company Profile ...Dividend History ...List of ETFs holding CRTX$46.24$19.35$73.84
289.Tricida (TCDA)$1.34 billion-29.15%Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of TRC101, a non-absorbed orally-administered polymer drug that has completed Phase III clinical trials to...See Company Profile ...Dividend History ...List of ETFs holding TCDA$26.74$18.02$44.3
290.Black Diamond Therapeutics (BDTX)$1.33 billion-6.21%Black Diamond Therapeutics, Inc., a biotechnology company, discover and develops small molecule, tumor-agnostic therapies for cancer treatment. Its lead product candidate is BDTX-189, an inhibitor of non-canonical and oncogenic mutations of ErbB kinases epidermal growth factor receptor (EGFR) and tyrosine-protein kinase. The company is also developing allosteric-EGFR mutation inhibitors; and various ea...See Company Profile ...Dividend History ...List of ETFs holding BDTX$37.03$17.63$46.25
291.NantKwest (NK)$1.31 billion223.48%NantKwest, Inc., a clinical-stage immunotherapy biotechnology company, develops immunotherapeutic treatments for cancer, infectious diseases, and inflammatory diseases in the United States. The compan...See Company Profile ...Dividend History ...List of ETFs holding NK$12.26$1.04$13.11
292.Arvinas Holding Co (ARVN)$1.31 billion-18.74%Arvinas Holding Company, LLC, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead products include ARV-110, prote...See Company Profile ...Dividend History ...List of ETFs holding ARVN$33.39$15.19$61.57
293.Theravance Biopharma (TBPH)$1.3 billion-20.28%Theravance Biopharma, Inc. (Theravance Biopharma) is a biopharmaceutical company. The Company is engaged in creating medicines for patients suffering from serious illness. The Company operates in the segment of discovery ...See Company Profile ...Dividend History ...List of ETFs holding TBPH$20.64$15.72$31.54
294.Coherus BioSciences (CHRS)$1.27 billion-0.61%Coherus BioSciences, Inc., incorporated on September 29, 2010, is a late-stage clinical biologics platform company. The Company is engaged in the business of developing and commercializing biosimilar products. The Companys ...See Company Profile ...Dividend History ...List of ETFs holding CHRS$17.89$10.86$23.91
295.Compugen (CGEN)$1.26 billion165.44%Compugen Ltd., incorporated on February 10, 1993, is a therapeutic discovery company. The Company focuses on infrastructure to discover drug targets and develop therapeutics. The Company is engaged in the ...See Company Profile ...Dividend History ...List of ETFs holding CGEN$15.82$2.96$17.85
296.Odonate Therapeutics (ODT)$1.24 billion19.14%Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It focuses on the development of tesetaxel, an orally administered chemotherapy agent for patients with a...See Company Profile ...Dividend History ...List of ETFs holding ODT$38.66$18.07$46.5
297.Arcutis Biotherapeutics (ARQT)$1.22 billion46.79%Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical cream formulation of roflumilast that is in Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of ARQ-151 for t...See Company Profile ...Dividend History ...List of ETFs holding ARQT$32$17.1$40.88
298.Supernus Pharma (SUPN)$1.21 billion-2.78%Supernus Pharmaceuticals, Inc., incorporated on March 30, 2005, is a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. The Company offers ...See Company Profile ...Dividend History ...List of ETFs holding SUPN$23.06$13.12$34.11
299.Cardiovascular (CSII)$1.2 billion-37.54%Cardiovascular Systems, Inc., incorporated on December 6, 2000, is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with ...See Company Profile ...Dividend History ...List of ETFs holding CSII$30.35$26$55.22
300.Rocket Pharmaceuticals (RCKT)$1.19 billion-5.49%Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating pediatric diseases. It has two lentiviral vector (LVV) programs under clinical testing to treat fanconi anemia, a genetic defect in the bone marrow that reduces production of ...See Company Profile ...Dividend History ...List of ETFs holding RCKT$21.51$9.01$27.59
301.Atrion (ATRI)$1.18 billion-14.31%Atrion Corporation (Atrion), incorporated on December 30, 1996, is engaged in developing and manufacturing products, primarily for medical applications. The Companys medical products range from fluid delivery devices to ophthalmic ...See Company Profile ...Dividend History ...List of ETFs holding ATRI$643.93$579$846.15
302.Cerus (CERS)$1.17 billion68.72%Cerus Corporation, incorporated on July 31, 1996, is a biomedical products company. The Company is engaged in developing and commercializing the INTERCEPT Blood System for blood safety. The Company operates ...See Company Profile ...Dividend History ...List of ETFs holding CERS$7.12$2.71$7.49
303.Arcus Biosciences (RCUS)$1.17 billion150.69%Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing cancer immunotherapies in the United States. It is developing various products for treating solid tumors, including AB928, an adenosine receptor antagonist that is in Phase I clinical trial; AB680, a CD73 inhibitor; AB122, an anti-PD-1 antibody that is ...See Company Profile ...Dividend History ...List of ETFs holding RCUS$25.32$6.3$37.41
304.Aphria (APHA)$1.16 billion-17.05%Aphria Inc. produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health p...See Company Profile ...Dividend History ...List of ETFs holding APHA$4.33$1.95$7.6
305.Health Catalyst (HCAT)$1.16 billion-12.19%Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its products include analytics platform, accountable care and financial, benchmarking and comparative analytics, care management and population health, clinical analytics, operations and performance management, patient safety, and services. The company is headquartered in Salt Lake City, Utah....See Company Profile ...Dividend History ...List of ETFs holding HCAT$30.47$17.48$49.85
306.Atara Biotherapeutics (ATRA)$1.14 billion-6.8%Atara Biotherapeutics, Inc., incorporated on August 22, 2012, is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for patients with severe and life-threatening diseases. The Company operates ...See Company Profile ...Dividend History ...List of ETFs holding ATRA$15.35$4.52$19.36
307.Transgenomic (TBIO)$1.1 billion115.48%Transgenomic, Inc. (Transgenomic), incorporated on March 6, 1997, is a biotechnology company. The Company is engaged in advancing personalized medicine for the detection and treatment of cancer, and inherited diseases ...See Company Profile ...Dividend History ...List of ETFs holding TBIO$17.54$6.8$28.09
308.Phreesia (PHR)$1.1 billion9.91%Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company's Phreesia Platform offers a suite of solutions to manage the patient intake process and an integrated payments solution for processing of patient payments. It deploys its platform in a range of modalities, including through Phreesia Mobile, a patients...See Company Profile ...Dividend History ...List of ETFs holding PHR$29.28$16.01$34.85
309.Aimmune Therapeutics (AIMT)$1.1 billion-49.87%Aimmune Therapeutics, Inc., incorporated on June 24, 2011, is a clinical-stage biopharmaceutical company developing a therapeutic approach, including the development of product candidates, for the treatment of peanut and other ...See Company Profile ...Dividend History ...List of ETFs holding AIMT$16.78$10.09$37
310.GenMark Diagnostics (GNMK)$1.1 billion224.12%GenMark Diagnostics, Inc., incorporated on February 12, 2010, is a molecular diagnostics company. The Company is focused on developing and commercializing multiplex molecular tests that aid in the diagnosis of ...See Company Profile ...Dividend History ...List of ETFs holding GNMK$15.59$3.36$15.97
311.Athenex (ATNX)$1.09 billion-12.84%Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of various therapies for the treatment of cancer and related conditions. The company's Orascovery product...See Company Profile ...Dividend History ...List of ETFs holding ATNX$13.31$5.63$21.1
312.The Providence Service (PRSC)$1.07 billion31.23%The Providence Service Corporation (Providence), incorporated on December 20, 1996, is a holding company. The Company, through its subsidiaries, is engaged in the provision of healthcare and workforce development services ...See Company Profile ...Dividend History ...List of ETFs holding PRSC$77.66$40.4$82.43
313.Akero Therapeutics (AKRO)$1.06 billion66.94%Akero Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of transformative treatments for serious metabolic diseases with high unmet medical need. Its lead product candidate is AKR-001, which completed Phase Ib clinical trial for the treatment of non-alcoholic steatohepatitis disease. The company was formerly known as Pippin Pharmaceuticals, Inc...See Company Profile ...Dividend History ...List of ETFs holding AKRO$37.06$10.78$38.63
314.Phibro Animal Health (PAHC)$1.05 billion4.15%Phibro Animal Health Corporation (Phibro), incorporated on January 27, 2014, is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, ...See Company Profile ...Dividend History ...List of ETFs holding PAHC$25.86$16.87$33.97
315.Dermira (DERM)$1.03 billion23.68%Dermira, Inc., incorporated on August 18, 2010, is a biopharmaceutical company. As of December 31, 2016, the Companys portfolio included three late-stage product candidates that target unmet needs and market ...See Company Profile ...Dividend History ...List of ETFs holding DERM$18.75$5.25$19.48
316.Arcturus Therapeutics (ARCT)$1.02 billion356.85%Arcturus Therapeutics Ltd., an RNA medicines company, develops nucleic acid medicines to treat diseases with unmet medical needs. Its RNA therapeutics platforms could be applied in various types of RNA medicine...See Company Profile ...Dividend History ...List of ETFs holding ARCT$49.66$8.49$62.97
317.Meridian Bioscience (VIVO)$1.01 billion141.56%Meridian Bioscience, Inc., incorporated on June 25, 1976, is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic test kits for gastrointestinal, ...See Company Profile ...Dividend History ...List of ETFs holding VIVO$23.6$5.51$24.94
318.BioXcel Therapeutics (BTAI)$1.01 billion242.09%BioXcel Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on novel artificial intelligence-based drug development in the fields of neuroscience and immuno-oncology in the United States. Th...See Company Profile ...Dividend History ...List of ETFs holding BTAI$49.98$3.76$61.5
319.Enanta Pharma (ENTA)$1.01 billion-18.32%Enanta Pharmaceuticals, Inc., incorporated on July 25, 1995, is a research and development-focused biotechnology company. The Company uses chemistry-driven approach and drug discovery solutions to create small molecule drugs for ...See Company Profile ...Dividend History ...List of ETFs holding ENTA$50.46$38.4$89.25
320.Kura Oncology (KURA)$999.52 million30.04%Kura Oncology, Inc., incorporated on November 16, 2007, is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing personalized therapeutics for the treatment of solid tumors and ...See Company Profile ...Dividend History ...List of ETFs holding KURA$17.88$6.35$21.42
321.US Physical Therapy (USPH)$997.2 million-32.1%U.S. Physical Therapy, Inc., incorporated on April 1, 1992, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative ...See Company Profile ...Dividend History ...List of ETFs holding USPH$77.64$45.13$148.48
322.Amphastar Pharma (AMPH)$996.04 million11.77%Amphastar Pharmaceuticals, Inc., incorporated on May 19, 2004, is a specialty pharmaceutical company. The Company focuses primarily on developing, manufacturing, marketing and selling generic and injectable, inhalation and intranasal products. ...See Company Profile ...Dividend History ...List of ETFs holding AMPH$21.56$12.33$22.85
323.Rite Aid (RAD)$994.51 million17.65%Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. It operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy...See Company Profile ...Dividend History ...List of ETFs holding RAD$18.2$5.04$23.88
324.Gossamer Bio (GOSS)$988.33 million-16.57%Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. It is developing GB001, an oral antagonist of prostaglandin D2 receptor 2 that is in Phase IIb clinical trial for the treatment of moderate-to-severe eosinophilic asthma, as we...See Company Profile ...Dividend History ...List of ETFs holding GOSS$13.04$7.52$27.15
325.Tilray (TLRY)$961.44 million-55.05%Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, ...See Company Profile ...Dividend History ...List of ETFs holding TLRY$7.7$2.43$46.67
326.PetIQ (PETQ)$960.98 million35.17%PetIQ, Inc. operates as a pet health and wellness company. It provides veterinarian services and veterinarian-grade pet products, including prescription (Rx) medications, over-the-counter (OTC) flea and tick pr...See Company Profile ...Dividend History ...List of ETFs holding PETQ$33.86$15.83$36.5
327.Dynavax (DVAX)$959.58 million54.2%Dynavax Technologies Corporation (Dynavax), incorporated on November 6, 2000, is a clinical-stage immunotherapy company focused on leveraging the bodys innate and adaptive immune responses through toll-like receptor (TLR) stimulation. The ...See Company Profile ...Dividend History ...List of ETFs holding DVAX$8.82$1.8$9.74
328.Lantheus (LNTH)$958.38 million-30.03%Lantheus Holdings, Inc., incorporated on November 30, 2007, is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and ...See Company Profile ...Dividend History ...List of ETFs holding LNTH$14.35$8.67$29.04
329.Rhythm Pharmaceuticals (RYTM)$956.79 million-5.49%Rhythm Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of peptide therapeutics for the treatment of rare genetic disorders of obesity in the United States. Its peptide candidates include Setmelanotide, a melanocortin-4 receptor agonist, which is in Phase III clinical trial to treat POMC and leptin receptor ...See Company Profile ...Dividend History ...List of ETFs holding RYTM$21.7$12.99$25.86
330.BioCryst Pharma (BCRX)$954.33 million56.81%BioCryst Pharmaceuticals, Inc., incorporated on November 15, 1991, is a biotechnology company. The Company designs, optimizes and develops small molecule drugs that block enzymes involved in the pathogenesis of diseases. ...See Company Profile ...Dividend History ...List of ETFs holding BCRX$5.41$1.38$6.29
331.Achillion Pharma (ACHN)$947.02 million12.11%Achillion Pharmaceuticals, Inc., incorporated on August 5, 1998, is a biopharmaceutical company. The Company is engaged in the discovery and development of small molecule drug therapies for infectious diseases and ...See Company Profile ...Dividend History ...List of ETFs holding ACHN$6.76$2.35$7.01
332.Inmode (INMD)$936.09 million-27.19%InMode Ltd. designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radio frequency technologies. The company offers minimally-invasive aesthetic medical products for procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin re...See Company Profile ...Dividend History ...List of ETFs holding INMD$28.54$13.06$58.76
333.National HealthCare (NHC)$927.45 million-30.13%National HealthCare Corporation (NHC), incorporated on September 26, 1997, is principally engaged in the operation of skilled nursing facilities, assisted living facilities, independent living facilities and homecare programs. The Company ...See Company Profile ...Dividend History ...List of ETFs holding NHC$60.39$55.88$89.55
334.OraSure (OSUR)$924.32 million61.52%OraSure Technologies, Inc. (OraSure), incorporated on May 5, 2000, is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, ...See Company Profile ...Dividend History ...List of ETFs holding OSUR$12.97$5.23$18.27
335.Phathom Pharma (PHAT)$919.91 million1.99%Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. It has the rights in the United States, Europe, and Canada to vonoprazan, a potassium competitive acid blocker (P-CAB) in late clinical-stage development for the treatment of gastric acid-related diseases. The company also provides plans to initi...See Company Profile ...Dividend History ...List of ETFs holding PHAT$31.76$18.51$64.54
336.Vapotherm (VAPO)$906.98 million247.62%Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company offers precision flow systems, such as Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI ...See Company Profile ...Dividend History ...List of ETFs holding VAPO$42.27$6.86$43.3
337.Replimune Group (REPL)$906.71 million56.93%Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development of oncolytic immunotherapies to treat cancer. The company uses its proprietary Immulytic platform to design and develop product candidates that are intended to activate the immune system against cancer. Its lead product candidate is RP1, a selectively replicating version ...See Company Profile ...Dividend History ...List of ETFs holding REPL$22.52$8.58$26.22
338.Retrophin (RTRX)$901.52 million47.11%Retrophin, Inc. (Retrophin), incorporated on February 7, 2008, is a biopharmaceutical company. The Company is focused on the development, acquisition and commercialization of therapies for the treatment of serious, catastrophic ...See Company Profile ...Dividend History ...List of ETFs holding RTRX$20.89$8.98$21.91
339.Myriad Genetics (MYGN)$861.85 million-57.55%Myriad Genetics, Inc. (Myriad), incorporated on November 6, 1992, is a molecular diagnostic company. The Company is engaged in the discovery, development and marketing of transformative molecular diagnostic tests. The ...See Company Profile ...Dividend History ...List of ETFs holding MYGN$11.56$9.24$48.4
340.Heska (HSKA)$852.13 million-5.43%Heska Corporation, incorporated on March 27, 1997, sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products ...See Company Profile ...Dividend History ...List of ETFs holding HSKA$90.73$50$110.9
341.Accelerate Diagnostics (AXDX)$851.72 million-8.82%Accelerate Diagnostics, Inc., incorporated on December 24, 2012, is an in vitro diagnostics company engaged in providing solutions that develop patient outcomes through the diagnosis of serious infections. The Companys ...See Company Profile ...Dividend History ...List of ETFs holding AXDX$15.41$4.53$22.13
342.Vaxart (VXRT)$842.14 million2434.29%Vaxart, Inc., a clinical-stage company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes tablet vaccines that are designed to protect against norovirus, seasonal influenza, and respiratory syncytial virus. It is also developing therapeutic immune-oncology vaccines ...See Company Profile ...Dividend History ...List of ETFs holding VXRT$8.87$0.25$14.3
343.ImmunoGen (IMGN)$840.64 million-5.68%ImmunoGen, Inc., incorporated on March 27, 1981, is a clinical-stage biotechnology company that develops targeted cancer therapeutics using its antibody-drug conjugate (ADC) technology. The Company is engaged in the discovery ...See Company Profile ...Dividend History ...List of ETFs holding IMGN$4.82$1.95$7.07
344.Endo International (ENDP)$831.53 million-22.81%Endo International plc, incorporated on October 31, 2013, is a generics and specialty branded pharmaceutical company. The Company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals and International ...See Company Profile ...Dividend History ...List of ETFs holding ENDP$3.62$1.97$7.1
345.Cara Therapeutics (CARA)$818.93 million8.63%Cara Therapeutics, Inc., incorporated on July 2, 2004, is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing chemical entities designed to alleviate pain and pruritus by ...See Company Profile ...Dividend History ...List of ETFs holding CARA$17.5$8.88$27.55
346.Krystal Biotech (KRYS)$818.68 million-24.81%Krystal Biotech, Inc., a gene therapy company, develops and commercializes pharmaceutical products for patients suffering from dermatological diseases in the United States. The company's lead product candidate ...See Company Profile ...Dividend History ...List of ETFs holding KRYS$41.64$31.89$66.85
347.Inogen (INGN)$806.28 million-46.48%Inogen, Inc., incorporated on November 27, 2001, is a medical technology company. The Company develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients ...See Company Profile ...Dividend History ...List of ETFs holding INGN$36.57$31.21$76.89
348.Cellectis (CLLS)$802.35 million-4.67%Cellectis SA is a France-based company active in the field of genome engineering and genomic surgery. The Company specializes in the research, development and commercialization of rational genome engineering technologies. ...See Company Profile ...Dividend History ...List of ETFs holding CLLS$16.32$7.32$21.97
349.G1 Therapeutics (GTHX)$798.52 million-19.94%G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel small molecule therapeutics for the treatment of patients with cancer in ...See Company Profile ...Dividend History ...List of ETFs holding GTHX$21.16$8.8$41.8
350.Omeros (OMER)$795.86 million3.62%Omeros Corporation, incorporated on June 16, 1994, is a biopharmaceutical company. The Company is engaged in discovering, developing and commercializing small-molecule and protein therapeutics for large-market, as well as orphan ...See Company Profile ...Dividend History ...List of ETFs holding OMER$14.6$8.5$20.92
351.OrthoPediatrics (KIDS)$794.3 million-13.19%OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and in...See Company Profile ...Dividend History ...List of ETFs holding KIDS$40.79$28.19$51.48
352.Provention Bio (PRVB)$791.57 million-5.23%Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics and cutting-edge solutions to intercept and prevent immune-mediated disea...See Company Profile ...Dividend History ...List of ETFs holding PRVB$14.12$4.72$18.5
353.Castle Biosciences (CSTL)$791.44 million18.94%Castle Biosciences, Inc., a commercial-stage dermatological cancer, develops and commercializes diagnostic and prognostic tests for cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify stage I and II patients at high risk of metastasis based on biological information from 31 genes within their tumor tissue. The company also offers DecisionDx-UM test, ...See Company Profile ...Dividend History ...List of ETFs holding CSTL$40.88$15.26$44.53
354.Autolus Therapeutics (AUTL)$787.35 million14.17%Autolus Therapeutics plc, a biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company is developing AUTO1, a CD19-targeting programmed T cell therapy, which is in Phase I tri...See Company Profile ...Dividend History ...List of ETFs holding AUTL$15.07$3$19.34
355.Assembly Biosciences (ASMB)$782.39 million16.86%Assembly Biosciences, Inc. operates as a clinical stage biotechnology company. It develops oral therapeutic candidates for the treatment of hepatitis B virus (HBV) infection and novel class of oral sy...See Company Profile ...Dividend History ...List of ETFs holding ASMB$23.91$8.13$25.07
356.Morphic Holding (MORF)$775.68 million47.49%Morphic Holding, Inc., a biopharmaceutical company, focuses on the discovery and development of oral small-molecule integrin therapeutics. The company's lead product candidates in clinical development are MORF-720, a selective oral avb6 specific integrin inhibitor for the treatment of idiopathic pulmonary fibrosis; and a4b7 specific integrin inhibitors for the treatment of inflammatory bowel disease. I...See Company Profile ...Dividend History ...List of ETFs holding MORF$25.31$9.9$33.5
357.VBI Vaccines (VBIV)$774.98 million143.48%VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines to address unmet needs in infectious disease and immuno-oncology in Israel and internationally. The company offers Sci-B-Vac, a third-generation hepatitis B vaccine for adults, children, and newborns; and eVLP, a vaccine platform for the design of enveloped virus-like particle vaccines ...See Company Profile ...Dividend History ...List of ETFs holding VBIV$3.36$0.47$3.54
358.Stoke Therapeutics (STOK)$760.03 million-18.61%Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops antisense oligonucleotide medicines to treat the underlying causes of severe genetic diseases. Its lead product candidate, STK-001, to treat Dravet syndrome, a severe and progressive genetic epilepsy. Stoke Therapeutics, Inc. has a partnership with Invitae Corporation to offer epilepsy panel testing. The company was formerly k...See Company Profile ...Dividend History ...List of ETFs holding STOK$23.05$15.82$39.04
359.RadNet (RDNT)$757 million-26.01%RadNet, Inc., incorporated on June 19, 2008, is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly ...See Company Profile ...Dividend History ...List of ETFs holding RDNT$15.02$5.81$23.45
360.Kadmon (KDMN)$756.92 million4.42%Kadmon Holdings, Inc., incorporated on September 15, 2010, is an integrated biopharmaceutical company engaged in the discovery, development and commercialization of small molecules and biologics to address disease areas of ...See Company Profile ...Dividend History ...List of ETFs holding KDMN$4.73$2.04$5.5
361.Homology Medicines (FIXX)$750.09 million-19.86%Homology Medicines, Inc., a genetic medicines company, focuses on translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases. Its proprietary platfo...See Company Profile ...Dividend History ...List of ETFs holding FIXX$16.59$11.05$24
362.PetMed Express (PETS)$748.58 million57.82%PetMed Express, Inc. (PetMed Express), doing business as 1800PetMeds, incorporated on January 3, 1997, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products ...See Company Profile ...Dividend History ...List of ETFs holding PETS$37.12$15$41.59
363.Quanterix (QTRX)$742.84 million14.81%Quanterix Corporation, a life sciences company, develops and markets ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics in North America, Euro...See Company Profile ...Dividend History ...List of ETFs holding QTRX$27.13$10.9$33.67
364.Tactile Technology (TCMD)$731.62 million-43.65%Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices for the treatment of chronic diseases in the United States. The company offers proprietary Flexito...See Company Profile ...Dividend History ...List of ETFs holding TCMD$38.04$29.47$71.65
365.Codexis (CDXS)$726.52 million-23.01%Codexis, Inc., incorporated on January 31, 2002, is a developer of biocatalysts for the pharmaceutical and fine chemicals markets. The Companys technologies enable scale-up and implementation of biocatalytic solutions for ...See Company Profile ...Dividend History ...List of ETFs holding CDXS$12.31$8.43$19.07
366.CryoLife (CRY)$726.5 million-28.94%CryoLife, Inc. (CryoLife), incorporated on January 19, 1984, is a medical device manufacturer and processor, and is engaged in the distribution of medical devices and implantable human tissues used in ...See Company Profile ...Dividend History ...List of ETFs holding CRY$19.25$12.63$33
367.Applied Therapeutics (APLT)$716.69 million18.73%Applied Therapeutics, Inc., a biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-001 that is in phase II clinical trials for treating diabetic cardiomyopathy, as well as is in phase I clinical trials to treat diabetic peripheral neuropathy. The company's preclinical stage products include AT-001...See Company Profile ...Dividend History ...List of ETFs holding APLT$32.39$8.09$57.39
368.Aprea Therapeutics (APRE)$715.86 million-25.91%Aprea Therapeutics, Inc., a biopharmaceutical company, develops and commercializes cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its lead product candidate is APR-246, a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes and acute myeloid leukemia. The company was founded in 2006 and is h...See Company Profile ...Dividend History ...List of ETFs holding APRE$34$15.1$53.11
369.Frequency Therapeutics (FREQ)$695.62 million27.95%Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on harnessing the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. Its Progenitor Cell Activation approach, uses combinations of small molecules to activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which has...See Company Profile ...Dividend History ...List of ETFs holding FREQ$22.43$11.17$28.78
370.ZIOPHARM Oncology (ZIOP)$688.93 million-31.89%ZIOPHARM Oncology, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing a portfolio of immuno-oncology therapies for treating heterogenous solid tumors and unknown anti...See Company Profile ...Dividend History ...List of ETFs holding ZIOP$3.22$1.8$7.25
371.Geron (GERN)$679.7 million61.03%Geron Corporation (Geron), incorporated on November 28, 1990, is a biopharmaceutical company, which supports the clinical stage development of a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies by Janssen Biotech, ...See Company Profile ...Dividend History ...List of ETFs holding GERN$2.19$0.75$2.4
372.Agenus (AGEN)$679.11 million-1.72%Agenus Inc., a clinical-stage immuno-oncology company, focuses on the discovery and development of therapies that engage the body's immune system to fight cancer. The company offers Retrocyte Display,...See Company Profile ...Dividend History ...List of ETFs holding AGEN$4$1.82$4.79
373.Oyster Point Pharma (OYST)$678.54 million8.06%Oyster Point Pharma, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ocular surface diseases in the United States. It is involved in developing OC-01, a nicotinic acetylcholine receptor agonist that is in Phase IIb clinical trial to treat the signs and symptoms of dry eye disease, as well as Phase III cl...See Company Profile ...Dividend History ...List of ETFs holding OYST$26.41$13.26$41.37
374.Vericel (VCEL)$662.22 million-15.63%Vericel Corporation (Vericel), formerly Aastrom Biosciences, Inc., incorporated on March 24, 1989, is a commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of therapies that enable the body ...See Company Profile ...Dividend History ...List of ETFs holding VCEL$14.68$6.78$19.95
375.Molecular Templates (MTEM)$658.97 million3.08%Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other diseases. The company primarily dev...See Company Profile ...Dividend History ...List of ETFs holding MTEM$14.41$4.51$19.12
376.Protagonist Therapeutics (PTGX)$654.5 million160.28%Protagonist Therapeutics, Inc., incorporated on August 22, 2006, is a clinical-stage biopharmaceutical company with a peptide technology platform focused on discovering and developing new chemical entities (NECs) to address significant ...See Company Profile ...Dividend History ...List of ETFs holding PTGX$18.35$4.47$19.67
377.Rapt Therapeutics (RAPT)$653.46 million-2.9%RAPT Therapeutics, Inc., a clinical stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. The company develops small molecules that are designed to modulate the critical immune responses underlying these diseases. Its lead oncology drug candidate is FLX4...See Company Profile ...Dividend History ...List of ETFs holding RAPT$26.81$10.52$51.21
378.Radius Health (RDUS)$652.22 million-30.26%Radius Health, Inc., incorporated on February 4, 2008, is a biopharmaceutical company. The Company is focused on the developing therapeutics in the areas of osteoporosis, oncology and endocrine diseases. The ...See Company Profile ...Dividend History ...List of ETFs holding RDUS$14.06$10.32$29.97
379.Cue Biopharma (CUE)$645.81 million42.95%Cue Biopharma, Inc., a biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers and autoimmune disorders. The company's lead drug ca...See Company Profile ...Dividend History ...List of ETFs holding CUE$22.7$6.54$31.69
380.AVROBIO (AVRO)$642.87 million-11.38%AVROBIO, Inc., a clinical stage gene therapy company, focuses on developing ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose. The company's gene therapies employ hematopoie...See Company Profile ...Dividend History ...List of ETFs holding AVRO$17.84$9.76$29.32
381.Eagle Pharma (EGRX)$641.28 million-22%Eagle Pharmaceuticals, Inc., incorporated on January 2, 2007, is a specialty pharmaceutical company. The Company focuses on developing and commercializing injectable products in the critical care and oncology areas. The ...See Company Profile ...Dividend History ...List of ETFs holding EGRX$46.86$33.8$64.94
382.Vanda Pharma (VNDA)$628.97 million-29.74%Vanda Pharmaceuticals Inc., incorporated on November 13, 2002, is a biopharmaceutical company. The Company is focused on the development and commercialization of therapies to address unmet medical needs. Its product ...See Company Profile ...Dividend History ...List of ETFs holding VNDA$11.53$7.12$17.85
383.Ardelyx (ARDX)$624.29 million-6.66%Ardelyx, Inc., incorporated on October 18, 2007, is a clinical-stage biopharmaceutical company. The Companys therapeutics focuses on addressing cardiorenal and gastrointestinal (GI) diseases. The Company operates through the research, development ...See Company Profile ...Dividend History ...List of ETFs holding ARDX$7.01$2.1$8.81
384.Stemline Therapeutics (STML)$621.2 million11.29%Stemline Therapeutics, Inc., incorporated on August 8, 2003, is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing oncology therapeutics. The Company is developing approximately three clinical stage ...See Company Profile ...Dividend History ...List of ETFs holding STML$11.83$3.21$18.22
385.Aerie Pharma (AERI)$618.96 million-44.89%Aerie Pharmaceuticals, Inc., incorporated on June 22, 2005, is a clinical-stage pharmaceutical company. The Company is engaged in the discovery, development and commercialization of therapies for the treatment of patients ...See Company Profile ...Dividend History ...List of ETFs holding AERI$13.32$10.8$26.34
386.AnaptysBio (ANAB)$617.83 million39.38%AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing antibody product candidates focused on unmet medical needs in inflammation. The company's proprietary anti-inflammatory pipeline i...See Company Profile ...Dividend History ...List of ETFs holding ANAB$22.65$10$56.72
387.Quotient (QTNT)$614.35 million-18.3%Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, and commercializes conventional reagent products used for blood grouping in the transfusion diagnostics market worldwi...See Company Profile ...Dividend History ...List of ETFs holding QTNT$7.77$2.4$11.3
388.Trillium Therapeutics (TRIL)$613.02 million607.77%Trillium Therapeutics Inc., a clinical-stage immuno-oncology company, develops therapies for the treatment of cancer. The company's lead program is TTI-621, a SIRPaFc fusion protein that acts a soluble decoy receptor preventing CD47 from delivering its inhibitory signal, which is in Phase I clinical trial for advanced hematologic malignancies, and solid ...See Company Profile ...Dividend History ...List of ETFs holding TRIL$7.29$0.24$9.66
389.Atreca (BCEL)$595.93 million36.59%Atreca, Inc., a biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-101 product candidate reacts in vitro with a maj...See Company Profile ...Dividend History ...List of ETFs holding BCEL$21.13$9.51$29.35
390.MiMedx (MDXG)$595.78 million-28.76%MiMedx Group, Inc. (MiMedx), incorporated on February 28, 2008, is an integrated developer, processor and marketer of regenerative biomaterial products and bioimplants human placental tissue, skin and bone. The Company ...See Company Profile ...Dividend History ...List of ETFs holding MDXG$5.4$2.95$7.95
391.Kala Pharmaceuticals (KALA)$595.6 million189.7%Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies using its proprietary nanoparticle-based Mucus Penetrating Particles (MPP) technology for t...See Company Profile ...Dividend History ...List of ETFs holding KALA$10.69$3.24$14.68
392.Orthofix International (OFIX)$587.79 million-33.72%Orthofix International N.V. (Orthofix), incorporated on October 19, 1987, is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. ...See Company Profile ...Dividend History ...List of ETFs holding OFIX$30.61$22.11$55.17
393.Collegium Pharmaceutical (COLL)$585.77 million-17.1%Collegium Pharmaceutical, Inc., incorporated on July 01, 2014, is a specialty pharmaceutical company. The Company is engaged in developing and commercializing abuse-deterrent products that incorporate its DETERx platform technology for ...See Company Profile ...Dividend History ...List of ETFs holding COLL$17.06$10.01$25.59
394.Pacific Biosciences of California (PACB)$583.92 million-26.26%Pacific Biosciences of California, Inc., incorporated on July 14, 2000, designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. The Company is engaged in the development, ...See Company Profile ...Dividend History ...List of ETFs holding PACB$3.79$2.2$6.07
395.Surgery Partners (SGRY)$583 million-26.71%Surgery Partners, Inc., incorporated on April 2, 2015, is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services ...See Company Profile ...Dividend History ...List of ETFs holding SGRY$11.47$4$19.74
396.Corbus Pharma (CRBP)$582.1 million47.07%Corbus Pharmaceuticals Holdings, Inc., incorporated on December 18, 2013, is a clinical-stage pharmaceutical company. The Company is focused on the development and commercialization of therapeutics to treat rare, chronic and ...See Company Profile ...Dividend History ...List of ETFs holding CRBP$8.03$3.29$8.78
397.Varex Imaging (VREX)$581.42 million-50.12%Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, computer-aided diagnostic software, collimators, automatic exposur...See Company Profile ...Dividend History ...List of ETFs holding VREX$14.87$14.27$33
398.Clovis Oncology (CLVS)$578.98 million-36.91%Clovis Oncology, Inc., incorporated on April 20, 2009, is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and other international markets. The ...See Company Profile ...Dividend History ...List of ETFs holding CLVS$6.58$2.93$17.37
399.Surmodics (SRDX)$573.19 million1.67%Surmodics, Inc., incorporated on June 27, 1979, is a provider of medical device and in vitro diagnostic technologies to the healthcare industry. The Company operates through two segments: Medical Device ...See Company Profile ...Dividend History ...List of ETFs holding SRDX$42.12$22.06$49
400.Crinetics Pharmaceuticals (CRNX)$565.6 million-31.37%Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. I...See Company Profile ...Dividend History ...List of ETFs holding CRNX$17.22$10.63$26.67
401.Syndax Pharma (SNDX)$557.31 million75.85%Syndax Pharmaceuticals, Inc., incorporated on October 11, 2005, is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The Company?ÇÖs product candidate, ...See Company Profile ...Dividend History ...List of ETFs holding SNDX$15.44$5.35$21.97
402.Tivity Health (TVTY)$557.11 million-43.51%Tivity Health, Inc., formerly Healthways, Inc., incorporated on September 2, 1981, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, ...See Company Profile ...Dividend History ...List of ETFs holding TVTY$11.49$1.92$26.07
403.Athersys (ATHX)$541.16 million123.58%Athersys, Inc., incorporated on June 7, 2005, is an international biotechnology company that is focused primarily in the field of regenerative medicine. The Companys MultiStem cell therapy, an allogeneic stem ...See Company Profile ...Dividend History ...List of ETFs holding ATHX$2.75$1.13$4.38
404.LeMaitre Vascular (LMAT)$536.63 million-26.04%LeMaitre Vascular, Inc., incorporated on June 15, 1998, is a provider of medical devices for the treatment of peripheral vascular disease. The Company develops, manufactures and markets medical devices and ...See Company Profile ...Dividend History ...List of ETFs holding LMAT$26.59$18.76$38.64
405.UroGen Pharma (URGN)$534.12 million-27.03%UroGen Pharma Ltd., a clinical stage biopharmaceutical company, focuses on developing novel therapies for urological pathologies. Its lead product candidates, MitoGel and VesiGel are proprietary formulations of the chemotherapy drug Mitomycin C, a generic drug, which is currently used off-label for urothelial cancer treatment in a water-based formulation as an ...See Company Profile ...Dividend History ...List of ETFs holding URGN$24.35$13.12$37.08
406.Syros Pharma (SYRS)$528.67 million67.44%Syros Pharmaceuticals, Inc., incorporated on November 9, 2011, is a biopharmaceutical company. The Company offers a gene control platform designed to analyze the unexploited region of deoxyribonucleic acid (DNA) in ...See Company Profile ...Dividend History ...List of ETFs holding SYRS$11.57$4.26$12.39
407.AC Immune SA (ACIU)$523.14 million-14.55%AC Immune Ltd is a Switzerland-based company engaged in the medical biotechnology sector. It develops treatments for Alzheimers and other neurodegenerative diseases, such as Down syndrome, glaucoma and Parkinsons, and ...See Company Profile ...Dividend History ...List of ETFs holding ACIU$7.28$4.07$10.14
408.Prevail Therapeutics (PRVL)$519.18 million-4.11%Prevail Therapeutics Inc., a gene therapy company, focuses on developing and commercializing disease-modifying AAV-based gene therapies for patients with devastating neurodegenerative diseases. The company's lead product candidate is PR001 for the treatment of Parkinson's disease with GBA1 mutation and neuronopathic Gaucher disease. It is also developing PR006 for the treatment of frontotemporal dement...See Company Profile ...Dividend History ...List of ETFs holding PRVL$15.18$7.41$19.96
409.Catalyst Pharma (CPRX)$519.14 million33.87%Catalyst Pharmaceuticals, Inc., formerly Catalyst Pharmaceutical Partners, Inc., incorporated on July 21, 2006, is a development-stage biopharmaceutical company. The Company is focused on developing and commercializing therapies for people with ...See Company Profile ...Dividend History ...List of ETFs holding CPRX$5.02$2.55$7.67
410.Cel-Sci (CVM)$518.6 million50.6%CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and other diseases. The company's lead investigational immunotherapy is Multikine, which is und...See Company Profile ...Dividend History ...List of ETFs holding CVM$13.78$5.8$18
411.Anika Therapeutics (ANIK)$512.56 million-30.4%Anika Therapeutics, Inc., incorporated on February 28, 1992, is an orthopedic medicines company. The Company is engaged in developing, manufacturing and commercializing products based on its hyaluronic acid (HA) technology. ...See Company Profile ...Dividend History ...List of ETFs holding ANIK$36.09$22.01$75.72
412.Nextcure (NXTC)$511.82 million-66.98%NextCure, Inc., a biopharmaceutical company, engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase Iu002FII clinical trials for the treatment of advanced or metastatic solid tumors. The company is also developing NC410, is a novel immunomedicine designed to block...See Company Profile ...Dividend History ...List of ETFs holding NXTC$18.6$16.04$109
413.Innate Pharma Sa (IPHA)$510.34 million0.47%Innate Pharma S.A., a clinical-stage biotechnology company, discovers and develops therapeutic antibodies for the treatment of cancer in France and internationally. The company offers IPH4102, an anti-KIR3DL2 humanized cytotoxicity-inducing antibody, which is in Phase II clinical trial for cutaneous T-cell lymphomas; Monalizumab, an immune checkpoint inhibitor that is in Phase II clinical trial to trea...See Company Profile ...Dividend History ...List of ETFs holding IPHA$6.47$3.3$8.24
414.Scholar Rock Holding (SRRK)$509.05 million29.29%Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of various medicines for the treatment of serious diseases in which signaling by protein growth factors pl...See Company Profile ...Dividend History ...List of ETFs holding SRRK$17.04$6.95$21.92
415.Orchard Therapeutics (ORTX)$507.72 million-62.04%Orchard Therapeutics plc, integrated biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases. The company's gene therapy approach seeks to transform a patient's hematop...See Company Profile ...Dividend History ...List of ETFs holding ORTX$5.22$5.17$17.48
416.DBV (DBVT)$506.51 million-57.29%DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy ...See Company Profile ...Dividend History ...List of ETFs holding DBVT$4.57$2.02$13.49
417.Brookdale Senior Living (BKD)$500.04 million-62.45%Brookdale Senior Living Inc., incorporated on June 28, 2005, operates senior living communities in the United States. The Company operates independent living, assisted living and dementia-care communities and continuing care ...See Company Profile ...Dividend History ...List of ETFs holding BKD$2.73$1.47$8.8
418.Viking Therapeutics (VKTX)$499.46 million-14.21%Viking Therapeutics, Inc., incorporated on October 24, 2012, is a clinical-stage biopharmaceutical company. The Company focuses on the development of therapies for metabolic and endocrine disorders. The Companys clinical program, ...See Company Profile ...Dividend History ...List of ETFs holding VKTX$6.88$3.26$8.87
419.Fulcrum Therapeutics (FULC)$494.89 million8.53%Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule that are developing for the treatment of facioscapulohumeral muscular dystrophy, a rare, progressive, and disabling muscle wasting disord...See Company Profile ...Dividend History ...List of ETFs holding FULC$18.06$4.37$22.96
420.Mirum Pharmaceuticals (MIRM)$494.09 million-20.64%Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its lead product candidate is maralixibat, an investigational oral drug for the treatment of Alagille syndrome (ALGS), progressive familial intrahepatic cholestasis (PFIC), and biliary atresia disease (BA). The company is...See Company Profile ...Dividend History ...List of ETFs holding MIRM$19.46$6.51$28.31
421.Rubius Therapeutics (RUBY)$493.32 million-35.47%Rubius Therapeutics, Inc. focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases through its rubius erythrocyte design cellular therapy platform. The company is developing various RCTs, such as RTX-134 for treatment of classic and moderate phenylketonuria; RTX-Uricase 002FURAT1 for treatment of chronic ...See Company Profile ...Dividend History ...List of ETFs holding RUBY$6.13$3.35$16.16
422.Co-Diagnostics (CODX)$492.58 million1893.33%Co-Diagnostics, Inc., a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and or analysis of nucleic acid molecules. It also ...See Company Profile ...Dividend History ...List of ETFs holding CODX$17.94$0.81$29.72
423.BioSpecifics (BSTC)$489.98 million17.16%BioSpecifics Technologies Corp. (BioSpecifics), incorporated on November 1, 1990, is a biopharmaceutical company. The Company is engaged in the development of an injectable collagenase clostridium histolyticum (CCH) for multiple indications. ...See Company Profile ...Dividend History ...List of ETFs holding BSTC$66.71$42$69.51
424.Celldex Therapeutics (CLDX)$488.07 million463.68%Celldex Therapeutics, Inc., incorporated on December 9, 1983, is a biopharmaceutical company. The Company is focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer ...See Company Profile ...Dividend History ...List of ETFs holding CLDX$12.57$1.5$13.91
425.Satsuma Pharma (STSA)$486.9 million42.28%Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops a novel therapeutic product for the acute treatment of migraine. Its product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in Phase III clinical trials and can be self-administered with a proprietary pre-filled single-use nasal delivery dev...See Company Profile ...Dividend History ...List of ETFs holding STSA$28$8.61$36.1
426.Voyager Therapeutics (VYGR)$486.45 million-6.24%Voyager Therapeutics, Inc., incorporated on June 19, 2013, is a clinical-stage gene therapy company. The Company focuses on developing treatments for patients suffering from severe diseases of the central nervous ...See Company Profile ...Dividend History ...List of ETFs holding VYGR$13.08$6.26$27.5
427.Aptose Biosciences (APTO)$486.05 million11.99%Aptose Biosciences Inc. (Aptose), incorporated on November 1, 2006, is a clinical-stage biotechnology company. The Company is engaged in the development of anticancer drugs that target specific epigenetic processes and ...See Company Profile ...Dividend History ...List of ETFs holding APTO$6.35$1.82$9.25
428.BeyondSpring (BYSI)$485.65 million4.06%BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on the development of cancer therapies. The company is advancing its lead asset, Plinabulin, into a Phase 2 3 clinical trial for the r...See Company Profile ...Dividend History ...List of ETFs holding BYSI$16.13$9.38$23
429.Owens and Minor (OMI)$476.34 million46.23%Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare services company in the United States, the United Kingdom, Ireland, France, Germany, and other European countries. It oper...See Company Profile ...Dividend History ...List of ETFs holding OMI$7.56$2.43$9.69
430.Flexion Therapeutics (FLXN)$474.71 million-40.53%Flexion Therapeutics, Inc., incorporated on November 5, 2007, is a specialty pharmaceutical company. The Company is focused on the development and commercialization of therapies for the treatment of patients with ...See Company Profile ...Dividend History ...List of ETFs holding FLXN$12.31$5.01$22.98
431.Ocular Therapeutix (OCUL)$471.43 million90.13%Ocular Therapeutix, Inc., incorporated on September 12, 2006, is a biopharmaceutical company. The Company is focused on the development and commercialization of therapies for diseases and conditions of the eye ...See Company Profile ...Dividend History ...List of ETFs holding OCUL$7.51$2.46$9.24
432.SIGA Technologies (SIGA)$470.08 million21.59%SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security markets in the United States. Its lead product is TPOXX, an orally administered antiviral drug for the treatmen...See Company Profile ...Dividend History ...List of ETFs holding SIGA$5.8$3.96$6.32
433.Centogene NV (CNTG)$468.33 million134.16%Centogene B.V. operates as a commercial-stage rare disease company worldwide. It focuses on transforming clinical and genetic data into medical solutions for patients, physicians, and pharmaceutical companies. The company develops rare disease platform, a data repository, which includes epidemiologic, phenotypic, and heterogenetic data that enhances methods for identifying and monitoring rare hereditar...See Company Profile ...Dividend History ...List of ETFs holding CNTG$23.58$7.8$28.71
434.Xenon Pharma (XENE)$466.9 million1.83%Xenon Pharmaceuticals Inc. (Xenon), incorporated on May 17, 2000, is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing a pipeline of differentiated therapeutics for orphan indications. ...See Company Profile ...Dividend History ...List of ETFs holding XENE$13.35$7$18.45
435.Transmedics Group (TMDX)$465.23 million-9.73%Transmedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor ...See Company Profile ...Dividend History ...List of ETFs holding TMDX$17.16$10.1$27.42
436.BioLife (BLFS)$456.9 million8.65%BioLife Solutions, Inc. (BioLife), incorporated on March 25, 1998, is engaged in developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical ...See Company Profile ...Dividend History ...List of ETFs holding BLFS$17.58$7.37$21.18
437.89Bio (ETNB)$455.89 million25.71%89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate, BIO89-100, a glycoPEGylated analog of fibroblast growth factor 21 that is being developed for the treatment of nonalcoholic steatohepatitis. The company also intends to develop BIO89-100 for the treat...See Company Profile ...Dividend History ...List of ETFs holding ETNB$33.05$14$47.25
438.Intersect ENT (XENT)$452.25 million-44.22%Intersect ENT, Inc., incorporated on October 6, 2003, is a commercial-stage drug-device company. The Company develops drugs for patients with ear, nose and throat (ENT) conditions. The Company has developed ...See Company Profile ...Dividend History ...List of ETFs holding XENT$13.89$5.97$31.46
439.Personalis (PSNL)$451.56 million30.64%Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies. It offers NeXT Platform, which provides data for cancer therapy development, personalized therapies, therapy selection, and diagnostics. The company also provides a complementary liquid biopsy assay that analyzes various human genes...See Company Profile ...Dividend History ...List of ETFs holding PSNL$14.24$4.27$25.64
440.Merus (MRUS)$450.14 million10.09%Merus NV is a biotechnology company based in the Netherlands. The Company develops differentiating therapeutics for cancer patients. The product programs in the Merus pipeline are based on the Biclonics ...See Company Profile ...Dividend History ...List of ETFs holding MRUS$15.5$10.19$20.95
441.Avadel Pharma (AVDL)$449.34 million2.38%Avadel Pharmaceuticals, PLC is a specialty pharmaceutical company. The Company offers various drug delivery platforms, including Micropump, LiquiTime, Trigger Lock and Medusa. Micropump is a microparticulate system that allows the ...See Company Profile ...Dividend History ...List of ETFs holding AVDL$7.73$1.82$13.49
442.SI-BONE (SIBN)$448.58 million-26.6%SI-BONE, Inc., a medical device company, develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. It offers iFuse, an implant system to fuse...See Company Profile ...Dividend History ...List of ETFs holding SIBN$15.78$7.2$23.1
443.Antares Pharma (ATRS)$447.01 million-42.55%Antares Pharma, Inc. (Antares), incorporated on April 29, 2005, is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The Company develops, manufactures ...See Company Profile ...Dividend History ...List of ETFs holding ATRS$2.7$1.6$5.13
444.MeiraGTx (MGTX)$443.49 million-40.71%MeiraGTx Holdings plc, an integrated clinical stage gene therapy company, develops various gene therapy products for the lives of patients suffering from acquired and inherited disorders. The company focuses on...See Company Profile ...Dividend History ...List of ETFs holding MGTX$11.87$8.82$30.23
445.Catasys (CATS)$441.67 million59.1%Catasys, Inc. provides big data predictive analytics, artificial intelligence and telehealth, combined with human intervention services to health plans and other third party payors. It offers OnTrak solution to...See Company Profile ...Dividend History ...List of ETFs holding CATS$25.95$8.55$32.55
446.AxoGen (AXGN)$437.78 million-38.46%AxoGen, Inc., incorporated on June 20, 1977, offers surgical solutions for peripheral nerve injuries. The Company provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. Its ...See Company Profile ...Dividend History ...List of ETFs holding AXGN$11.01$7.16$22.1
447.BioDelivery Sciences Intl (BDSI)$436.72 million-31.01%BioDelivery Sciences International, Inc., incorporated on April 18, 2002, is a specialty pharmaceutical company. The Company develops and commercializes, either on its own or in partnerships with third parties, applications ...See Company Profile ...Dividend History ...List of ETFs holding BDSI$4.36$2.85$7.21
448.Precision Biosciences (DTIL)$429.41 million-40.39%Precision BioSciences, Inc. operates as a genome editing company and develops therapeutic products in the United States. It operates through two segments, Therapeutic and Food. The company offers ARCUS, a genome editing platform to cure cancers and genetic disorders. The Therapeutic segment develops allogeneic CAR T immunotherapy that recognizes and kills cancer cells; and engages in the in vivo gene c...See Company Profile ...Dividend History ...List of ETFs holding DTIL$8.28$4.6$23.67
449.Prothena (PRTA)$427.05 million-32.41%Prothena Corporation Public Limited Company, incorporated on September 26, 2012, is a global biotechnology company. The Company is focused on the discovery, development and commercialization of immunotherapies for the treatment ...See Company Profile ...Dividend History ...List of ETFs holding PRTA$10.7$6.71$17.63
450.Magenta Therapeutics (MGTA)$426 million-41.75%Magenta Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing medicines to bring the curative power of bone marrow transplant to patients. It is developing C100, C200, and C300 t...See Company Profile ...Dividend History ...List of ETFs holding MGTA$8.83$5.76$16.19
451.Puma Biotechnology (PBYI)$425.53 million23.54%Puma Biotechnology, Inc., incorporated on September 15, 2010, is a biopharmaceutical company that focuses on the development and commercialization of products for the treatment of cancer. The Company focuses on ...See Company Profile ...Dividend History ...List of ETFs holding PBYI$10.81$5.5$15
452.DURECT (DRRX)$425.1 million-42.89%Durect Corporation, incorporated on February 6, 1998, is a biopharmaceutical company with research and development programs. The Companys research and development programs fall into two categories: new chemical entities derived ...See Company Profile ...Dividend History ...List of ETFs holding DRRX$2.17$0.64$3.95
453.XBiotech (XBIT)$422.41 million-21.59%XBiotech Inc., incorporated on September 23, 2005, is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing True Human monoclonal antibodies for treating a range of different ...See Company Profile ...Dividend History ...List of ETFs holding XBIT$14.64$6.84$26.4
454.Establishment Labs (ESTA)$417.59 million-35.29%Establishment Labs Holdings Inc., a medical technology company, designs, develops, manufactures, and markets medical devices for aesthetic plastic surgery, reconstructive plastic surgery, and aesthetic dermatol...See Company Profile ...Dividend History ...List of ETFs holding ESTA$17.9$7.56$29.78
455.TherapeuticsMD (TXMD)$415.68 million-36.78%TherapeuticsMD, Inc., incorporated on July 20, 2010, is a womens healthcare company, which is engaged in creating and commercializing products for women. The Company is focused on pursuing the regulatory ...See Company Profile ...Dividend History ...List of ETFs holding TXMD$1.53$0.85$4.32
456.Harpoon Therapeutics (HARP)$413.97 million11.97%Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company's lead TriTAC product candidate is HPN424 that is in Phase I clinical trial for the treatment of metastatic castration-resistant p...See Company Profile ...Dividend History ...List of ETFs holding HARP$16.56$10.27$25.02
457.Seres Therapeutics (MCRB)$409.46 million63.48%Seres Therapeutics, Inc., incorporated on October 18, 2010, is a microbiome therapeutics platform company. The Company is engaged in developing a class of biological drugs, which is referred as Ecobiotic ...See Company Profile ...Dividend History ...List of ETFs holding MCRB$5.64$2.15$6.59
458.Ovid Therapeutics (OVID)$408.47 million79.76%Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate wh...See Company Profile ...Dividend History ...List of ETFs holding OVID$7.46$1.74$9.4
459.Aeglea BioTherapeutics (AGLE)$405.8 million19.11%Aeglea BioTherapeutics, Inc., incorporated on December 16, 2013, is a biotechnology company. The Company is engaged in the development of enzyme-based therapeutics in the field of amino acid metabolism to ...See Company Profile ...Dividend History ...List of ETFs holding AGLE$9.1$3.5$11.38
460.Spectrum Pharma (SPPI)$402.4 million-5.08%Spectrum Pharmaceuticals, Inc., incorporated on November 18, 2002, is a biotechnology company. The Company operates through developing and commercializing oncology and hematology drug products segment. It has a product portfolio ...See Company Profile ...Dividend History ...List of ETFs holding SPPI$3.46$1.74$10.57
461.Vermillion (VRML)$400.75 million393.83%Vermillion, Inc., incorporated on May 23, 2000, is a diagnostic service and bio-analytic solutions provider. The Company is engaged in the business of developing and commercializing diagnostic tests for gynecologic ...See Company Profile ...Dividend History ...List of ETFs holding VRML$4$0.35$5.78
462.Fulgent Genetics (FLGT)$399.24 million42.64%Fulgent Genetics, Inc. is a technology company. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. The Company has developed ...See Company Profile ...Dividend History ...List of ETFs holding FLGT$18.4$5.95$20.6
463.Unity Biotechnology (UBX)$398.06 million12.34%Unity Biotechnology, Inc., a preclinical biotechnology company, engages in the research and development of therapeutics to extend human health span. The company's lead drug candidates include UBX0101 for musculoskeletal disease with an initial focus on osteoarthritis; and UBX1967 for ophthalmologic diseases. It is also developing programs in pulmonary disorders. The ...See Company Profile ...Dividend History ...List of ETFs holding UBX$8.1$4.62$10.38
464.Avid Bioservices (CDMO)$389.93 million-10.04%Avid Bioservices, Inc., a biologics contract development and manufacturing company, focuses on the development and current Good Manufacturing Practices (cGMP) manufacture of biopharmaceutical products derived f...See Company Profile ...Dividend History ...List of ETFs holding CDMO$6.9$3.02$8.38
465.MannKind (MNKD)$385.78 million40.31%MannKind Corporation (MannKind), incorporated on February 14, 1991, is a biopharmaceutical company. The Company is focused on the discovery and development of therapeutic products for diseases, such as diabetes. The ...See Company Profile ...Dividend History ...List of ETFs holding MNKD$1.81$0.8$2.48
466.AngioDynamics (ANGO)$383.17 million-36.54%AngioDynamics, Inc., incorporated on July 30, 1992, designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment ...See Company Profile ...Dividend History ...List of ETFs holding ANGO$10.16$7.48$22.09
467.Albireo Pharma (ALBO)$383.03 million0.59%Albireo Pharma, Inc., formerly Biodel Inc., incorporated on December 8, 2003, is a specialty biopharmaceutical company. The Company is focused on the development and commercialization of bile acid modulators to ...See Company Profile ...Dividend History ...List of ETFs holding ALBO$25.57$11.26$31.99
468.Community Health (CYH)$382.93 million10.34%Community Health Systems, Inc., incorporated on June 6, 1996, is an operator of general acute care hospitals and outpatient facilities in communities across the country. The Company operates through hospital ...See Company Profile ...Dividend History ...List of ETFs holding CYH$3.2$1.79$7.47
469.Organogenesis (ORGO)$379.87 million-25.57%Organogenesis Holdings Inc., a regenerative medicine company, focuses on the development, manufacture, and commercialization of solutions for the advanced wound care, and surgical and sports medicine markets in...See Company Profile ...Dividend History ...List of ETFs holding ORGO$3.58$2.47$8.34
470.China Cord Blood (CO)$379.24 million-37.6%Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, pr...See Company Profile ...Dividend History ...List of ETFs holding CO$3.12$2.54$5.9
471.ANI Pharma (ANIP)$378 million-50.33%ANI Pharmaceuticals, Inc., incorporated on April 11, 2001, is an integrated specialty pharmaceutical company. The Company is engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The Company ...See Company Profile ...Dividend History ...List of ETFs holding ANIP$30.63$28.28$86.96
472.CytomX Therapeutics (CTMX)$377.95 million-0.96%CytomX Therapeutics, Inc., incorporated on September 16, 2010, is a clinical-stage, oncology-focused biopharmaceutical company. The Company uses its Probody technology platform to create cancer immunotherapies against clinically validated targets, as ...See Company Profile ...Dividend History ...List of ETFs holding CTMX$8.23$3.6$15.44
473.Osmotica Pharmaceuticals (OSMT)$376.95 million-8.44%Osmotica Pharmaceuticals plc, an integrated biopharmaceutical company, develops, manufactures, and commercializes specialty products that target markets with underserved patient populations. The company's promo...See Company Profile ...Dividend History ...List of ETFs holding OSMT$6.4$2.7$7.97
474.Calithera Biosciences (CALA)$373.35 million-7.18%Calithera Biosciences, Inc., incorporated on March 9, 2010, is a clinical-stage pharmaceutical company. The Company focuses on discovering and developing small molecule drugs directed against tumor and immune cell targets ...See Company Profile ...Dividend History ...List of ETFs holding CALA$5.3$2.45$8.18
475.Brainstorm Cell Therapeutics (BCLI)$367.42 million191.59%Brainstorm Cell Therapeutics Inc., incorporated on November 15, 2006, is a biotechnology company. The Company is engaged in developing adult stem cell therapies for debilitating neurodegenerative disorders, such as Amyotrophic ...See Company Profile ...Dividend History ...List of ETFs holding BCLI$12.48$3.43$13.61
476.Kamada (KMDA)$366.98 million21.23%Kamada Ltd. develops, produces, and markets specialty plasma-derived protein therapeutics. It operates through two segments, Proprietary Products and Distribution. The company offers respiratory products, inclu...See Company Profile ...Dividend History ...List of ETFs holding KMDA$8.28$4.4$9.91
477.Ideaya Biosciences (IDYA)$365.94 million80.27%IDEAYA Biosciences, Inc., an oncology-focused precision medicine company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's product candidate in clinical development is IDE196, a protein kinase C inhibitor for genetically-defined cancers having GNAQ or GNA11 gene mutations. Its preclinical pipeline includes vari...See Company Profile ...Dividend History ...List of ETFs holding IDYA$13.52$2.95$19.97
478.Cytosorbents (CTSO)$365.21 million161.82%CytoSorbents Corporation, incorporated on April 25, 2002, is a critical care focused immunotherapy company. The Company is engaged in commercializing its product, CytoSorb, which is a blood purification technology with ...See Company Profile ...Dividend History ...List of ETFs holding CTSO$10.08$3.49$11.24
479.Tcr2 Therapeutics (TCRR)$364.27 million5.95%TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, develops novel T cell receptor therapies for patients suffering from cancer. The company's lead product candidates include TC-210, mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which initiated in phase Iu002FII clinical trial for the treatment of non-small cell lung cancer (NSCLC), ovarian can...See Company Profile ...Dividend History ...List of ETFs holding TCRR$15.13$5.84$21.06
480.MEI Pharma (MEIP)$363.58 million38.31%MEI Pharma, Inc., a pharmaceutical company, focuses on the clinical development of novel therapies for the treatment of cancer. The company's clinical drug candidate includes Pracinostat, an oral avai...See Company Profile ...Dividend History ...List of ETFs holding MEIP$3.43$0.72$4.46
481.Health Insurance Innovations (HIIQ)$363.05 million41.99%Health Insurance Innovations, Inc., incorporated on October 26, 2012, is a developer, distributor and cloud-based administrator of individual and family health insurance plans (IFPs) and supplemental products, which include short-term ...See Company Profile ...Dividend History ...List of ETFs holding HIIQ$27.39$15.6$35
482.Progenics Pharma (PGNX)$355.05 million-19.45%Progenics Pharmaceuticals, Inc., incorporated on December 1, 1986, is engaged in developing medicines and other products for targeting and treating cancer. The Companys pipeline includes therapeutic agents designed to target ...See Company Profile ...Dividend History ...List of ETFs holding PGNX$4.1$1.89$6.37
483.Oxford Immunotec Global (OXFD)$345.08 million-19.88%Oxford Immunotec Global PLC, incorporated on August 16, 2013, is a diagnostics company. The Company is focused on developing and commercializing tests for under-served immune-regulated conditions. The Companys product lines ...See Company Profile ...Dividend History ...List of ETFs holding OXFD$13.3$8.37$17.77
484.WAVE Life Sciences (WVE)$344.46 million20.2%WAVE Life Sciences Ltd. is a genetic medicines company. The Company, through its synthetic chemistry drug development platform, designs, develops and commercializes a pipeline of nucleic acid therapeutic candidates for ...See Company Profile ...Dividend History ...List of ETFs holding WVE$9.64$6.61$39.98
485.Affimed (AFMD)$334.74 million60.22%Affimed N.V., incorporated on May 1, 2014, is a clinical-stage biopharmaceutical company focused on discovering and developing cancer immunotherapies. The Companys product candidates are developed in the field of immuno-oncology, ...See Company Profile ...Dividend History ...List of ETFs holding AFMD$4.39$1.42$4.79
486.PDL BioPharma (PDLI)$334.5 million-11.54%PDL BioPharma, Inc., incorporated on July 24, 1986, seeks to provide return for its shareholders by acquiring and managing a portfolio of companies, products, royalty agreements and debt facilities in ...See Company Profile ...Dividend History ...List of ETFs holding PDLI$2.88$2.06$3.86
487.Rigel Pharma (RIGL)$320.28 million-11.21%Rigel Pharmaceuticals, Inc., incorporated on June 14, 1996, is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of targeted drugs in the therapeutic areas of ...See Company Profile ...Dividend History ...List of ETFs holding RIGL$1.9$1.23$3.1
488.Cellular Biomedicine (CBMG)$318.41 million1.11%Cellular Biomedicine Group, Inc. (CBMG), incorporated on January 18, 2013, is a biomedicine company. The Company is engaged in the development of treatments for cancerous and degenerative diseases utilizing cell-based ...See Company Profile ...Dividend History ...List of ETFs holding CBMG$16.42$10.98$18.99
489.BiondVax Pharma (BVXV)$315.76 million229.3%BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company. The Company holds a worldwide exclusive license granted by Yeda Research and Development Ltd., the commercial arm of the Weizmann Institute, Israel, ...See Company Profile ...Dividend History ...List of ETFs holding BVXV$30.79$5.2$33.5
490.ViewRay (VRAY)$315.43 million-49.29%ViewRay, Inc., incorporated on October 6, 2013, through its subsidiary ViewRay Technologies, Inc., designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat ...See Company Profile ...Dividend History ...List of ETFs holding VRAY$2.14$1.11$9.76
491.Fluidigm (FLDM)$313.23 million27.3%Fluidigm Corporation, incorporated on March 29, 2007, creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial ...See Company Profile ...Dividend History ...List of ETFs holding FLDM$4.43$1.17$12.26
492.Utah Medical Products (UTMD)$311.5 million-20.74%Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry worldwide. The company offers fetal monitoring accessories, vacuum-assisted delivery sys...See Company Profile ...Dividend History ...List of ETFs holding UTMD$85.52$75.33$112.26
493.Urovant Sciences (UROV)$310.15 million-35.07%Urovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for urologic conditions. It is developing vibegron, an oral, once-daily, small molecule beta-3 agonist that is in Phase III trials for the treatment of overactive bladder (OAB) and OAB in men with benign prostatic hyperplasia; and in ...See Company Profile ...Dividend History ...List of ETFs holding UROV$10.07$6.55$15.98
494.Sutro Biopharma (STRO)$301.38 million-23.64%Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-f...See Company Profile ...Dividend History ...List of ETFs holding STRO$8.4$6$12.75
495.Neptune and Bioresources (NEPT)$297.07 million8.73%Neptune Technologies & Bioressources Inc. is a solution provider of omega-3s and other functional ingredients to branded marketers in the nutraceutical industry, primarily in North America. The Company is engaged ...See Company Profile ...Dividend History ...List of ETFs holding NEPT$2.99$0.96$6.57
496.Liquidia Technologies (LQDA)$297.07 million83.88%Liquidia Technologies, Inc., a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of human therapeutics. Its lead product candidate, LIQ861, an inhaled dry powder fo...See Company Profile ...Dividend History ...List of ETFs holding LQDA$7.87$2.65$12.1
497.Concert Pharma (CNCE)$296.24 million8.23%Concert Pharmaceuticals, Inc., incorporated on April 12, 2006, is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of small molecule drugs. The Company operates through ...See Company Profile ...Dividend History ...List of ETFs holding CNCE$9.99$5.36$13.09
498.Alphatec (ATEC)$291.1 million-35.9%Alphatec Holdings, Inc., incorporated on March 4, 2005, is a medical technology company. The Company through its subsidiary, Alphatec Spine, Inc. and its subsidiaries (Alphatec Spine), designs, develops, manufactures and ...See Company Profile ...Dividend History ...List of ETFs holding ATEC$4.55$2.19$7.93
499.Menlo Therapeutics (MNLO)$289.99 million-62.72%Menlo Therapeutics Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of serlopitant for the treatment of pruritus associated with dermatologic conditions in the Unit...See Company Profile ...Dividend History ...List of ETFs holding MNLO$1.73$1$7.48
500.iRadimed (IRMD)$288.36 million2.35%IRADIMED CORPORATION (IRADIMED), incorporated on April 8, 2014, develops, manufactures, markets and distributes Magnetic Resonance Imaging (MRI) compatible products, and provides non-magnetic intravenous (IV) infusion pump systems. The Company operates ...See Company Profile ...Dividend History ...List of ETFs holding IRMD$23.93$14.41$28.43
501.Abeona Therapeutics (ABEO)$284.57 million3.98%Abeona Therapeutics, Inc. (Abeona), formerly PlasmaTech Biopharmaceuticals, Inc., incorporated on June 22, 1989, is focused on developing and delivering gene therapy and plasma-based products for rare diseases. The Companys lead ...See Company Profile ...Dividend History ...List of ETFs holding ABEO$3.4$1.35$5.19
502.Pfenex (PFNX)$283.25 million-24.77%Pfenex Inc., incorporated on November 19, 2009, is a clinical-stage biotechnology company. The Company is engaged in the development of biosimilar and therapeutic equivalent products to branded therapeutics and other ...See Company Profile ...Dividend History ...List of ETFs holding PFNX$8.26$5.26$14
503.Spero Therapeutics (SPRO)$282.36 million42.66%Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel treatments for multi-drug resistant (MDR) bacterial infections in the United S...See Company Profile ...Dividend History ...List of ETFs holding SPRO$13.71$5.25$14.48
504.Bicycle Therapeutics (BCYC)$281.26 million64.9%Bicycle Therapeutics Limited, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase Iu002FIIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The company's oncology product candidates also comprise ...See Company Profile ...Dividend History ...List of ETFs holding BCYC$15.55$6.24$19.79
505.ChromaDex (CDXC)$279.72 million5.57%Chromadex Corporation, incorporated on June 19, 2008, and its subsidiaries ChromaDex, Inc., ChromaDex Analytics, Inc. and Spherix Consulting, Inc. provide research and quality-control products and services to the natural products ...See Company Profile ...Dividend History ...List of ETFs holding CDXC$4.55$2.5$5.8
506.Anavex Life Sciences (AVXL)$279.38 million79.54%Anavex Life Sciences Corp., incorporated on January 23, 2004, is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and ...See Company Profile ...Dividend History ...List of ETFs holding AVXL$4.65$2.2$6.31
507.Hookipa Pharma (HOOK)$274.66 million-12.43%HOOKIPA Pharma Inc., a clinical-stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase 2 clinical trial in cytomegalovirus-negative patients awaiting kidney transplantation from cytomegalovirus-posi...See Company Profile ...Dividend History ...List of ETFs holding HOOK$10.71$5.8$14.37
508.AMAG Pharma (AMAG)$270.41 million-35.17%AMAG Pharmaceuticals, Inc., incorporated on November 9, 1981, is a pharmaceutical company. The Companys segment is the manufacture, development and commercialization of products and services for use in treating various ...See Company Profile ...Dividend History ...List of ETFs holding AMAG$7.89$4.41$13.53
509.iBio (IBIO)$269.54 million800%iBio, Inc., incorporated on April 17, 2008, is a biotechnology company. The Company is focused on commercializing its technologies and product candidates and providing product development and manufacturing services to ...See Company Profile ...Dividend History ...List of ETFs holding IBIO$2.25$0.05$3.4
510.Cabaletta Bio (CABA)$269.42 million-19.76%Cabaletta Bio, Inc. operates as a clinical-stage biotechnology company that focuses on the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. The company's proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells that produce disease-causing autoantibodies or pathogenic B cell...See Company Profile ...Dividend History ...List of ETFs holding CABA$11.21$5.51$19.63
511.Taiwan Liposome (TLC)$268.15 million9.63%Taiwan Liposome Company, Ltd., a clinical-stage specialty pharmaceutical company, engages in the development and commercialization of nanomedicines that combine its proprietary lipid-assembled drug delivery pla...See Company Profile ...Dividend History ...List of ETFs holding TLC$5.92$2.48$8.54
512.Lannett Co (LCI)$267.93 million-24.72%Lannett Company, Inc., incorporated on December 3, 1991, develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Company manufactures and/or distributes prescription products with the exception of ...See Company Profile ...Dividend History ...List of ETFs holding LCI$6.64$5.46$15.52
513.ProQR Therapeutics (PRQR)$267.82 million-45.91%ProQR Therapeutics N.V. (ProQR), formerly ProQR Therapeutics B.V., is a pre-clinical stage biopharmaceutical company. The Company is engaged in the discovery and development of Ribonucleic Acid (RNA)-based therapeutics for the ...See Company Profile ...Dividend History ...List of ETFs holding PRQR$5.36$4.46$10.98
514.Kaleido Biosciences (KLDO)$259.96 million44.02%Kaleido BioSciences, Inc. develops microbiome metabolic therapies. It offers treatment for hyperammonemia, a metabolic condition generally characterized by elevated levels of ammonia in the blood; infections caused by multi-drug resistant bacteria; chronic kidney disease; atherosclerotic cardiovascular disease; and drug or disease induced diarrhea. Kaleido BioSciences, Inc. has a collaboration agreemen...See Company Profile ...Dividend History ...List of ETFs holding KLDO$7.23$2.82$10.36
515.SeaSpine (SPNE)$259.5 million-20.73%SeaSpine Holdings Corporation, incorporated on February 12, 2015, is a medical technology company. The Company is focused on the design, development and commercialization of surgical solutions for the treatment of ...See Company Profile ...Dividend History ...List of ETFs holding SPNE$9.52$4.02$16.78
516.Pulse Biosciences (PLSE)$257.02 million-23.79%Pulse Biosciences, Inc., formerly Electroblate, Inc., incorporated on May 19, 2014, is a development-stage medical device company using a platform technology called Nano-Pulse Electro-Signaling (NPES). NPES is a local and ...See Company Profile ...Dividend History ...List of ETFs holding PLSE$10.22$5.11$17.45
517.ADMA Biologics (ADMA)$253.86 million-26.5%ADMA Biologics, Inc., incorporated on June 2, 2006, is a late-stage biopharmaceutical company that develops, manufactures and intends to market specialty plasma-based biologics for the treatment and prevention of infectious ...See Company Profile ...Dividend History ...List of ETFs holding ADMA$2.94$1.45$5.48
518.Marinus Pharma (MRNS)$253.44 million11.57%Marinus Pharmaceuticals, Inc., incorporated on August 14, 2003, is a clinical-stage biopharmaceutical company. The Company focuses on developing and commercializing therapeutics to treat epilepsy and neuropsychiatric disorders. Its clinical-stage product ...See Company Profile ...Dividend History ...List of ETFs holding MRNS$2.41$0.77$4.72
519.MediciNova (MNOV)$251.19 million-15.43%MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is dev...See Company Profile ...Dividend History ...List of ETFs holding MNOV$5.7$2.79$10.84
520.Nymox Pharmaceutical (NYMX)$249.94 million58.41%Nymox Pharmaceutical Corp is a Canada-based biopharmaceutical company. The Company is focused on developing its drug candidate, NX-1207, for the treatment of benign prostatic hyperplasia (BPH) and the treatment of ...See Company Profile ...Dividend History ...List of ETFs holding NYMX$3.49$1.49$4.79
521.Tiziana Life Sciences (TLSA)$249.5 million172.43%Tiziana Life Sciences Plc, a clinical stage biotechnology company, focuses on the discovery and development of therapeutics to treat diseases in oncology and immunology in the United Kingdom. The company's prod...See Company Profile ...Dividend History ...List of ETFs holding TLSA$7.41$1.54$8.56
522.Evofem Biosciences (EVFM)$249.47 million-48.62%Evofem Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes women's sexual and reproductive health products. Its lead product candidate is Amphora that is in Phase 3 trial ...See Company Profile ...Dividend History ...List of ETFs holding EVFM$3.17$2.73$7.5
523.Verrica Pharmaceuticals (VRCA)$249.37 million-39.21%Verrica Pharmaceuticals Inc. develops and commercializes dermatological treatments in the United States. The company is advancing its lead product VP-102, a proprietary topical therapy, in various common skin indications, including Molluscum contagiosum and Verruca Vulgaris. It is also developing 2 Phase 3 trials in molluscum contagiosum under NCT03377803 and NCT03377790. ...See Company Profile ...Dividend History ...List of ETFs holding VRCA$9.66$6.79$18.67
524.Redhill Biopharma (RDHL)$247.59 million15.65%RedHill Biopharma Ltd., incorporated on August 3, 2009, is a biopharmaceutical company. The Company is focused on the development and commercialization of clinical-stage, orally-administered, small molecule drugs for the treatment ...See Company Profile ...Dividend History ...List of ETFs holding RDHL$7.02$3.26$9.12
525.Verastem (VSTM)$243.8 million11.94%Verastem, Inc., incorporated on August 4, 2010, is a biopharmaceutical company. The Company is focused on discovering and developing drugs to improve outcomes for patients with cancer. The Company operates ...See Company Profile ...Dividend History ...List of ETFs holding VSTM$1.5$0.83$4.67
526.Altimmune (ALT)$241.84 million492.06%Altimmune, Inc., a clinical stage immunotherapeutic biotechnology company, focuses on discovering and developing immunotherapies and vaccines to address the unmet medical needs. The company develops NasoVAX, an...See Company Profile ...Dividend History ...List of ETFs holding ALT$11.19$1.51$12.74
527.Selecta Biosciences (SELB)$241.47 million15.97%Selecta Biosciences, Inc., incorporated on December 10, 2007, is a clinical-stage biopharmaceutical company. The Company using its synthetic vaccine particle (SVP) technology to discover and develop targeted therapies that are ...See Company Profile ...Dividend History ...List of ETFs holding SELB$2.76$1.28$4.83
528.Eiger BioPharma (EIGR)$237.79 million-36.31%Eiger BioPharmaceuticals, Inc., formerly Celladon Corporation, incorporated on February 24, 2012, is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of products for the treatment ...See Company Profile ...Dividend History ...List of ETFs holding EIGR$9.49$4.55$15.82
529.CymaBay Therapeutics (CBAY)$236.96 million75.51%CymaBay Therapeutics, Inc., incorporated on October 5, 1988, is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies to treat metabolic diseases, including serious rare and orphan diseases. ...See Company Profile ...Dividend History ...List of ETFs holding CBAY$3.44$1.21$6.97
530.Gritstone Oncology (GRTS)$235.89 million-29.43%Gritstone Oncology Inc. is engaged in the discovery and development of cancer immunotherapies. The company focuses on developing tumor-specific neo-antigens-based therapies for non-small cell lung cancer. Grits...See Company Profile ...Dividend History ...List of ETFs holding GRTS$6.33$5.42$12.96
531.Agile Therapeutics (AGRX)$231.99 million6.4%Agile Therapeutics, Inc., incorporated on December 5, 1997, is a womens health specialty pharmaceutical company. The Company is focused on the development and commercialization of prescription contraceptive products. Its product ...See Company Profile ...Dividend History ...List of ETFs holding AGRX$2.66$0.35$4.77
532.Fortress Biotech (FBIO)$230.93 million8.95%Fortress Biotech, Inc., formerly Coronado Biosciences, Inc., incorporated on June 28, 2006, is a biopharmaceutical company. The Company is involved in the development of immunotherapy agents for the treatment of ...See Company Profile ...Dividend History ...List of ETFs holding FBIO$2.8$1.04$3.2
533.CASI Pharma (CASI)$229.08 million-26.54%CASI Pharmaceuticals, Inc., incorporated on September 18, 1991, is a biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of therapeutics for cancer and other medical needs. ...See Company Profile ...Dividend History ...List of ETFs holding CASI$2.27$1.15$3.82
534.Kezar Life Sciences (KZR)$228.84 million24.69%Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of small molecule therapeutics to treat unmet needs in autoimmunity and cancer in the United States. I...See Company Profile ...Dividend History ...List of ETFs holding KZR$5$2.18$9.79
535.Five Prime Therapeutics (FPRX)$228.24 million35.73%Five Prime Therapeutics, Inc., incorporated on December 20, 2001, is a clinical-stage biotechnology company focused on discovering and developing protein therapeutics. The Company has three product candidates in clinical development ...See Company Profile ...Dividend History ...List of ETFs holding FPRX$6.23$1.75$7.25
536.Alpha Pro Tech (APT)$225.8 million384.84%Alpha Pro Tech, Ltd., together with its subsidiaries, engages in developing, manufacturing, and marketing a line of disposable protective apparel, building supply products, and infection control produ...See Company Profile ...Dividend History ...List of ETFs holding APT$16.63$3.2$41.59
537.Summit Therapeutics (SMMT)$223.88 million108.13%Summit Therapeutics plc, a biopharmaceutical company, focuses on the discovery, development, and commercialization of novel medicines to treat rare and infectious diseases in the United Kingdom and North Americ...See Company Profile ...Dividend History ...List of ETFs holding SMMT$3.33$1.18$5.49
538.American Renal Associates (ARA)$223.69 million-36.07%American Renal Associates Holdings, Inc., incorporated on March 18, 2010, is a dialysis service provider in the United States focused on joint venture (JV) partnerships with physicians. As of December ...See Company Profile ...Dividend History ...List of ETFs holding ARA$6.63$5.57$13.8
539.Paratek Pharma (PRTK)$223.42 million28.54%Paratek Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics based upon tetracycline chemistry in the United States. Its lead produ...See Company Profile ...Dividend History ...List of ETFs holding PRTK$5.18$2.5$5.89
540.Veru (VERU)$222.87 million-4.78%Veru Inc. operates as an oncology and urology biopharmaceutical company. The company operates through two segments, Commercial, and Research and Development. It offers FC2 Female Condom for unintended pregnancy and sexually transmitted infections, including HIV 002FAIDS and the Zika virus; and PREBOOST benzocaine medicated individual wipes for the prevention of ...See Company Profile ...Dividend History ...List of ETFs holding VERU$3.19$1.67$4.74
541.XOMA (XOMA)$219.74 million-26.92%XOMA Corporation, incorporated on December 31, 2011, is a development-stage biotechnology company with a portfolio of therapeutic antibodies. The Company focuses on the discovery and development of monoclonal antibody-based therapeutics. ...See Company Profile ...Dividend History ...List of ETFs holding XOMA$19.95$14.14$28.85
542.Gamida Cell (GMDA)$219.49 million3.49%Gamida Cell Ltd., a clinical stage biopharmaceutical company, focuses on developing cell therapies to cure cancer, and rare and serious hematologic diseases in the United States, the European Union, and interna...See Company Profile ...Dividend History ...List of ETFs holding GMDA$4.45$2.6$7.7
543.Invacare (IVC)$218.22 million-29.71%Invacare Corporation, incorporated on March 23, 1971, is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company designs, manufactures and distributes medical devices help people ...See Company Profile ...Dividend History ...List of ETFs holding IVC$6.34$3.9$11.63
544.Pluristem Therapeutics (PSTI)$217.69 million121.27%Pluristem Therapeutics Inc., incorporated on May 10, 2001, is a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The Companys lead ...See Company Profile ...Dividend History ...List of ETFs holding PSTI$8.74$2.82$13.29
545.MISONIX (MSON)$217.02 million-32.83%Misonix, Inc., incorporated on July 31, 1967, designs, manufactures, develops and markets minimally invasive therapeutic ultrasonic medical devices. The Companys products include BoneScalpel surgical system (BoneScalpel), SonaStar Surgical Aspirator (SonaStar), ...See Company Profile ...Dividend History ...List of ETFs holding MSON$12.5$6.71$26.55
546.InfuSystems (INFU)$216.15 million26.26%InfuSystem Holdings, Inc., incorporated on August 15, 2005, is a provider of infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers and ...See Company Profile ...Dividend History ...List of ETFs holding INFU$10.77$4.28$13.25
547.Aptinyx (APTX)$215.95 million38.3%Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous...See Company Profile ...Dividend History ...List of ETFs holding APTX$4.73$1.6$5.28
548.Jounce Therapeutics (JNCE)$215.22 million-27.61%Jounce Therapeutics, Inc., a clinical stage immunotherapy company, develops therapies for the treatment of cancer. Its lead product candidate is JTX-2011, a clinical stage monoclonal antibody that binds to and ...See Company Profile ...Dividend History ...List of ETFs holding JNCE$6.32$2.79$10
549.Genfit SA (GNFT)$215.15 million-71.86%Genfit SA, a biopharmaceutical company, develops therapeutic and diagnostic solutions for metabolic, inflammatory, and autoimmune or fibrotic diseases affecting primarily the liver and gastro-enterology. The company's lead products include Elafibranor, which is in pivotal Phase 3 clinical trials for the treatment of nonalcoholic steatohepatitis (NASH), as well as in Phase 2 study in patients with prima...See Company Profile ...Dividend History ...List of ETFs holding GNFT$5.6$5.15$22.48
550.Avid Bioservices (CDMOP)$212.77 million-2.48%Avid Bioservices, Inc., a biologics contract development and manufacturing company, focuses on the development and current Good Manufacturing Practices (cGMP) manufacture of biopharmaceutical products derived f...See Company Profile ...Dividend History ...List of ETFs holding CDMOP$26$17.51$29.5
551.Aduro Biotech (ADRO)$211.91 million122.03%Aduro Biotech, Inc., incorporated on May 5, 2011, is an immunotherapy company. The Company focuses on the discovery, development and commercialization of therapies that manage the treatment of various diseases, ...See Company Profile ...Dividend History ...List of ETFs holding ADRO$2.62$0.9$4.04
552.KalVista Pharma (KALV)$211.67 million-33.41%KalVista Pharmaceuticals, Inc., formerly Carbylan Therapeutics, Inc., incorporated on March 26, 2004, is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development, and commercialization of small molecule ...See Company Profile ...Dividend History ...List of ETFs holding KALV$11.86$5.61$19.16
553.Cutera (CUTR)$209.03 million-66.57%Cutera, Inc., incorporated on August 10, 1998, is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics ...See Company Profile ...Dividend History ...List of ETFs holding CUTR$11.97$9.07$39.15
554.OptiNose (OPTN)$208.41 million-50.76%OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, and throat; and allergy specialists in the United States. The ...See Company Profile ...Dividend History ...List of ETFs holding OPTN$4.54$3.28$11.66
555.Rafael (RFL)$207.53 million-26.46%Rafael Holdings, Inc. holds commercial real estate assets. The company, through its subsidiaries, engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Rafael Holdings, Inc. is headquartered in Newark, New ...See Company Profile ...Dividend History ...List of ETFs holding RFL$13.12$9.4$23.76
556.Strongbridge Biopharma (SBBP)$207.23 million82.78%Strongbridge Biopharma plc, incorporated on May 26, 2015, is a global commercial-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies for a range of diseases. ...See Company Profile ...Dividend History ...List of ETFs holding SBBP$3.82$1.43$4.63
557.icad (ICAD)$206.14 million16.09%iCAD, Inc., incorporated on February 24, 1984, is a provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer. The Company provides ...See Company Profile ...Dividend History ...List of ETFs holding ICAD$9.02$5.5$15.31
558.Mallinckrodt (MNK)$206.07 million-30.09%Mallinckrodt public limited company, incorporated on January 9, 2013, develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such ...See Company Profile ...Dividend History ...List of ETFs holding MNK$2.44$1$8.77
559.Evelo Biosciences (EVLO)$204.37 million9.11%Evelo Biosciences, Inc., a biotechnology company, focuses on the development of monocolonal microbials for the treatment of inflammatory diseases and cancer. It is involved in developing EDP1066 and EDP1815, wh...See Company Profile ...Dividend History ...List of ETFs holding EVLO$4.43$3.01$9.27
560.Retractable (RVP)$203.94 million316%Retractable Technologies, Inc., incorporated on May 9, 1994, designs, develops and manufactures safety medical products for the healthcare industry. The Company markets VanishPoint and PatientSafe products. The VanishPoint products are ...See Company Profile ...Dividend History ...List of ETFs holding RVP$6.24$0.62$7.95
561.The Joint (JYNT)$203.7 million-9.48%The Joint Corp., incorporated on March 10, 2010, develops, owns, operates, supports and manages chiropractic clinics through direct ownership, management arrangements, franchising and the sale of regional developer rights throughout ...See Company Profile ...Dividend History ...List of ETFs holding JYNT$14.61$7.67$21.8
562.Lexicon Pharma (LXRX)$203.24 million-54.22%Lexicon Pharmaceuticals, Inc., incorporated on July 7, 1995, is a biopharmaceutical company. The Company focuses on the development and commercialization of breakthrough treatments for human disease. The Companys drug programs ...See Company Profile ...Dividend History ...List of ETFs holding LXRX$1.9$1.13$6.49
563.Fennec Pharmaceuticals (FENC)$203.2 million24.38%Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product candidate is the Sodium Thiosulfate, which has com...See Company Profile ...Dividend History ...List of ETFs holding FENC$8.06$3.75$9.75
564.BioSig Technologies (BSGM)$202.37 million20.61%BioSig Technologies, Inc., a development stage medical device company, engages in developing a proprietary biomedical signal processing technology platform to extract information from physiologic signals. Its p...See Company Profile ...Dividend History ...List of ETFs holding BSGM$7.14$2.36$12.43
565.RTI Surgical (RTIX)$201.42 million-1.46%RTI Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It processes donated human musculoskeletal and o...See Company Profile ...Dividend History ...List of ETFs holding RTIX$2.7$1.46$5.4
566.Cerecor (CERC)$199.23 million-51.39%Cerecor, Inc., incorporated on January 31, 2011, is a clinical stage biopharmaceutical company. The Company is engaged in developing drug candidates for patients with neurological and psychiatric disorders. The Company ...See Company Profile ...Dividend History ...List of ETFs holding CERC$2.62$1.52$6.19
567.Sientra (SIEN)$197.38 million-55.87%Sientra, Inc., incorporated on August 29, 2003, is a medical aesthetics company. The Companys primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, ...See Company Profile ...Dividend History ...List of ETFs holding SIEN$3.95$1$9.71
568.Chiasma (CHMA)$196.96 million-6.05%Chiasma, Inc., incorporated on April 12, 2001, is a biopharmaceutical company. The Company is engaged in developing and commercializing oral forms of therapies that are available only by injection. Using ...See Company Profile ...Dividend History ...List of ETFs holding CHMA$4.66$2.88$9.25
569.Sol-Gel Technologies (SLGL)$196.65 million-50.09%Sol-Gel Technologies Ltd., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery ...See Company Profile ...Dividend History ...List of ETFs holding SLGL$8.56$5$21
570.scPharmaceuticals (SCPH)$195.04 million28.62%scPharmaceuticals Inc., a clinical-stage pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is Furoscix, a drug-dev...See Company Profile ...Dividend History ...List of ETFs holding SCPH$7.28$3.55$11.99
571.Lakeland Industries (LAKE)$193.11 million124.17%Lakeland Industries, Inc. (Lakeland), incorporated on April 30, 1986, manufactures and sells a line of safety garments and accessories for the industrial and public protective clothing market. The Companys product ...See Company Profile ...Dividend History ...List of ETFs holding LAKE$24.21$9.7$28
572.Aravive (ARAV)$192.91 million-11.78%Aravive, Inc., a clinical stage biotechnology company, focuses on developing therapies for solid tumors and hematologic malignancies. It is developing AVB-S6-500, a GAS6 binding protein and AXL decoy receptor, ...See Company Profile ...Dividend History ...List of ETFs holding ARAV$12.06$3.34$15.62
573.Chimerix (CMRX)$188.89 million50.25%Chimerix, Inc., incorporated on April 7, 2000, is a biotechnology company. The Company is focused on discovering, developing and commercializing medicines that address unmet medical needs. Its lead compound, brincidofovir, ...See Company Profile ...Dividend History ...List of ETFs holding CMRX$3.05$1.19$3.98
574.Enochian Biosciences (ENOB)$187.39 million-19.72%Enochian Biosciences Inc., a biopharmaceutical company, identifies, develops, manufactures, and commercializes gene therapies for HIV AIDS and cancer patients. Its lead candidate include ENO-1001 a genetic...See Company Profile ...Dividend History ...List of ETFs holding ENOB$4.03$1.95$13.43
575.Lifevantage (LFVN)$186.5 million-16.53%LifeVantage Corporation, incorporated on June 10, 1988, is a science-based network marketing company. The Company focuses on helping people achieve their health, wellness and financial independence goals. The Company provides ...See Company Profile ...Dividend History ...List of ETFs holding LFVN$13.03$7.75$17.25
576.IMV (IMV)$186.14 million4.83%IMV Inc., a clinical-stage immuno-oncology company, together with its subsidiaries, develops products based on its platform and products with a primary focus on T cell activating therapies for cancer. The compa...See Company Profile ...Dividend History ...List of ETFs holding IMV$3.04$1.35$5.12
577.Galera Therapeutics (GRTX)$185.94 million-43.09%Galera Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is GC4419, a small molecule dismutase mimetic, which is in Phase III clinical trial for the treatment of radiation-induced severe oral mucositis in patients with head and neck cancer, as...See Company Profile ...Dividend History ...List of ETFs holding GRTX$7.49$5.58$19.5
578.ContraFect (CFRX)$183.78 million6.44%ContraFect Corporation, incorporated on March 5, 2008, is a clinical-stage biotechnology company. The Company is focused on discovering and developing therapeutic protein and antibody products for the treatment of infectious ...See Company Profile ...Dividend History ...List of ETFs holding CFRX$6.61$2.69$13.4
579.Tela Bio (TELA)$183.55 million-1.62%TELA Bio, Inc., a medical technology company, focuses on the design, development, and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. It offers reinforced tissue matrix products for a variety of reconstruction procedures, including hernia repair, abdominal wall reconstruction, and plastic and reconstructive surgery. The company provides a portfolio of O...See Company Profile ...Dividend History ...List of ETFs holding TELA$12.74$5.25$23.55
580.Foamix Pharma (FOMX)$183.15 million-10.21%Foamix Pharmaceuticals Ltd., incorporated on January 19, 2003, is a clinical-stage pharmaceutical company. The Company is engaged in the development and commercialization of foam-based formulations, using its technology, which includes ...See Company Profile ...Dividend History ...List of ETFs holding FOMX$2.99$1.97$4.84
581.LogicBio Therapeutics (LOGC)$183.02 million8.47%LogicBio Therapeutics, Inc., a genome editing company, focuses on developing medicines to treat rare diseases in patients with unmet medical need using GeneRide technology platform. The GeneRide technology is d...See Company Profile ...Dividend History ...List of ETFs holding LOGC$7.81$3.05$14
582.Alpine Immune Sciences (ALPN)$181.42 million154.17%Alpine Immune Sciences, Inc. focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, inflammatory disorders, and other diseases. Its lead programs include ALPN-101...See Company Profile ...Dividend History ...List of ETFs holding ALPN$9.76$2.05$15
583.ERYTECH Pharma (ERYP)$181.22 million23.58%ERYTECH Pharma S.A., a biopharmaceutical company, develops therapies for severe forms of cancer and orphan diseases. It is developing a pipeline of product candidates targeting solid and liquid tumors for patie...See Company Profile ...Dividend History ...List of ETFs holding ERYP$9.12$3.5$12
584.Axcella Health (AXLA)$180.63 million25.69%Axcella Health Inc., a biotechnology company, researches and develops novel multifactorial interventions to support health and address dysregulated metabolism in the United States. The company develops its products based on its AXA Development Platform. It offers AXA1665 for use in treating hepatic encephalopathy; AXA1125 and AXA1957 to treat non-alcoholic fatty liver disease; AXA2678 for use in treati...See Company Profile ...Dividend History ...List of ETFs holding AXLA$5.04$2.25$9.63
585.Accuray (ARAY)$180.13 million-29.43%Accuray Incorporated, incorporated on February 22, 2001, is a radiation oncology company. The Company develops, manufactures, sells and supports treatment solutions. It develops, manufactures and markets medical devices used in ...See Company Profile ...Dividend History ...List of ETFs holding ARAY$1.99$1.33$4.68
586.Nature's Sunshine Products (NATR)$179.15 million3.02%Natures Sunshine Products, Inc. (NSP), incorporated on November 26, 1976, together with its subsidiaries, is a natural health and wellness company. The Company is engaged in the manufacturing and direct ...See Company Profile ...Dividend History ...List of ETFs holding NATR$9.2$5.5$10.85
587.Surface Oncology (SURF)$179.07 million245.74%Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies. The company's lead product candidate is the SRF231 that is in Phase I clinical trial targeting p...See Company Profile ...Dividend History ...List of ETFs holding SURF$6.5$1.15$7.66
588.Trevena (TRVN)$174.71 million94.05%Trevena Inc., incorporated on November 9, 2007, is a biopharmaceutical company, which is engaged in developing various therapies. The Company is developing OLINVO, a u-receptor G protein pathway selective modulator ...See Company Profile ...Dividend History ...List of ETFs holding TRVN$1.63$0.46$1.91
589.Pieris Pharma (PIRS)$173.7 million-8.29%Pieris Pharmaceuticals, Inc., incorporated on May 24, 2013, is a clinical-stage biopharmaceutical company. The Companys pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment, an inhaled Anticalin to treat uncontrolled ...See Company Profile ...Dividend History ...List of ETFs holding PIRS$3.32$1.6$6.04
590.Soliton (SOLY)$172.7 million-25.77%Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. It is developing a product for the removal of tattoos. The company was founded in 2012 and is headquartered in Houston, Texas....See Company Profile ...Dividend History ...List of ETFs holding SOLY$8.15$6.64$21.97
591.NuCana (NCNA)$172.14 million-13.11%NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. It is developing Acelarin that is in Phase I clinical trials for the treatment of adva...See Company Profile ...Dividend History ...List of ETFs holding NCNA$5.3$3.81$10.94
592.Apyx Medical (APYX)$171.26 million-40.78%Apyx Medical Corporation provides products in the cosmetic and surgical markets worldwide. The company markets Helium Plasma Technology under the Renuvion brand name in the cosmetic surgery market and under the...See Company Profile ...Dividend History ...List of ETFs holding APYX$5.01$2.81$8.59
593.Soleno Therapeutics (SLNO)$168.67 million-27.89%Soleno Therapeutics, Inc. focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate, diazoxide choline controlled-release (DCCR), a tablet for...See Company Profile ...Dividend History ...List of ETFs holding SLNO$2.12$1.18$4.39
594.CRH Medical (CRHM)$165.1 million-34.01%CRH Medical Corporation provides various products and services to gastroenterologists for the treatment of gastrointestinal diseases in the United States, Canada, and internationally. It offers CRH O'Regan syst...See Company Profile ...Dividend History ...List of ETFs holding CRHM$2.29$0.86$4.43
595.Luna Innovations (LUNA)$164.32 million-26.06%Luna Innovations Incorporated, incorporated on April 4, 2003, develops, manufactures and markets fiber optic sensing and test, and measurement products. The Company is focused on bringing technology solutions to measure ...See Company Profile ...Dividend History ...List of ETFs holding LUNA$5.39$4.25$9.32
596.Nemaura Medical (NMRD)$163.92 million120.9%Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes specialty medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by perso...See Company Profile ...Dividend History ...List of ETFs holding NMRD$7.82$2.5$16.5
597.GlycoMimetics (GLYC)$163.44 million-29.11%GlycoMimetics, Inc., incorporated on April 4, 2003, is a clinical-stage biotechnology company. The Company focuses on the discovery and development of glycomimetic drugs. The Company operates through the identification and ...See Company Profile ...Dividend History ...List of ETFs holding GLYC$3.75$1.82$13.44
598.Galectin Therapeutics (GALT)$163.1 million0%Galectin Therapeutics Inc., incorporated on January 26, 2001, is a clinical-stage biopharmaceutical company engaged in drug research and development to create therapies for fibrotic disease and cancer. The Companys drug ...See Company Profile ...Dividend History ...List of ETFs holding GALT$2.86$1.5$4.5
599.Avenue Therapeutics (ATXI)$161.82 million1.04%Avenue Therapeutics, Inc., a specialty pharmaceutical company, acquires, licenses, develops, and commercializes products primarily for use in the acute intensive care hospital setting. Its product candidat...See Company Profile ...Dividend History ...List of ETFs holding ATXI$9.7$4.96$11.83
600.Aytu Bioscience (AYTU)$161.62 million38.14%Aytu BioScience, Inc., a specialty healthcare company, focuses on developing and commercializing novel products in the field of hypogonadism (low testosterone), insomnia, and male infertility in the U...See Company Profile ...Dividend History ...List of ETFs holding AYTU$1.34$0.34$2.99
601.Outlook Therapeutics (OTLK)$160.27 million122.03%Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibody for various ophthalmic indications. Its lead product candidate is ONS-5...See Company Profile ...Dividend History ...List of ETFs holding OTLK$1.31$0.5$2.89
602.T2 Biosystems (TTOO)$158.99 million13.68%T2 Biosystems, Inc., incorporated on April 27, 2006, is an in vitro diagnostics company that is engaged in developing a technology platform offering an alternative to diagnostic methodologies. The Company ...See Company Profile ...Dividend History ...List of ETFs holding TTOO$1.33$0.24$3.21
603.Tyme Technologies (TYME)$158.41 million-10%Tyme Technologies, Inc., a clinical-stage biotechnology company, develops novel cancer therapeutics. It is developing SM-88, a combination therapy based on dysfunctional metyrosine derivatives in Phase II development for metastatic pancreatic cancer and biomarker-recurrent prostate cancer. The company was founded in 2011 and is headquartered in New York, New ...See Company Profile ...Dividend History ...List of ETFs holding TYME$1.26$0.86$2.04
604.Cidara Therapeutics (CDTX)$157.06 million-0.52%Cidara Therapeutics, Inc., formerly K2 Therapeutics, Inc., incorporated on December 06, 2012, is a clinical-stage biotechnology company. The Company is engaged in the discovery, development and commercialization of anti-infectives. The ...See Company Profile ...Dividend History ...List of ETFs holding CDTX$3.82$1.22$4.45
605.VolitionRX (VNRX)$154.4 million-29.54%VolitionRx Limited, incorporated on September 24, 1998, is a clinical-stage life sciences company. The Company is focused on developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases. ...See Company Profile ...Dividend History ...List of ETFs holding VNRX$3.34$2.22$6.84
606.Aquestive Therapeutics (AQST)$153.81 million-21.31%Aquestive Therapeutics, Inc., a specialty pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs. Its products are developed using its Ph...See Company Profile ...Dividend History ...List of ETFs holding AQST$4.58$1.41$10
607.Kindred Biosciences (KIN)$152.05 million-54.36%Kindred Biosciences, Inc., incorporated on September 25, 2012, is a development-stage biopharmaceutical company. The Company is focused on developing therapies for pets. The Companys product pipeline consists of small molecules ...See Company Profile ...Dividend History ...List of ETFs holding KIN$3.87$3.11$11.93
608.Matinas BioPharma (MTNB)$151.14 million-66.52%Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. The company enables the delivery of life-changing medicines ...See Company Profile ...Dividend History ...List of ETFs holding MTNB$0.76$0.49$2.49
609.vTv Therapeutics (VTVT)$150.45 million29.41%vTv Therapeutics Inc., incorporated on April 02, 2015, is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of orally administered small molecule drug candidates. The ...See Company Profile ...Dividend History ...List of ETFs holding VTVT$2.2$1.23$4.23
610.CorMedix (CRMD)$149.45 million-21.43%CorMedix Inc., incorporated on July 28, 2006, is a commercial pharmaceutical and medical device company. The Company in-licenses, develops and commercializes prophylactic and therapeutic products for the prevention and treatment ...See Company Profile ...Dividend History ...List of ETFs holding CRMD$5.72$2.16$9.99
611.Applied Genetic (AGTC)$145.06 million24.56%Applied Genetic Technologies Corporation, incorporated on October 24, 2003, is a clinical-stage biotechnology company. The Company develops gene therapy products designed to manage the lives of patients with severe diseases ...See Company Profile ...Dividend History ...List of ETFs holding AGTC$5.63$2.29$10.42
612.Actinium Pharma (ATNM)$144.19 million65.86%Actinium Pharmaceuticals, Inc. (Actinium), incorporated on March 20, 2013, is a clinical-stage biopharmaceutical company engaged in developing cancer treatments. The Company is engaged in developing therapies for diseases using its ...See Company Profile ...Dividend History ...List of ETFs holding ATNM$0.36$0.16$0.62
613.Exagen (XGN)$143.34 million-55.35%Exagen Inc. operates as a commercial-stage diagnostics company, develops and markets products for the diagnosis, prognosis, and monitoring of patients affected by autoimmune rheumatic diseases (ARDs). Its lead product includes Avise SLE+CT, a proprietary diagnostic test that provides an enhanced solution for patients with a range of ARDs, such as systemic lupus erythematosus (SLE), rheumatoid arthritis...See Company Profile ...Dividend History ...List of ETFs holding XGN$11.34$10.29$29.86
614.Celyad SA (CYAD)$143.07 million-2.78%Celyad SA, formerly Cardio3 Biosciences SA is a Belgium-based drug developing company. The Company develops stem cell-based therapies for cardiovascular disease. The Company focuses on developing regenerative therapies to treat ...See Company Profile ...Dividend History ...List of ETFs holding CYAD$10.13$4.1$14.98
615.Minerva Neurosciences (NERV)$142.76 million-48.8%Minerva Neurosciences, Inc., incorporated on April 23, 2007, is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of a portfolio of product candidates to treat ...See Company Profile ...Dividend History ...List of ETFs holding NERV$3.64$1.81$15.22
616.Greenlane (GNLN)$141.4 million6.6%Greenlane Holdings, Inc. distribute consumption accessories and vaporization products to wholesale and retail customers in the United States and Canada. The company offers vaporizers and parts, cleaning products, grinders and storage containers, pipes, rolling papers, and customized lines of specialty packaging. It also operates e-commerce Websites, such as VaporNation.com and VapeWorld.com. The compan...See Company Profile ...Dividend History ...List of ETFs holding GNLN$3.36$1.02$9.68
617.ObsEva SA (OBSV)$140.23 million-21.99%ObsEva SA, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy disorders. It is developi...See Company Profile ...Dividend History ...List of ETFs holding OBSV$2.98$1.63$11.12
618.Fonar (FONR)$140.18 million8.28%Fonar Corporation (Fonar), incorporated on July 17, 1978, is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilizes MRI technology for the ...See Company Profile ...Dividend History ...List of ETFs holding FONR$21.32$11$25.99
619.Corvus Pharma (CRVS)$138.51 million-8.92%Corvus Pharmaceuticals, Inc., incorporated on January 27, 2014, is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of immuno-oncology therapies. The Company is developing drugs ...See Company Profile ...Dividend History ...List of ETFs holding CRVS$4.96$1.01$6.88
620.Solid Biosciences (SLDB)$137.75 million-32.81%Solid Biosciences Inc. engages in identifying and developing therapies for duchenne muscular dystrophy in the United States. Its lead product candidate includes SGT-001, a gene therapy that is in Phase I I...See Company Profile ...Dividend History ...List of ETFs holding SLDB$2.99$1.96$13.58
621.Mustang Bio (MBIO)$137.55 million-21.57%Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel cancer immunotherapy products based on the chimeric antigen receptor engine...See Company Profile ...Dividend History ...List of ETFs holding MBIO$3.2$1.78$4.85
622.PhaseBio Pharmaceuticals (PHAS)$136.13 million-22.59%PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapies to treat orphan diseases with an initial focus on cardiopulmonary ...See Company Profile ...Dividend History ...List of ETFs holding PHAS$4.73$2.6$12.22
623.Biofrontera AG (BFRA)$135.72 million-40.19%Biofrontera AG, a biopharmaceutical company, engages in the development and commercialization pharmaceutical products for the treatment of dermatological conditions and diseases caused primarily by exposure to ...See Company Profile ...Dividend History ...List of ETFs holding BFRA$6.19$5.41$17.25
624.Avalon GloboCare (AVCO)$134.92 million-11.92%Avalon GloboCare Corp., together with its subsidiaries, engages in integrating and managing healthcare services and resources in the United States. It provides medical related consulting services and develops A...See Company Profile ...Dividend History ...List of ETFs holding AVCO$1.7$0.5$2.65
625.Harvard Bioscience (HBIO)$134.72 million15.08%Harvard Bioscience, Inc., incorporated on October 8, 2000, is a developer, manufacturer and marketer of a range of scientific instruments, systems and lab consumables used for basic research, drug discovery, ...See Company Profile ...Dividend History ...List of ETFs holding HBIO$3.51$1.39$3.77
626.InflaRx (IFRX)$133.66 million29.29%InflaRx N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing inhibitors using C5a technology primarily in the United States and Europe. Its C5a is an inflammatory mediator inv...See Company Profile ...Dividend History ...List of ETFs holding IFRX$5.12$2.17$9.7
627.Harrow Health (HROW)$131.43 million-34.06%Harrow Health, Inc. owns a portfolio of healthcare businesses, primarily ophthalmology pharmaceutical compounding business, ImprimisRx, in the United States. It develops, produces, and sells medications, includ...See Company Profile ...Dividend History ...List of ETFs holding HROW$5.13$3.33$8.25
628.Catalyst Biosciences (CBIO)$130.98 million-12.78%CB 813dThe Companys product candidate, CB 813d, is a next-generation Factor VIIa that has completed Phase I clinical trial. The clinical trial has evaluated the safety and tolerability, pharmacokinetics, pharmacodynamics ...See Company Profile ...Dividend History ...List of ETFs holding CBIO$5.94$3.43$8.94
629.Orgenesis (ORGS)$130.88 million27.68%Orgenesis Inc., a service and research company, focus on the development and manufacture of cell therapy for advanced medicinal products in the field of regenerative medicine industry. It operates through two s...See Company Profile ...Dividend History ...List of ETFs holding ORGS$5.95$2.35$8.2
630.Evolus (EOLS)$130.19 million-68.28%Evolus, Inc. provides medical aesthetic products for physicians and their patients in the United States. It offers DWP-450, an injectable 900 kilodalton botulinum toxin type A complex designed to address the ne...See Company Profile ...Dividend History ...List of ETFs holding EOLS$3.86$3.08$20.27
631.Aesthetic Medical (AIH)$130.11 million-12.54%Aesthetic Medical International Holdings Group Limited provides aesthetic medical services. It offers surgical aesthetic treatments, such as eye and nose surgery, breast augmentation, and liposuction; and non-surgical aesthetic treatments comprising minimally invasive and energy-based treatments, including laser, ultrasound, and ultraviolet light treatments. The company also provides general healthcare...See Company Profile ...Dividend History ...List of ETFs holding AIH$5.51$5.51$12.56
632.Rockwell Medical (RMTI)$129.85 million-22.95%Rockwell Medical, Inc. (Rockwell), incorporated on October 25, 1996, is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with products and services for the treatment ...See Company Profile ...Dividend History ...List of ETFs holding RMTI$1.88$1.31$3.85
633.Electromed (ELMD)$129.8 million76.88%Electromed, Inc., incorporated on October 16, 1992, develops, manufactures and markets airway clearance products, which apply High Frequency Chest Wall Oscillation (HFCWO) therapy in pulmonary care for patients of all ...See Company Profile ...Dividend History ...List of ETFs holding ELMD$15.3$5.18$19.73
634.Milestone Scientific (MLSS)$129.47 million49.64%Milestone Scientific Inc. (Milestone), incorporated on August 17, 1989, is engaged in providing computer-controlled injection technologies and solutions for the medical and dental markets. The Company uses its CompuFlo technology ...See Company Profile ...Dividend History ...List of ETFs holding MLSS$2.08$0.37$3.05
635.Kitov Pharma (KTOV)$129.11 million2.13%Kitov Pharma Ltd, through its subsidiaries, operates as a development stage biopharmaceutical company in Israel. It develops combination drugs for the simultaneous treatment of pain caused by osteoarthritis and...See Company Profile ...Dividend History ...List of ETFs holding KTOV$0.79$0.22$1.44
636.Aldeyra Therapeutics (ALDX)$129 million-25.47%Aldeyra Therapeutics, Inc., formerly Aldexa Therapeutics, Inc., incorporated on August 13, 2004, is a biotechnology company. The Companys principal activities include raising capital and research and development activities. The Companys ...See Company Profile ...Dividend History ...List of ETFs holding ALDX$4.33$1.48$8.05
637.Arbutus Biopharma (ABUS)$128.27 million-33.09%Arbutus Biopharma Corporation, formerly Tekmira Pharmaceuticals Corporation, is a therapeutic solutions company. The Company is engaged in discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B ...See Company Profile ...Dividend History ...List of ETFs holding ABUS$1.86$0.82$3.66
638.Bellerophon Therapeutics (BLPH)$127.08 million154.86%Bellerophon Therapeutics, Inc., incorporated on October 17, 2013, is a clinical-stage therapeutics company. The Company is focused on developing products at the intersection of drugs and devices that address medical ...See Company Profile ...Dividend History ...List of ETFs holding BLPH$13.38$3.19$26
639.Celsion (CLSN)$126.23 million122.22%Celsion Corporation (Celsion), incorporated on May 17, 2000, is an oncology drug development company. The Company is focused on developing a portfolio of cancer treatments, including directed chemotherapies, deoxyribonucleic acid ...See Company Profile ...Dividend History ...List of ETFs holding CLSN$3.8$0.69$6.5
640.La Jolla Pharmaceutical (LJPC)$125.03 million16.54%La Jolla Pharmaceutical Company, incorporated on May 8, 2012, is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapies to improve outcomes in patients ...See Company Profile ...Dividend History ...List of ETFs holding LJPC$4.58$2.3$11.41
641.AVEO Pharma (AVEO)$124.9 million-23.42%AVEO Pharmaceuticals, Inc. (AVEO), incorporated on October 19, 2001, is a biopharmaceutical company. The Companys platform delivers insights into cancer and related disease. The Companys product candidates include Tivozanib, Ficlatuzumab, ...See Company Profile ...Dividend History ...List of ETFs holding AVEO$4.84$2.23$11.2
642.Five Star Quality Care (FVE)$123.01 million5.12%Five Star Senior Living Inc., formerly Five Star Quality Care, Inc., incorporated on September 17, 2001, operates senior living communities, including independent living communities, assisted living communities and skilled nursing ...See Company Profile ...Dividend History ...List of ETFs holding FVE$3.9$2.13$7.5
643.Catabasis Pharma (CATB)$120.99 million14.38%Catabasis Pharmaceuticals, Inc., incorporated on June 26, 2008, is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutics based on its Safely Metabolized ...See Company Profile ...Dividend History ...List of ETFs holding CATB$6.76$2.74$7.81
644.Genprex (GNPX)$120.91 million878.13%Genprex, Inc., a clinical-stage gene therapy biotechnology company, develops immunogene therapy products for treating cancer. Its lead drug candidate is Oncoprex, which is in Phase II clinical trials for the tr...See Company Profile ...Dividend History ...List of ETFs holding GNPX$3.13$0.23$7.03
645.Sierra Oncology (SRRA)$120.9 million-15.11%Sierra Oncology, Inc., formerly ProNAi Therapeutics, Inc., incorporated on May 8, 2003, is a clinical-stage drug development company. The Company?ÇÖs lead drug candidate, SRA737, is orally bioavailable small molecule inhibitor ...See Company Profile ...Dividend History ...List of ETFs holding SRRA$11.63$8.55$26.8
646.Palatin (PTN)$118.82 million-33.55%Palatin Technologies, Inc., incorporated on November 21, 1986, is a biopharmaceutical company. The Company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet ...See Company Profile ...Dividend History ...List of ETFs holding PTN$0.52$0.36$1.13
647.Champions Oncology (CSBR)$118.8 million18.37%Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an ap...See Company Profile ...Dividend History ...List of ETFs holding CSBR$9.86$4.02$10.28
648.Enzo Biochem (ENZ)$118.77 million-5.7%Enzo Biochem, Inc. (Enzo), incorporated on August 13, 1976, is a bioscience company focusing on delivering and applying technology capabilities to produce products and services. The Companys segments include Enzo ...See Company Profile ...Dividend History ...List of ETFs holding ENZ$2.48$1.56$4.85
649.Protalix BioTherapeutics (PLX)$118.42 million11.28%Protalix BioTherapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system, ProCellEx. Using its ProCellEx system, the ...See Company Profile ...Dividend History ...List of ETFs holding PLX$3.65$1.7$4.87
650.ESSA Pharma (EPIX)$117.49 million10.91%ESSA Pharma Inc., a pharmaceutical company, focuses on the development of small molecule drugs for the treatment of prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada....See Company Profile ...Dividend History ...List of ETFs holding EPIX$6.1$1.41$6.29
651.Genesis Healthcare (GEN)$117.11 million-57.05%Genesis Healthcare, Inc., incorporated on October 21, 2005, is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled ...See Company Profile ...Dividend History ...List of ETFs holding GEN$0.7$0.58$1.86
652.TFF Pharmaceuticals (TFFP)$116.14 million16.26%TFF Pharmaceuticals, Inc., an early-stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing, or TFF, technology platform. It intends to initially focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company was founded in 2018 and is based in Austin, Texas....See Company Profile ...Dividend History ...List of ETFs holding TFFP$6.22$3.44$6.92
653.Eloxx Pharmaceuticals (ELOX)$114.77 million-61.14%Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel therapeutics for the treatment of rare and ultra-rare premature stop codon diseases. Its lead...See Company Profile ...Dividend History ...List of ETFs holding ELOX$2.86$1.44$9.7
654.CTI BioPharma (CTIC)$114.21 million-1.9%CTI BioPharma Corp. (CTI), incorporated on September 4, 1991, is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers. The ...See Company Profile ...Dividend History ...List of ETFs holding CTIC$1.55$0.62$1.93
655.Savara (SVRA)$113.77 million-51.34%Savara Inc. operates as an orphan lung disease company. Its lead product candidate includes Molgradex, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for th...See Company Profile ...Dividend History ...List of ETFs holding SVRA$2.18$0.69$5.48
656.Leap Therapeutics (LPTX)$112.1 million78.57%Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-relate...See Company Profile ...Dividend History ...List of ETFs holding LPTX$2$0.57$3.18
657.Eton Pharmaceuticals (ETON)$111.7 million-25.83%Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical product using the U.S. Food and Drug Administration's 505(b)(2) regulatory pathway. It pr...See Company Profile ...Dividend History ...List of ETFs holding ETON$5.34$2.5$9.07
658.Otonomy (OTIC)$109.89 million-7.05%Otonomy, Inc., incorporated on May 6, 2008, is a biopharmaceutical company. The Company focuses on the development and commercialization of therapeutics for diseases and disorders of the ear. The Companys ...See Company Profile ...Dividend History ...List of ETFs holding OTIC$3.56$1.53$4.18
659.Ampio Pharma (AMPE)$109.63 million14.66%Ampio Pharmaceuticals, Inc., incorporated on March 24, 2010, is a biopharmaceutical company. The Company is focused primarily on the development of therapies to treat prevalent inflammatory conditions for which there ...See Company Profile ...Dividend History ...List of ETFs holding AMPE$0.67$0.26$0.91
660.22nd Century (XXII)$107.5 million-29.62%22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoid...See Company Profile ...Dividend History ...List of ETFs holding XXII$0.77$0.6$2.46
661.AquaBounty (AQB)$103.96 million49.31%AquaBounty Technologies, Inc., incorporated on December 17, 1991, is a biotechnology company engaged in research, development and commercialization of the commercial viability of a group of proteins, antifreeze proteins (AFPs). ...See Company Profile ...Dividend History ...List of ETFs holding AQB$3.24$1.52$4.08
662.Aptorum Group (APM)$103.31 million-78.55%Aptorum Group Limited, a pharmaceutical company, develops and commercializes a range of therapeutic and diagnostic technologies to treat unmet medical needs. It focuses on developing various drug molecules and ...See Company Profile ...Dividend History ...List of ETFs holding APM$3.4$1.66$23.62
663.Clearside Biomedical (CLSD)$102.65 million-34.83%Clearside Biomedical, Inc., incorporated on May 26, 2011, is a clinical biopharmaceutical company developing first-in-class drug therapies to treat blinding diseases of the eye. The Companys product candidates focus on ...See Company Profile ...Dividend History ...List of ETFs holding CLSD$1.89$0.56$4.13
664.Recro Pharma (REPH)$101.8 million-76.43%Recro Pharma, Inc., incorporated on November 15, 2007, is a clinical-stage specialty pharmaceutical company. The Company is engaged in developing products for hospitals and ambulatory care settings that is developing ...See Company Profile ...Dividend History ...List of ETFs holding REPH$4.32$4.15$19.21
665.Galmed Pharma (GLMD)$101.11 million-17.3%Galmed Pharmaceuticals Ltd., incorporated on July 31, 2013, is a clinical-stage biopharmaceutical company. The Company focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver ...See Company Profile ...Dividend History ...List of ETFs holding GLMD$4.78$3.02$7.38
666.Biocept (BIOC)$100.29 million163.79%Biocept, Inc., incorporated on June 28, 2013, is an early commercial-stage molecular oncology diagnostics company. The Company develops and commercializes circulating tumor cell (CTC) and circulating tumor deoxyribonucleic acid (ctDNA), ...See Company Profile ...Dividend History ...List of ETFs holding BIOC$0.77$0.21$1.15
667.Nabriva Therapeutics AG (NBRV)$99.96 million-47.03%Nabriva Therapeutics AG is an Austria-based clinical-stage biopharmaceutical company engaged in the research and development of antibiotics to treat infections. Its lead product candidate, lefamulin, is a pleuromutilin antibiotic for ...See Company Profile ...Dividend History ...List of ETFs holding NBRV$0.7$0.49$2.77
668.MediWound (MDWD)$99.87 million18.39%MediWound Ltd., incorporated on January 27, 2000, is a biopharmaceutical company. The Company focuses on developing, manufacturing and commercializing therapeutics products in the fields of severe burns, chronic and other ...See Company Profile ...Dividend History ...List of ETFs holding MDWD$3.67$1.44$4.14
669.Onconova Therapeutics (ONTX)$99.13 million54.66%Onconova Therapeutics, Inc., incorporated on December 22, 1998, is a clinical-stage biopharmaceutical company. The Company operates through the identification and development of oncology therapeutics segment. It is focused on discovering ...See Company Profile ...Dividend History ...List of ETFs holding ONTX$0.59$0.1$2.87
670.PAVmed (PAVM)$98.72 million73.33%PAVmed Inc., incorporated on June 26, 2014, is a medical device company organized to conceive, develop and commercialize a diversified pipeline of products. The Companys products include PortIO, Caldus, CarpX, ...See Company Profile ...Dividend History ...List of ETFs holding PAVM$2.08$0.81$3.45
671.Xeris Pharmaceuticals (XERS)$98.13 million-62.98%Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes ready-to-use injectable and infusible drug formulations. Its proprietary XeriSol and XeriJect formulation technologies allow for the subcutaneous and intramuscular delivery of highly-concentrated, ready-to-use formulations of peptides, proteins, antibodies, and small molecules using commercially available syrin...See Company Profile ...Dividend History ...List of ETFs holding XERS$2.61$1.42$12.94
672.Trevi Therapeutics (TRVI)$97.96 million46.4%Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions. The company's nalbuphine ER, which is in Phase IIbu002FIII clinical trial is an oral extended release formulation of nalbuphine that is used for the treatment of chronic pruritus, chronic cough in patients with idiop...See Company Profile ...Dividend History ...List of ETFs holding TRVI$5.49$1.33$8.49
673.Checkpoint Therapeutics (CKPT)$97.45 million2.91%Checkpoint Therapeutics, Inc., an immuno-oncology biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company...See Company Profile ...Dividend History ...List of ETFs holding CKPT$1.77$1.05$3.34
674.Windtree Therapeutics (WINT)$95.88 million64.71%Windtree Therapeutics, Inc., formerly Discovery Laboratories, Inc., incorporated on November 6, 1992, is a biotechnology company. The Company is focused on developing KL4 surfactant therapies for respiratory diseases and other ...See Company Profile ...Dividend History ...List of ETFs holding WINT$7$1.5$14.97
675.Fortress Biotech (FBIOP)$95.55 million-13.09%Fortress Biotech, Inc. develops and commercializes pharmaceutical and biotechnology products. The company develops CNDO-109, a lysate that treats cancer-related and other conditions; tramadol HCl for managing p...See Company Profile ...Dividend History ...List of ETFs holding FBIOP$17.8$12$21.95
676.DiaMedica Therapeutics (DMAC)$95.44 million39.18%DiaMedica Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of treatments for neurological and kidney diseases. The company's lead product is DM199, a recombinant human t...See Company Profile ...Dividend History ...List of ETFs holding DMAC$6.75$1.7$8.8
677.Navidea BioPharma (NAVB)$94.3 million213.49%Navidea Biopharmaceuticals, Inc. (Navidea), incorporated on April 28, 1988, is a biopharmaceutical company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. The Company is developing multiple ...See Company Profile ...Dividend History ...List of ETFs holding NAVB$3.95$0.49$4.45
678.Milestone Pharmaceuticals (MIST)$93.58 million-76.26%Milestone Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes etripamil for the treatment of cardiovascular indications. It is developing etripamil, a novel channel blocker that has completed Phase II clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada, as well as for treating atrial fibrillation and angina. The company ...See Company Profile ...Dividend History ...List of ETFs holding MIST$3.8$1.69$24.01
679.Stealth Biotherapeutics (MITO)$91.73 million-42.94%Stealth BioTherapeutics Corp, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. Its lead product candidate, Elamipretide, has the potential to treat rare genetic and common age-related mitochondrial diseases. The company's product candidates include SBT-20, a small peptide that targets and ...See Company Profile ...Dividend History ...List of ETFs holding MITO$1.86$0.9$14.41
680.EyePoint Pharmaceuticals (EYPT)$91.64 million-52.61%EyePoint Pharmaceuticals, Inc., a specialty biopharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases. The company's lead product is ILUVIEN for the treatment ...See Company Profile ...Dividend History ...List of ETFs holding EYPT$0.73$0.7$2.69
681.AcelRx Pharma (ACRX)$91.26 million-46.45%AcelRx Pharmaceuticals, Inc., incorporated on July 13, 2005, is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of moderate-to-severe acute pain. The Company ...See Company Profile ...Dividend History ...List of ETFs holding ACRX$1.13$0.7$3.02
682.Marker Therapeutics (MRKR)$91.2 million-31.94%Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor in...See Company Profile ...Dividend History ...List of ETFs holding MRKR$1.96$1.33$9.17
683.Biomerica (BMRA)$90.89 million170.71%Biomerica, Inc., incorporated on September 22, 1971, is a biomedical company, which develops, manufactures and markets medical diagnostic products for the early detection and monitoring of chronic diseases and medical ...See Company Profile ...Dividend History ...List of ETFs holding BMRA$8.04$2.05$23.39
684.Evoke Pharma (EVOK)$89.67 million124.07%Evoke Pharma, Inc., incorporated on January 29, 2007, is a specialty pharmaceutical company. The Company is focused primarily on the development of drugs to treat gastrointestinal (GI) disorders and diseases. ...See Company Profile ...Dividend History ...List of ETFs holding EVOK$3.63$0.73$5
685.Neon Therapeutics (NTGN)$88.93 million160.17%Neon Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in developing neoantigen-targeted therapies for cancers in the United States. It is developing NEO-PV-01, a neoantigen vaccine that is ...See Company Profile ...Dividend History ...List of ETFs holding NTGN$3.07$0.88$4.79
686.Senseonics (SENS)$87.3 million-58.32%Senseonics Holdings, Inc., incorporated on December 4, 2015, is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through ...See Company Profile ...Dividend History ...List of ETFs holding SENS$0.38$0.36$1.8
687.Assertio Therapeutics (ASRT)$86.02 million-34.71%Assertio Therapeutics, Inc., a specialty pharmaceutical company, engages in the development, sale, and licensing of products for pain and other central nervous system conditions in the United States. It offers ...See Company Profile ...Dividend History ...List of ETFs holding ASRT$0.82$0.55$3.55
688.Monopar Therapeutics (MNPR)$85.07 million-51.81%Monopar Therapeutics Inc., a biopharmaceutical company, engages in developing proprietary therapeutics to enhance clinical outcomes for cancer patients in the United States. It is involved in developing Validive, a clonidine mucobuccal tablet that has completed Phase II for the treatment of chemoradiation-induced severe oral mucositis; Camsirubicin, a proprietary doxorubicin analog that is in Phase II ...See Company Profile ...Dividend History ...List of ETFs holding MNPR$8$4.94$48
689.resTORbio (TORC)$84.19 million55.03%resTORbio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of aging-related diseases. Its lead program is targeting the...See Company Profile ...Dividend History ...List of ETFs holding TORC$2.31$0.86$11.96
690.OncoCyte (OCX)$84.02 million-44.44%OncoCyte Corporation (OncoCyte), incorporated on September 30, 2009, is a development-stage biotechnology company focused in the field of regenerative medicine. The Company is developing molecular cancer diagnostics utilizing a discovery ...See Company Profile ...Dividend History ...List of ETFs holding OCX$1.25$1.22$3.51
691.Cocrystal Pharma (COCP)$83.43 million220%Cocrystal Pharma, Inc., a clinical stage biotechnology company, engages in discovering and developing various novel antiviral therapeutics that target the replication machinery of hepatitis viruses, influenza v...See Company Profile ...Dividend History ...List of ETFs holding COCP$1.6$0.39$2.95
692.Organovo (ONVO)$83.3 million77.22%Organovo Holdings, Inc., incorporated on January 27, 2012, is an early commercial-stage company focused on developing and commercializing functional human tissues that can be employed in drug discovery and development, ...See Company Profile ...Dividend History ...List of ETFs holding ONVO$0.64$0.19$0.93
693.Sundial Growers (SNDL)$82.66 million-74.42%Sundial Growers Inc. engages in the production, distribution, and sale of cannabis for medical and adult recreational access in Canada. The company also focuses on supplying herbs and ornamental flowers, including basil, coriander, mint, dill, tulips, roses, and poinsettias in the United Kingdom. It serves the adult-use cannabis industry. The company offers its products under the Sundial, Top Leaf, and...See Company Profile ...Dividend History ...List of ETFs holding SNDL$0.77$0.37$13.22
694.Zynerba Pharma (ZYNE)$81.09 million-46.19%Zynerba Pharmaceuticals, Inc., incorporated on January 31, 2007, is a specialty pharmaceutical company. The Company is engaged in developing and commercializing transdermal synthetic cannabinoid treatments for patients with high unmet ...See Company Profile ...Dividend History ...List of ETFs holding ZYNE$3.25$2.55$15
695.Sanuwave Health (SNWV)$78.52 million62.44%SANUWAVE Health, Inc., a shock wave technology company, focuses on the development and commercialization of noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications wo...See Company Profile ...Dividend History ...List of ETFs holding SNWV$0.26$0.1$0.32
696.Sesen Bio (SESN)$78.08 million-32.01%Sesen Bio, Inc., a late-stage clinical company, develops next-generation antibody-drug conjugate therapies for patients with cancer. It develops its products based on its Targeted Protein Therapeutics (TPTs) pl...See Company Profile ...Dividend History ...List of ETFs holding SESN$0.71$0.37$1.54
697.Oramed Pharma (ORMP)$77.98 million-34.95%Oramed Pharmaceuticals Inc. (Oramed) is engaged in the field of oral delivery solutions for drugs and vaccines presently delivered via injection. OramedÆs flagship product, an orally ingestible insulin capsule in ...See Company Profile ...Dividend History ...List of ETFs holding ORMP$3.35$2.32$6.05
698.Oncolytics Biotech (ONCY)$77.74 million-59.87%Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing REOLYSIN, an im...See Company Profile ...Dividend History ...List of ETFs holding ONCY$1.91$0.35$6.02
699.Chembio Diagnostics (CEMI)$76.84 million-16.45%Chembio Diagnostics, Inc. (Chembio), incorporated on May 14, 1999, and its subsidiary, Chembio Diagnostic Systems, Inc., develop, manufacture, market and license rapid point-of-care diagnostic tests (POCTs) that detect infectious diseases. ...See Company Profile ...Dividend History ...List of ETFs holding CEMI$3.81$2.25$15.89
700.Heat Biologics (HTBX)$75.53 million85.85%Heat Biologics, Inc., incorporated on June 10, 2008, is a development-stage company focused on developing allogeneic, off-the-shelf cellular therapeutic vaccines to combat a range of cancers. The Company is an ...See Company Profile ...Dividend History ...List of ETFs holding HTBX$0.89$0.2$1.25
701.Unum Therapeutics (UMRX)$74.48 million231.94%Unum Therapeutics Inc., a clinical stage biopharmaceutical company, develops and commercializes immunotherapy products designed to harness the power of a patient's immune system to cure cancer. Its lead product candidate is the ACTR087 used in combination with rituximab, which is in Phase I clinical trials to treat adult patients with ...See Company Profile ...Dividend History ...List of ETFs holding UMRX$2.39$0.3$3.4
702.Aclaris Therapeutics (ACRS)$74.1 million-6.35%Aclaris Therapeutics, Inc., incorporated on July 13, 2012, is a clinical-stage specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing differentiated drugs for the treatment of dermatological ...See Company Profile ...Dividend History ...List of ETFs holding ACRS$1.77$0.7$2.38
703.EDAP TMS (EDAP)$72.56 million-43.79%EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldw...See Company Profile ...Dividend History ...List of ETFs holding EDAP$2.49$1.46$5.39
704.Adamas Pharma (ADMS)$72.09 million-32.45%Adamas Pharmaceuticals, Inc., incorporated on November 15, 2000, is a pharmaceutical company. The Company is engaged in developing medicines to manage the daily lives of those affected by chronic neurologic ...See Company Profile ...Dividend History ...List of ETFs holding ADMS$2.56$1.9$7.78
705.Concord Medical (CCM)$72.07 million-37.83%Concord Medical Services Holdings Limited, incorporated on November 27, 2007, is engaged in the leasing of radiotherapy and diagnostic imaging equipment, the provision of management services to hospitals. The Company ...See Company Profile ...Dividend History ...List of ETFs holding CCM$1.66$1.13$2.92
706.Celcuity (CELC)$71.92 million-34.21%Celcuity Inc., a cellular analysis company, discovers cancer sub-types and commercializes diagnostic tests to enhance the response rates of cancer patients treated with targeted therapies in the United States. ...See Company Profile ...Dividend History ...List of ETFs holding CELC$7$4.03$24.02
707.SCYNEXIS (SCYX)$71.77 million-20.19%SCYNEXIS, Inc., incorporated on November 4, 1999, is a pharmaceutical company, which is engaged in the discovery, development and commercialization of anti-infectives to address unmet therapeutic needs. The Company is ...See Company Profile ...Dividend History ...List of ETFs holding SCYX$0.73$0.5$1.44
708.Proteostasis Therapeutics (PTI)$70.92 million-40.35%Proteostasis Therapeutics, Inc. is a biopharmaceutical company. The Company is engaged in discovery and development of therapeutics that treat diseases caused by an imbalance in the proteostasis network, a set ...See Company Profile ...Dividend History ...List of ETFs holding PTI$1.36$0.61$4.72
709.Akari Therapeutics (AKTX)$70.6 million20.57%Akari Therapeutics, Plc, formerly Celsus Therapeutics Plc, incorporated on October 7, 2004, is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of treatments for a ...See Company Profile ...Dividend History ...List of ETFs holding AKTX$2.11$0.87$3.35
710.Anixa Biosciences (ANIX)$70.33 million-8.84%Anixa Biosciences, Inc., a cancer-focused biotechnology company, develops both diagnostics and therapeutics to detect cancer. The company is developing the Cchek platform, a series of non-invasive blood tests f...See Company Profile ...Dividend History ...List of ETFs holding ANIX$2.99$1.33$5.45
711.Happiness Biotech Group (HAPP)$69.25 million-39.25%Happiness Biotech Group Limited engages in the research, development, manufacture, and sale of nutraceutical and dietary supplements products made of Lucidum spore powder and others in the People's Republic of China. It also offers edible fungi. The company was founded in 2004 and is based in Nanping, China....See Company Profile ...Dividend History ...List of ETFs holding HAPP$2.77$2.44$6.1
712.Synlogic (SYBX)$67.65 million-20.16%Synlogic, Inc. a clinical-stage biopharmaceutical company, focuses on the discovery and development of synthetic biotic medicines to treat metabolic, inflammatory, and cancer diseases in the United States. Its ...See Company Profile ...Dividend History ...List of ETFs holding SYBX$2.06$1.35$9.13
713.CohBar (CWBR)$66.48 million-3.75%CohBar, Inc., a clinical stage biotechnology company, engages in the research and development of mitochondria based therapeutics (MBTs), an emerging class of drugs for the treatment of age-related diseases. The...See Company Profile ...Dividend History ...List of ETFs holding CWBR$1.54$0.87$4.25
714.Pro-Dex (PDEX)$66.35 million-0.8%Pro-Dex, Inc. (Pro-Dex), incorporated on March 6, 2002, designs and produces surgical and dental instruments and motion control products used in the medical, factory automation and scientific research industries. The ...See Company Profile ...Dividend History ...List of ETFs holding PDEX$17.41$11.4$23.9
715.Acasti Pharma (ACST)$66.06 million-70.61%Acasti Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing, clinically studying and marketing new pharmaceutical products to treat human cardiovascular conditions. The Company is involved ...See Company Profile ...Dividend History ...List of ETFs holding ACST$0.72$0.25$3.08
716.Verona Pharma (VRNA)$65.75 million-13.04%Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and IIa clinical trials that acts as a bronchodilator and an anti-inflammatory ...See Company Profile ...Dividend History ...List of ETFs holding VRNA$5$2.01$12.89
717.Daxor (DXR)$65.53 million79.26%Daxor Corporation, incorporated on May 5, 1971, is an investment company with medical instrumentation and biotechnology operations. The Company engages in the short selling of stock. The Company maintains a ...See Company Profile ...Dividend History ...List of ETFs holding DXR$16.85$7.77$17.9
718.Anpac Bio-Medical (ANPC)$65.19 million-48.27%Anpac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests to corporations and life insurance companies in the People's Republic of China and the United States. It also manufactures cancer differentiation analysis devices; and offers physical checkup package services. The company was founded in 2010 and is headquarte...See Company Profile ...Dividend History ...List of ETFs holding ANPC$5.82$5.06$12.18
719.Lipocine (LPCN)$64.64 million255.26%Lipocine Inc., incorporated on October 13, 2011, is a specialty pharmaceutical company. The Company is focused on applying its oral drug delivery technology for the development of pharmaceutical products in ...See Company Profile ...Dividend History ...List of ETFs holding LPCN$1.35$0.3$3.45
720.Brainsway (BWAY)$63.7 million-41.03%Brainsway Ltd. engages in the development and provision of technology solutions for non-invasive treatment of brain disorders in Israel and internationally. It offers deep transcranial magnetic stimulation systems for treating various conditions, including autism, Alzheimer's disease, bipolar disorders, chronic pains, depressive disorders, Parkinson's diseases, schizophrenia, smoking cessation, post-tr...See Company Profile ...Dividend History ...List of ETFs holding BWAY$5.75$5.1$12.53
721.Capricor Therapeutics (CAPR)$63.19 million246.09%Capricor Therapeutics, Inc., incorporated on January 26, 2007, is a clinical-stage biotechnology company focused on the discovery, development and commercialization of therapeutics. The Company focuses on discovering, developing and commercializing ...See Company Profile ...Dividend History ...List of ETFs holding CAPR$4.43$0.88$11.08
722.Citius Pharmaceuticals (CTXR)$62.81 million36.27%Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products. It primarily focuses on developing anti-infective, cancer care, and prescription products. T...See Company Profile ...Dividend History ...List of ETFs holding CTXR$1.39$0.4$1.97
723.NanoViricides (NNVC)$62.79 million175.7%NanoViricides, Inc., incorporated on April 1, 2005, is a nano-biopharmaceutical company. The Company is a development-stage company with several drugs in various stages of development. The Company focuses on its ...See Company Profile ...Dividend History ...List of ETFs holding NNVC$6.92$1.27$19.2
724.Vaccinex (VCNX)$62.42 million-22.68%Vaccinex, Inc. operates as a clinical-stage biotechnology company. It engages in the discovery and development of bio therapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is VX15 that is in Phase Ib 002FII clinical trials for ...See Company Profile ...Dividend History ...List of ETFs holding VCNX$3.75$3.22$12.23
725.Titan Medical (TMDI)$62.15 million66%Titan Medical Inc., a development stage company, focuses on design and development of robotic surgical system for application in minimally invasive surgery (MIS). The company is developing SPORT Surgical System...See Company Profile ...Dividend History ...List of ETFs holding TMDI$0.83$0.12$2.71
726.Zomedica Pharmaceuticals (ZOM)$61.95 million-48%Zomedica Pharmaceuticals Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. The company's lead drug product candidate is ZM-012, a tablet formulation of metronidazole targeting the treatment of acute diarrhea in dogs. It is also developing ZM-007, ...See Company Profile ...Dividend History ...List of ETFs holding ZOM$0.17$0.11$0.5
727.Trinity Biotech (TRIB)$61.06 million146.6%Trinity Biotech plc (Trinity Biotech), incorporated on January 22, 1992, develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. ...See Company Profile ...Dividend History ...List of ETFs holding TRIB$2.54$0.56$2.83
728.CollPlant (CLGN)$60.92 million65.26%CollPlant Holdings Ltd., a regenerative medicine company, focuses on developing and commercializing tissue repair products for three-dimensional (3D) bio-printing of tissues and organs, orthobiologics, and adva...See Company Profile ...Dividend History ...List of ETFs holding CLGN$9.42$3.35$14.55
729.Vascular Biogenics (VBLT)$60.35 million5%Vascular Biogenics Ltd., incorporated on January 31, 2000, is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of treatments for cancer. The Companys program ...See Company Profile ...Dividend History ...List of ETFs holding VBLT$1.26$0.9$1.64
730.Idera Pharma (IDRA)$59.11 million-3.85%Idera Pharmaceuticals, Inc., incorporated on August 24, 2005, is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapeutics for oncology and rare diseases. The Company utilizes ...See Company Profile ...Dividend History ...List of ETFs holding IDRA$1.75$0.81$3.58
731.ConforMIS (CFMS)$57.54 million-46.34%ConforMIS, Inc., incorporated on March 26, 2004, is a medical technology company. The Company uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants, which are ...See Company Profile ...Dividend History ...List of ETFs holding CFMS$0.8$0.5$3.88
732.Aridis Pharmaceuticals (ARDS)$57.29 million44.27%Aridis Pharmaceuticals Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening in...See Company Profile ...Dividend History ...List of ETFs holding ARDS$6.42$3.8$12.4
733.Genocea Biosciences (GNCA)$56.95 million-0.48%Genocea Biosciences, Inc., incorporated on August 16, 2006, is harnessing the power of T cell immunity to develop vaccines and immunotherapies. The Company uses its discovery platform, AnTigen Lead Acquisition ...See Company Profile ...Dividend History ...List of ETFs holding GNCA$2.06$1.1$3.94
734.miRagen Therapeutics (MGEN)$55.73 million118.75%Miragen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing proprietary RNA-targeted therapies with a specific focus on microRNAs and their role in diseases whe...See Company Profile ...Dividend History ...List of ETFs holding MGEN$1.05$0.31$2.47
735.Eyenovia (EYEN)$55.57 million-37.28%Eyenovia, Inc., a clinical stage biopharmaceutical company, engages in developing a pipeline of ophthalmology products in the United States. It is developing MicroProst, which is in Phase III clinical trials fo...See Company Profile ...Dividend History ...List of ETFs holding EYEN$2.81$1.11$5.06
736.Diffusion Pharma (DFFN)$54.9 million100.13%Diffusion Pharmaceuticals Inc., formerly RestorGenex Corporation, incorporated on June 17, 2015, is a clinical-stage biotechnology company. The Company is focused on developing standard-of-care treatments, including radiation therapy and chemotherapy. The ...See Company Profile ...Dividend History ...List of ETFs holding DFFN$0.92$0.21$2.72
737.Ekso Bionics (EKSO)$54.81 million20.33%Ekso Bionics Holdings, Inc., formerly PN Med Group, Inc., incorporated on January 30, 2012, designs, develops and sells wearable bionic human exoskeletons that have applications in healthcare, industrial, military and ...See Company Profile ...Dividend History ...List of ETFs holding EKSO$7.22$2.25$19.65
738.Soligenix (SNGX)$54.22 million40.69%Soligenix, Inc. (Soligenix), incorporated on January 16, 1987, is a late-stage biopharmaceutical company. The Company is focused on developing and commercializing products to treat rare diseases. The Company operates through ...See Company Profile ...Dividend History ...List of ETFs holding SNGX$2.04$0.85$3.54
739.Bioanalytical (BASI)$53.89 million0.2%Bioanalytical systems, Inc., incorporated on July 17, 1975, is an international contract research company providing drug discovery and development services and analytical instruments. The Company focuses on providing drug developers ...See Company Profile ...Dividend History ...List of ETFs holding BASI$4.96$1.95$6.5
740.Inmune Bio (INMB)$53.73 million-14.4%INmune Bio Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer. The company intends to develop and commercialize product candidates to treat diseases comprising hematologic malignancies and solid tumors. Its development programs include INKmune, which focuses on treating women with relapse refractory ovarian carcinoma; INB03 that tre...See Company Profile ...Dividend History ...List of ETFs holding INMB$4.97$2.2$10.35
741.Moleculin Biotech (MBRX)$53.58 million-3.58%Moleculin Biotech, Inc., incorporated on July 28, 2015, is a preclinical and clinical-stage pharmaceutical company. The Company is focused on the development of anti-cancer drug candidates. The Companys lead drug ...See Company Profile ...Dividend History ...List of ETFs holding MBRX$0.89$0.32$1.97
742.Aerpio Pharmaceuticals (ARPO)$52.36 million108.06%Aerpio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for ocular diseases. The company's lead product candidate is AKB-9778, a small molecule activator ...See Company Profile ...Dividend History ...List of ETFs holding ARPO$1.29$0.42$1.53
743.Cumberland Pharma (CPIX)$50.41 million-35.73%Cumberland Pharmaceuticals Inc. (Cumberland), incorporated on January 7, 1999, is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription products. The Company ...See Company Profile ...Dividend History ...List of ETFs holding CPIX$3.31$3.1$6.27
744.Equillium (EQ)$50.05 million-16.27%Equillium, Inc., a biotechnology company, develops products for autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. Its primary product candidate is EQ001, a clinical-stage mo...See Company Profile ...Dividend History ...List of ETFs holding EQ$2.83$2.2$6.14
745.Infinity Pharma (INFI)$49.87 million-9.55%Infinity Pharmaceuticals, Inc., incorporated on May 11, 2000, is a biopharmaceutical company. The Company is engaged in the discovery, development and delivery of medicines to treat diseases. The Company develops ...See Company Profile ...Dividend History ...List of ETFs holding INFI$0.87$0.6$1.75
746.Sensus Healthcare (SRTS)$49.55 million-15.25%Sensus Healthcare, Inc., formerly Sensus Healthcare, LLC, incorporated on May 7, 2010, is a manufacturer of superficial radiation therapy devices. The Company designs, manufactures and markets medical devices specializing in ...See Company Profile ...Dividend History ...List of ETFs holding SRTS$3$1.76$6.58
747.Microbot Medical (MBOT)$48.66 million-32.65%Microbot Medical Inc., formerly StemCells, Inc., incorporated on August 2, 1988, is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies ...See Company Profile ...Dividend History ...List of ETFs holding MBOT$6.85$4.3$20.15
748.Allena Pharmaceuticals (ALNA)$47.01 million-46.52%Allena Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, engages in the development and commercialization of oral enzyme therapeutics to treat patients with rare and severe metabolic, and ...See Company Profile ...Dividend History ...List of ETFs holding ALNA$1.46$0.53$6.3
749.Merrimack Pharma (MACK)$46.97 million11.43%Merrimack Pharmaceuticals, Inc., incorporated on July 6, 2010, is a biopharmaceutical company. The Company is engaged in discovering, developing and commercializing medicines consisting of therapeutics paired with companion diagnostics for ...See Company Profile ...Dividend History ...List of ETFs holding MACK$3.51$1.49$6.19
750.PolarityTE (PTE)$46.93 million-53.08%PolarityTE, Inc., a biotechnology and regenerative biomaterials company, focuses on discovering, designing, and developing a range of regenerative tissue products and biomaterials for the fields of medicine, bi...See Company Profile ...Dividend History ...List of ETFs holding PTE$1.22$0.78$5.79
751.Pulmatrix (PULM)$46.61 million111.63%Pulmatrix, Inc., incorporated on September 25, 2013, is a clinical stage biopharmaceutical company developing inhaled therapies to address serious pulmonary disease. The Company?ÇÖs product pipeline is focused on advancing treatments ...See Company Profile ...Dividend History ...List of ETFs holding PULM$1.82$0.61$2.06
752.Annovis Bio (ANVS)$46.51 million-29.3%Annovis Bio, Inc., a clinical stage drug platform company, focuses on developing compounds to address neurodegeneration. The company's lead compound is ANVS-401, which is in Phase 2a clinical trials for the treatment of chronic neurodegenerative diseases, such as Down syndrome, Alzheimer's disease (AD), and Parkinson's disease. It is also developing ANVS-301, a compound in Phase 1 clinical trials to in...See Company Profile ...Dividend History ...List of ETFs holding ANVS$6.78$2.42$10.61
753.OncoSec Medical (ONCS)$45.6 million9.39%OncoSec Medical Incorporated, incorporated on February 8, 2008, is a biotechnology company. The Company is focused on designing, developing and commercializing gene therapies, therapeutics and medical approaches to stimulate an ...See Company Profile ...Dividend History ...List of ETFs holding ONCS$1.98$1.04$2.97
754.Allied Healthcare Products (AHPI)$44.71 million820.66%Allied Healthcare Products, Inc., incorporated on December 19, 1979, manufactures a range of respiratory products used in the healthcare industry in a range of hospital and alternate site settings, including ...See Company Profile ...Dividend History ...List of ETFs holding AHPI$11.14$0.92$45
755.Zosano Pharma (ZSAN)$43.96 million-46.8%Zosano Pharma Corporation, incorporated on January 26, 2012, is a clinical-stage specialty pharmaceutical company. The Company has developed a transdermal microneedle patch system to deliver its formulations of existing drugs ...See Company Profile ...Dividend History ...List of ETFs holding ZSAN$0.81$0.41$3.52
756.Aileron Therapeutics (ALRN)$43.9 million101.75%Aileron Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing a novel class of therapeutics in the United States. The company's lead product candidate is ALRN...See Company Profile ...Dividend History ...List of ETFs holding ALRN$1.15$0.25$1.99
757.Forward Pharma AS (FWP)$43.9 million-1.85%Forward Pharma Au002FS operates as a biopharmaceutical company. The company focuses on developing FP187, a proprietary formulation of dimethyl fumarate used for the treatment of various inflammatory ...See Company Profile ...Dividend History ...List of ETFs holding FWP$6.37$4.61$12.72
758.Oragenics (OGEN)$43.6 million51.46%Oragenics, Inc., incorporated on November 6, 1996, develops, markets and sells probiotics specifically designed to enhance oral health for humans and pets, under the brand names Evora and ProBiora. The ...See Company Profile ...Dividend History ...List of ETFs holding OGEN$0.79$0.35$0.92
759.IsoRay (ISR)$43.33 million3.31%IsoRay, Inc., incorporated on July 13, 1983, is a medical technology company. The Company, through its subsidiary, IsoRay Medical, Inc., develops, manufactures and sells isotope-based medical products and devices for ...See Company Profile ...Dividend History ...List of ETFs holding ISR$0.64$0.29$1.06
760.Curis (CRIS)$43.17 million-30.59%Curis, Inc., incorporated on February 14, 2000, is a biotechnology company seeking to develop and commercialize drug candidates for the treatment of cancers. The Companys drug candidate is CUDC-907, an ...See Company Profile ...Dividend History ...List of ETFs holding CRIS$1.18$0.62$3.59
761.Immutep (IMMP)$42.02 million-41.34%Immutep Limited, a biotechnology company, engages in the research, development, and commercialization of biological products. The company develops immunotherapeutic products for the treatment of cancer and auto...See Company Profile ...Dividend History ...List of ETFs holding IMMP$1.05$0.53$3.1
762.Novan (NOVN)$41.04 million-83.92%Novan, Inc. is a late-stage pharmaceutical company. The Company is engaged in the development and commercialization of therapies using its nitric oxide platform. The Company develops product candidates using its ...See Company Profile ...Dividend History ...List of ETFs holding NOVN$0.51$0.22$3.72
763.Bellicum Pharma (BLCM)$40.45 million-37.91%Bellicum Pharmaceuticals, Inc., incorporated on July 14, 2004, is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing cellular immunotherapies for various forms of cancer, including hematological ...See Company Profile ...Dividend History ...List of ETFs holding BLCM$8.01$3.32$27.9
764.Bionano Genomics (BNGO)$40.17 million-61.4%Bionano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The company develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specific str...See Company Profile ...Dividend History ...List of ETFs holding BNGO$0.48$0.25$4.7
765.aTyr Pharma (LIFE)$40.06 million2.64%aTyr Pharma, Inc., incorporated on October 8, 2005, is a clinical-stage biotherapeutics company. The Company is engaged in the discovery and clinical development of medicines for patients suffering from severe, ...See Company Profile ...Dividend History ...List of ETFs holding LIFE$4.28$2.13$7.62
766.TransEnterix (TRXC)$39.61 million-72.99%TransEnterix, Inc., incorporated in August 19, 1988, is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), a ...See Company Profile ...Dividend History ...List of ETFs holding TRXC$0.4$0.28$25.22
767.ImmuCell (ICCC)$39.6 million6.6%ImmuCell Corporation, incorporated on February 9, 1987, is an animal health company. The Company operates in the development, acquisition, manufacture and sale of products that improve the health and productivity ...See Company Profile ...Dividend History ...List of ETFs holding ICCC$5.49$3.7$8.13
768.Neovasc (NVCN)$39.59 million-54.71%Neovasc Inc. (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Companys segment is the development, manufacture and marketing of ...See Company Profile ...Dividend History ...List of ETFs holding NVCN$2.45$1.24$8.65
769.Strata Skin Sciences (SSKN)$39.45 million-43.75%STRATA Skin Sciences, Inc., formerly MELA Sciences, Inc., incorporated on October 3, 1997, is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis ...See Company Profile ...Dividend History ...List of ETFs holding SSKN$1.17$0.75$2.92
770.HTG Molecular Diagnostics (HTGM)$39.01 million-10.43%HTG Molecular Diagnostics, Inc., incorporated on December 14, 2000, is a commercial-stage company that develops and markets a technology platform to facilitate the routine use of complex molecular profiling. The ...See Company Profile ...Dividend History ...List of ETFs holding HTGM$0.63$0.27$1.64
771.Opiant Pharmaceuticals (OPNT)$38.96 million-36.46%Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops pharmacological treatments for substance use, addictive and eating disorders. The company offers NARCAN nasal spray, a treatment to rev...See Company Profile ...Dividend History ...List of ETFs holding OPNT$9.15$8.05$18.23
772.Adamis Pharma (ADMP)$38.48 million-25.44%Adamis Pharmaceuticals Corporation, incorporated on April 22, 2004, is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products ...See Company Profile ...Dividend History ...List of ETFs holding ADMP$0.52$0.27$1.57
773.NovaBay Pharma (NBY)$38.38 million69.12%NovaBay Pharmaceuticals, Inc., formerly NovaCal Pharmaceuticals, Inc., incorporated on April 19, 2010, is a biopharmaceutical company, which develops products for the eye care market. The Company focuses on commercializing prescription ...See Company Profile ...Dividend History ...List of ETFs holding NBY$1.15$0.24$1.85
774.ASLAN Pharmaceuticals (ASLN)$36.79 million-3.94%ASLAN Pharmaceuticals Limited, a clinical-stage oncology-focused biopharmaceutical company, engages in the development of drugs for prevalent cancers. It targets diseases that are prevalent in Asia, and orphan ...See Company Profile ...Dividend History ...List of ETFs holding ASLN$1.95$0.35$8.18
775.Motus GI (MOTS)$36.65 million-44.54%Motus GI Holdings, Inc. operates as a medical technology company to enhance the endoscopy outcomes and experiences in the United States and Israel. It focuses on the development and commercialization of the Pur...See Company Profile ...Dividend History ...List of ETFs holding MOTS$1.27$0.46$3.4
776.Guardion Health Sciences (GHSI)$36.06 million91.41%Guardion Health Sciences, Inc., a specialty health sciences company, develops, formulates, and distributes condition-specific medical foods in the United States and internationally. It operates in two segments, Medical Foods and Vision Testing Diagnostics. The Medical Foods segment offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; MapcatSF, a medical device t...See Company Profile ...Dividend History ...List of ETFs holding GHSI$0.42$0.17$3.05
777.Neuronetics (STIM)$35.4 million-57.91%Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with psychiatric disorders. It offers NeuroStar Advanced Therapy System, a non-invasive and...See Company Profile ...Dividend History ...List of ETFs holding STIM$1.89$1.25$13.31
778.Cellectar Biosciences (CLRB)$35.28 million-34.67%Cellectar Biosciences, Inc., formerly Novelos Therapeutics, Inc., incorporated on June 24, 1996, is a clinical stage biopharmaceutical company. The Company is engaged in developing phospholipid ether-drug conjugates (PDCs) for the ...See Company Profile ...Dividend History ...List of ETFs holding CLRB$1.47$1.01$3.33
779.BioLineRx (BLRX)$35.08 million-23.56%BioLine RX Ltd is an Israel-based company engaged in the development of therapeutics, from preclinical-stage development to advanced clinical trials, for a range of medical needs. Its clinical therapeutic candidates ...See Company Profile ...Dividend History ...List of ETFs holding BLRX$1.72$1.06$4.75
780.Apollo Endosurgery (APEN)$34.55 million-42.81%Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. It develops and distributes devices for minimally invasive surgica...See Company Profile ...Dividend History ...List of ETFs holding APEN$1.63$1.24$3.79
781.Neos Therapeutics (NEOS)$34.33 million-54.3%Neos Therapeutics, Inc., incorporated on June 15, 2009, is a pharmaceutical company. The Company is focused on developing, manufacturing and commercializing products utilizing its modified-release drug delivery technology platform. The ...See Company Profile ...Dividend History ...List of ETFs holding NEOS$0.69$0.6$2.15
782.Entera Bio (ENTX)$34.28 million-12.15%Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product ...See Company Profile ...Dividend History ...List of ETFs holding ENTX$1.88$1.35$3.77
783.Acorda Therapeutics (ACOR)$34.12 million-65.15%Acorda Therapeutics, Inc., incorporated on March 17, 1995, is a biopharmaceutical company. The Company focuses on developing therapies that restore function and improve the lives of people with neurological disorders. ...See Company Profile ...Dividend History ...List of ETFs holding ACOR$0.71$0.7$7.15
784.Hoth Therapeutics (HOTH)$34.09 million-58.97%Hoth Therapeutics, Inc., a biopharmaceutical company, focuses on developing targeted therapeutics for eczema, dermatological and chronic wound disorders, psoriasis, and acne. It intends to use the BioLexa Platform to develop 2 topical cream products that treat eczema and reduces post-procedure infections for patients undergoing aesthetic dermatology procedures. The company has a sponsored research agre...See Company Profile ...Dividend History ...List of ETFs holding HOTH$2.54$2.31$7.87
785.Advaxis (ADXS)$34.05 million-35.73%Advaxis, Inc., incorporated on February 28, 2002, is a clinical-stage biotechnology company focused on the discovery, development and commercialization of Listeria monocytogenes (Lm)-Listeriolysin O (LLO) cancer immunotherapies. These immunotherapies are ...See Company Profile ...Dividend History ...List of ETFs holding ADXS$0.55$0.21$1.73
786.AgeX Therapeutics (AGE)$33.9 million-50.54%AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of therapeutics for age-related degenerative diseases in the United Stated. The company is developing AGEX-BAT1...See Company Profile ...Dividend History ...List of ETFs holding AGE$0.9$0.67$3.36
787.Genetic (GENE)$33.6 million15.58%Genetic Technologies Limited, incorporated on January 5, 1987, is a molecular diagnostics company. The Company is engaged in the provision of molecular risk assessment for cancer. The Company offers predictive ...See Company Profile ...Dividend History ...List of ETFs holding GENE$2.3$1.41$5.36
788.NewLink Genetics (NLNK)$33.22 million-64.82%NewLink Genetics Corporation (NewLink), incorporated on June 4, 1999, is a clinical-stage immuno-oncology company focused on discovering, developing and commercializing immunotherapeutic products for the treatment of cancer. The Companys portfolio ...See Company Profile ...Dividend History ...List of ETFs holding NLNK$0.89$0.82$9.54
789.Tonix Pharma Holding (TNXP)$33.03 million-48.24%Tonix Pharmaceuticals Holding Corp. (Tonix), incorporated on November 16, 2007, is a clinical-stage pharmaceutical company. The Companys drug development programs are directed toward disorders affecting the central nervous system (CNS), ...See Company Profile ...Dividend History ...List of ETFs holding TNXP$0.61$0.39$12.3
790.electroCore (ECOR)$32.72 million-46.03%electroCore, LLC, a bioelectronic medicine company, engages in developing a range of patient-administered non-invasive vagus nerve stimulation therapies for the treatment of various conditions in neurology, rhe...See Company Profile ...Dividend History ...List of ETFs holding ECOR$0.86$0.32$5.64
791.Sintx Technologies (SINT)$32.6 million28.86%Sintx Technologies, Inc., a biomaterial company, develops, manufactures, and commercializes a range of medical devices based on its silicon nitride technology platform in the United States, Europe, and South Am...See Company Profile ...Dividend History ...List of ETFs holding SINT$1.92$0.28$4.39
792.Atossa Genetics (ATOS)$32.23 million122.93%Atossa Genetics Inc., incorporated on April 30, 2009, is a clinical-stage pharmaceutical company focused on the development of therapeutics and delivery methods for the treatment of breast cancer and other ...See Company Profile ...Dividend History ...List of ETFs holding ATOS$3.5$0.76$4.27
793.Acer Therapeutics (ACER)$32.08 million-21.95%Acer Therapeutics Inc., a pharmaceutical company, develops therapies for the treatment of rare diseases with critical unmet medical needs. Its product candidates include Celiprolol for the treatment of vascular...See Company Profile ...Dividend History ...List of ETFs holding ACER$3.13$1.08$7.25
794.CNS Pharmaceuticals (CNSP)$32.08 million-50.63%CNS Pharmaceuticals, Inc., a preclinical stage pharmaceutical company, focuses on the development of anti-cancer drug candidates for the treatment of primary and metastatic brain, and central nervous system tumors. Its lead drug candidate is Berubicin, which completed Phase I clinical trial that is used for the treatment of glioblastoma. The company was founded in 2017 and is based in Houston, Texas....See Company Profile ...Dividend History ...List of ETFs holding CNSP$1.95$1.26$5.69
795.OpGen (OPGN)$32 million83.19%OpGen, Inc. (OpGen), incorporated on January 22, 2001, is a precision medicine company using molecular diagnostics and informatics to combat infectious disease. The Company is engaged in developing molecular information ...See Company Profile ...Dividend History ...List of ETFs holding OPGN$2.07$0.92$12.8
796.Immuron (IMRN)$31.31 million99.45%Immuron Limited, a biopharmaceutical company, focuses on the research and development of immunomodulatory polyclonal antibodies for the treatment and prevention of various diseases through its oral immunoglobul...See Company Profile ...Dividend History ...List of ETFs holding IMRN$7.24$1.55$28.99
797.Sunesis Pharma (SNSS)$31.19 million-17.65%Sunesis Pharmaceuticals, Inc., incorporated on February 10, 1998, is a biopharmaceutical company. The Company focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of ...See Company Profile ...Dividend History ...List of ETFs holding SNSS$0.28$0.2$1.13
798.Caladrius Biosciences (CLBS)$30.64 million-21.51%Caladrius Biosciences, Inc., formerly NeoStem, Inc., incorporated on October 18, 1980, through its subsidiary, PCT, LLC, a Caladrius Company (PCT), provides development and manufacturing services to the cell therapy industry ...See Company Profile ...Dividend History ...List of ETFs holding CLBS$1.97$1.05$3.64
799.Millendo Therapeutics (MLND)$30.59 million-76.11%Millendo Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of various treatments for orphan endocrine diseases in the United States. The company's lead drug candidates i...See Company Profile ...Dividend History ...List of ETFs holding MLND$1.61$1.26$12.16
800.IRIDEX (IRIX)$30.34 million-1.79%IRIDEX Corporation, incorporated on November 21, 1995, is a provider of therapeutic-based laser consoles, delivery devices and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. The Company operates ...See Company Profile ...Dividend History ...List of ETFs holding IRIX$2.2$1.22$4.24
801.Aptevo Therapeutics (APVO)$30.29 million4.11%Aptevo Therapeutics Inc., incorporated on February 22, 2016, is a biotechnology company. The Company is focused on oncology and hematology therapeutics. The Company is engaged in the discovery, development, commercialization ...See Company Profile ...Dividend History ...List of ETFs holding APVO$9.37$2.94$14.28
802.Cleveland BioLabs (CBLI)$29.59 million281.67%Cleveland BioLabs, Inc. (CBLI), incorporated on June 5, 2003, is a biopharmaceutical company. The Company is engaged in developing approaches to activate the immune system and address serious medical needs. ...See Company Profile ...Dividend History ...List of ETFs holding CBLI$2.29$0.5$5
803.VistaGen Therapeutics (VTGN)$29.49 million-23.38%VistaGen Therapeutics, Inc., incorporated on October 6, 2005, is a clinical-stage biopharmaceutical company. The Company is engaged in developing and commercializing product candidates for patients with diseases and disorders involving ...See Company Profile ...Dividend History ...List of ETFs holding VTGN$0.53$0.29$1.49
804.Psychemedics (PMD)$29.34 million-41.97%Psychemedics Corporation (Psychemedics), incorporated on September 24, 1986, provides hair testing for drugs of abuse, utilizing a hair analysis method involving digestion of hair, enzyme immunoassay (EIA) technology and confirmation ...See Company Profile ...Dividend History ...List of ETFs holding PMD$5.31$4.54$10.69
805.Alimera Sciences (ALIM)$28.78 million-24.54%Alimera Sciences, Inc. (Alimera), incorporated on June 4, 2003, is a pharmaceutical company. The Company is engaged in the research, development and commercialization of prescription ophthalmic pharmaceuticals. The Company operates ...See Company Profile ...Dividend History ...List of ETFs holding ALIM$5.72$0$9.98
806.Titan Pharma (TTNP)$28.7 million57.89%Titan Pharmaceuticals, Inc. (Titan), incorporated on February 7, 1992, is a specialty pharmaceutical company. The Company is engaged in developing therapeutics for the treatment of medical disorders. The Companys segment ...See Company Profile ...Dividend History ...List of ETFs holding TTNP$0.3$0.14$1.32
807.Neurotrope (NTRP)$28.41 million22.45%Neurotrope, Inc., a biopharmaceutical company, focuses on the development of a product platform for the treatment of Alzheimer's disease (AD). Its lead product candidate is bryostatin, a natural product isolate...See Company Profile ...Dividend History ...List of ETFs holding NTRP$1.2$0.63$7.34
808.Correvio Pharma (CORV)$27.79 million2.41%Correvio Pharma Corp., a specialty pharmaceutical company, provides various products to meet the needs of acute care physicians and patients worldwide. It develops, acquires, and commercializes various brands f...See Company Profile ...Dividend History ...List of ETFs holding CORV$0.42$0.21$2.79
809.PLx Pharma (PLXP)$27.47 million-31.35%PLx Pharma Inc., a late-stage specialty pharmaceutical company, focuses on developing non-steroidal anti-inflammatory drugs (NSAIDs) and other analgesics. The company's lead product candidates are Aspertec 81 m...See Company Profile ...Dividend History ...List of ETFs holding PLXP$3$1.8$6.96
810.Can-Fite Biopharma (CANF)$27.27 million-42.73%Can Fite Biofarma Ltd is an Israel-based biopharmaceutical company. The Company develops new treatments for autoimmune diseases and cancer. The Company?ÇÖs drugs are CF101 for Psoriasis treatment, RA treatment, for ...See Company Profile ...Dividend History ...List of ETFs holding CANF$1.89$1.08$4.95
811.Evogene (EVGN)$27.23 million-29.61%Evogene Ltd. (Evogene) is a biotechnology company for the improvement of crop productivity. The Company is engaged in developing seed traits for improved yield and abiotic stress tolerance, seed traits ...See Company Profile ...Dividend History ...List of ETFs holding EVGN$1.07$0.75$1.83
812.Dare Bioscience (DARE)$26.51 million21.32%Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing women's reproductive health products in the United States. The company intends to develop therapies in the...See Company Profile ...Dividend History ...List of ETFs holding DARE$0.99$0.69$2.22
813.Kazia Therapeutics (KZIA)$26.42 million-14.06%Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops therapies for a range of oncology indications. Its lead product is GDC-0084, a small molecule inhibitor of the PI3K AKT u0...See Company Profile ...Dividend History ...List of ETFs holding KZIA$3.73$2.27$9.74
814.DarioHealth (DRIO)$26.1 million4.88%DarioHealth Corp, formerly Labstyle Innovations Corp, incorporated on August 11, 2011, is a digital health (mHealth) company. The Company is engaged in developing and commercializing a technology providing consumers with ...See Company Profile ...Dividend History ...List of ETFs holding DRIO$6.88$0.2$11.25
815.Spring Bank Pharma (SBPH)$25.64 million-5.06%Spring Bank Pharmaceuticals, Inc., incorporated on May 12, 2008, is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of a class of therapeutics using its ...See Company Profile ...Dividend History ...List of ETFs holding SBPH$1.5$0.8$5.7
816.China Pharma (CPHI)$25.4 million142.83%China Pharma Holdings, Inc., incorporated on January 28, 1999, is a holding company. The Company conducts its production, marketing, finance, development and administrative activities through its subsidiary, Hainan Helpson Medical ...See Company Profile ...Dividend History ...List of ETFs holding CPHI$0.58$0.21$1.4
817.AzurRx BioPharma (AZRX)$23.98 million-18.26%AzurRx BioPharma, Inc., incorporated on January 30, 2014, is a clinical development-stage biopharmaceutical company. The Company is engaged in the research and development of non-systemic biologics for the treatment of ...See Company Profile ...Dividend History ...List of ETFs holding AZRX$0.85$0.37$1.94
818.CytRx (CYTR)$23.71 million143.1%CytRx Corporation, incorporated on February 28, 1985, is a biopharmaceutical research and development company specializing in oncology. The Company is focused on the clinical development of aldoxorubicin, its modified version ...See Company Profile ...Dividend History ...List of ETFs holding CYTR$0.71$0.21$0.85
819.Regulus Therapeutics (RGLS)$23.69 million-3.6%Regulus Therapeutics Inc., incorporated on September 5, 2007, is a biopharmaceutical company focused on discovering and developing drugs that target microribonucleic acid (microRNAs) to treat a range of diseases. The ...See Company Profile ...Dividend History ...List of ETFs holding RGLS$0.86$0.43$1.74
820.CHF Solutions (CHFS)$23.53 million-30.58%CHF Solutions, Inc., an early-stage medical device company, develops cardiac and coronary disease products primarily in the United States. The company focuses on commercializing the Aquadex FlexFlow system, whi...See Company Profile ...Dividend History ...List of ETFs holding CHFS$0.6$0.3$3.09
821.IntelGenx Technologies (IGXT)$23.16 million-55.32%IntelGenx Technologies Corp., a drug delivery company, focuses on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. It offers RIZAPORT, an oral thin ...See Company Profile ...Dividend History ...List of ETFs holding IGXT$0.21$0.12$0.7
822.Innovate Biopharmaceuticals (INNT)$23.14 million0%Innovate Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for autoimmune and inflammatory diseases. The company's lead product candidate is INN-202 that has completed Pha...See Company Profile ...Dividend History ...List of ETFs holding INNT$0.56$0.37$1.29
823.Interpace Diagnostics (IDXG)$22.32 million10.6%Interpace Diagnostics Group, Inc., formerly PDI, Inc., incorporated on February 10, 1998, is focused on developing and commercializing molecular diagnostic tests principally focused on early detection of high potential progressors ...See Company Profile ...Dividend History ...List of ETFs holding IDXG$5.53$3.8$11
824.Biolase (BIOL)$22.26 million-19.6%BIOLASE, Inc. (BIOLASE), incorporated on February 10, 1987, is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company markets, sells, and ...See Company Profile ...Dividend History ...List of ETFs holding BIOL$0.44$0.21$1.98
825.Eyegate Pharma (EYEG)$21.98 million-52.59%Eyegate Pharmaceuticals, Inc., incorporated on December 28, 2004, is a clinical-stage specialty pharmaceutical company. The Company is focused on developing and commercializing therapeutics and drug delivery systems for treating diseases ...See Company Profile ...Dividend History ...List of ETFs holding EYEG$4.75$2.25$12.89
826.Biostage (BSTG)$21.79 million24.88%Biostage, Inc., formerly Harvard Apparatus Regenerative Technology, Inc., incorporated on May 3, 2012, is a biotechnology company. The Company is engaged in developing bioengineered organ implants based on its Cellframe ...See Company Profile ...Dividend History ...List of ETFs holding BSTG$2.51$1.79$4.88
827.Iterum Therapeutics (ITRM)$21.78 million-72.89%Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing anti-infectives for multi-drug resistant pathogens in Ireland and the United States. The company is developing sulopenem, ...See Company Profile ...Dividend History ...List of ETFs holding ITRM$1.22$1.12$7.65
828.Cyclacel Pharma (CYCC)$21.43 million558.21%Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's oncology development programs include sapaci...See Company Profile ...Dividend History ...List of ETFs holding CYCC$4.41$3.85$19.6
829.Second Sight Medical Products (EYES)$20.92 million-84.76%Second Sight Medical Products, Inc., incorporated on May 22, 2003, is engaged in developing, manufacturing and marketing prosthetic devices that restore vision to blind individuals. The Companys product, the Argus ...See Company Profile ...Dividend History ...List of ETFs holding EYES$0.91$0.71$8.96
830.Akers Biosciences (AKER)$20.69 million5.62%Akers Biosciences, Inc., incorporated on March 9, 1989, develops, manufactures and supplies point-of-care screening and testing products designed to bring health-related information to the patient or clinician. The Companys product ...See Company Profile ...Dividend History ...List of ETFs holding AKER$3.38$1.55$16.32
831.SELLAS Life Sciences (SLS)$20.42 million-29.3%SELLAS Life Sciences Group, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications. The company's lead product candidate is g...See Company Profile ...Dividend History ...List of ETFs holding SLS$3.04$1.46$12.5
832.Adial Pharmaceuticals (ADIL)$20.31 million-37.34%Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic agents for the treatment of alcohol use disorders in the United States. Its lead product is AD0...See Company Profile ...Dividend History ...List of ETFs holding ADIL$1.51$1$3.17
833.Intec Pharma (NTEC)$19.95 million-42.4%Intec Pharma Ltd., a clinical stage biopharmaceutical company, focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel. Its Accordion Pill is an oral drug delivery syst...See Company Profile ...Dividend History ...List of ETFs holding NTEC$0.29$0.13$4.37
834.Lianluo Smart (LLIT)$19.8 million108.3%Lianluo Smart Ltd, formerly Dehaier Medical Systems Limited, incorporated on July 22, 2003, distributes and provides after-sale services for medical equipment in China through its subsidiary Beijing Dehaier Medical Technology ...See Company Profile ...Dividend History ...List of ETFs holding LLIT$0.69$0.32$3.38
835.Capital Senior Living (CSU)$19.61 million-79.33%Capital Senior Living Corporation, incorporated on October 25, 1996, is an operator of senior housing communities in the United States. The Company provides senior living services to the elderly, including ...See Company Profile ...Dividend History ...List of ETFs holding CSU$0.64$0.45$5.64
836.Bio-Path (BPTH)$19.09 million-35.29%Bio-Path Holdings, Inc. is a clinical and preclinical stage oncology focused antisense drug development company. The Company utilizes a technology that achieves systemic delivery for target specific protein inhibition for ...See Company Profile ...Dividend History ...List of ETFs holding BPTH$5.17$2.92$17.53
837.ReWalk Robotics (RWLK)$18.89 million-38.43%ReWalk Robotics Ltd., incorporated on June 20, 2001, is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or ...See Company Profile ...Dividend History ...List of ETFs holding RWLK$1.33$0.41$5.3
838.Tetraphase Pharma (TTPH)$18.84 million-8.19%Tetraphase Pharmaceuticals, Inc. (Tetraphase), incorporated on July 7, 2006, is a clinical-stage biopharmaceutical company. The Company uses its chemistry technology to create antibiotics for multidrug-resistant infections. The Company is developing ...See Company Profile ...Dividend History ...List of ETFs holding TTPH$2.58$0.56$10.4
839.KemPharm (KMPH)$18.58 million-25.63%KemPharm, Inc., incorporated on May 28, 2014, is a clinical-stage specialty pharmaceutical company. The Company is engaged in the discovery and development of prodrugs. The Company uses its Ligand Activated ...See Company Profile ...Dividend History ...List of ETFs holding KMPH$0.28$0.12$1.79
840.Conatus Pharma (CNAT)$18.44 million39%Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines for the treatment of liver diseases in the United States. Its product candidates includ...See Company Profile ...Dividend History ...List of ETFs holding CNAT$0.56$0.23$0.75
841.Avinger (AVGR)$17.83 million-69.54%Avinger, Inc., incorporated on March 8, 2007, is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients ...See Company Profile ...Dividend History ...List of ETFs holding AVGR$0.35$0.24$3.15
842.ReShape Lifesciences (RSLS)$17.8 million-43.48%ReShape Lifesciences Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology, vBloc Therapy is designed to intermittently block the vagus nerve using electrical impulses. The company's product portfolio includes ...See Company Profile ...Dividend History ...List of ETFs holding RSLS$3.25$2.91$14.4
843.Jaguar Animal Health (JAGX)$17.39 million-32.5%Jaguar Animal Health, Inc., incorporated on June 6, 2013, is an animal health company. The Company is focused on developing and commercializing gastrointestinal products for companion and production animals, foals, ...See Company Profile ...Dividend History ...List of ETFs holding JAGX$0.54$0.35$3.85
844.Check-Cap (CHEK)$16.79 million-67.64%Check-Cap Ltd. (Check-Cap), incorporated on April 5, 2009, is a clinical-stage medical diagnostics company. The Company is engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays ...See Company Profile ...Dividend History ...List of ETFs holding CHEK$0.56$0.44$2.37
845.ProPhase Labs (PRPH)$16.34 million-28.43%ProPhase Labs, Inc., incorporated on August 24, 1989, manufactures, markets and distributes a range of homeopathic and healthcare products. The Company is engaged in the research and development of over-the-counter ...See Company Profile ...Dividend History ...List of ETFs holding PRPH$1.41$1.2$2.59
846.TrovaGene (TROV)$15.89 million-4.03%Trovagene, Inc. (TrovaGene), incorporated on September 21, 2009, is a molecular diagnostic company. The Company focuses on the development and commercialization of a molecular diagnostic technology for use in disease ...See Company Profile ...Dividend History ...List of ETFs holding TROV$1.19$0.7$5.75
847.MYOS RENS Technology (MYOS)$15.88 million19.01%MYOS RENS Technology Inc. (MYOS), formerly MYOS Corporation, incorporated on April 11, 2007, is an early-stage bionutrition and biotherapeutics company. The Company is focused on the discovery, development and commercialization ...See Company Profile ...Dividend History ...List of ETFs holding MYOS$1.44$0.74$3.85
848.Achieve Life Sciences (ACHV)$15.87 million-20.17%Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes smoking cessation aids in the United States and internationally. The company offers Cytisine, a plant-based alka...See Company Profile ...Dividend History ...List of ETFs holding ACHV$0.42$0.23$2.51
849.China Sxt Pharma (SXTC)$15.78 million-30.62%China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. It offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi,...See Company Profile ...Dividend History ...List of ETFs holding SXTC$0.57$0.34$3.22
850.Ra Medical Systems (RMED)$15.72 million-59.81%Ra Medical Systems, Inc., a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians ...See Company Profile ...Dividend History ...List of ETFs holding RMED$0.45$0.35$3.63
851.ARCA biopharma (ABIO)$14.58 million12.61%ARCA biopharma, Inc. (ARCA), incorporated on March 16, 2004, is a biopharmaceutical company. The Company is principally focused on developing genetically-targeted therapies for cardiovascular diseases. The Companys lead product candidate ...See Company Profile ...Dividend History ...List of ETFs holding ABIO$6.43$2.21$22
852.Digirad (DRAD)$14.44 million19.38%Digirad Corporation, incorporated on January 2, 1997, provides healthcare solutions. The Companys portfolio of mobile healthcare solutions and medical equipment and services include diagnostic imaging and patient monitoring, provides hospitals, ...See Company Profile ...Dividend History ...List of ETFs holding DRAD$3.08$1.99$8.84
853.VIVUS (VVUS)$14.43 million-70.31%VIVUS, Inc., incorporated on May 16, 1996, is a biopharmaceutical company. The Company operates in the development and commercialization of therapeutic products segment. It provides over two therapies approved by ...See Company Profile ...Dividend History ...List of ETFs holding VVUS$0.81$0.76$4.75
854.Precipio (PRPO)$14.03 million-38.54%Precipio, Inc., a cancer diagnostics company, provides diagnostic products and services to the oncology market. It also develops a platform to eradicate the problem of misdiagnosis within academic institutions....See Company Profile ...Dividend History ...List of ETFs holding PRPO$1.26$0.55$3.93
855.Shineco (TYHT)$13.42 million-22.06%Shineco, Inc., incorporated on August 20, 1997, is a holding company. The Company provides health and well-being focused plant-based products by using its subsidiaries and variable interest entities vertically- and ...See Company Profile ...Dividend History ...List of ETFs holding TYHT$0.49$0.35$1.07
856.ENDRA Life Sciences (NDRA)$13.05 million-46.43%ENDRA Life Sciences Inc. develops medical imaging technology based on the thermos-acoustic effect that improves the sensitivity and specificity of clinical ultrasound systems. It offers diagnostic imaging techn...See Company Profile ...Dividend History ...List of ETFs holding NDRA$0.9$0.6$2.25
857.Teligent (TLGT)$12.98 million460.47%Teligent, Inc., incorporated on August 26, 1977, is a specialty generic pharmaceutical company. Under the Companys own label, it markets and sells generic injectable pharmaceutical products in the United States ...See Company Profile ...Dividend History ...List of ETFs holding TLGT$2.41$2.36$109000
858.Aevi Genomic Medicine (GNMX)$12.89 million10.6%Aevi Genomic Medicine, Inc., formerly Medgenics, Inc., incorporated on January 27, 2000, is focused on genomic medicine. The Company is engaged in unlocking the potential of genomic medicine to translate ...See Company Profile ...Dividend History ...List of ETFs holding GNMX$0.17$0.11$0.33
859.Dynatronics (DYNT)$12.8 million11.73%Dynatronics Corporation, incorporated on April 29, 1983, is a manufacturer and distributor of physical medicine products. The Companys products include a line of medical equipment for physical medicine applications, including ...See Company Profile ...Dividend History ...List of ETFs holding DYNT$0.93$0.63$3.7
860.Xtant Medical (XTNT)$12.66 million-40.19%Xtant Medical Holdings, Inc., formerly Bacterin International Holdings, Inc., incorporated on August 8, 2006, develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The ...See Company Profile ...Dividend History ...List of ETFs holding XTNT$0.96$0.55$3.5
861.Imac (IMAC)$12.61 million-16.56%IMAC Holdings, Inc. provides orthopedic therapies through a chain of innovative medical advancements and care regeneration centers in the United States. Its outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, back pain, knee pain, joint pain, ligament and tendon damage, and other related soft tissue conditions. A...See Company Profile ...Dividend History ...List of ETFs holding IMAC$1.26$0.42$5.35
862.AEterna Zentaris (AEZS)$12.54 million-43.21%Aeterna Zentaris Inc., incorporated on October 12, 1990, is a specialty biopharmaceutical company engaged in developing and commercializing treatments in oncology, endocrinology and womens health. The Company operates through the ...See Company Profile ...Dividend History ...List of ETFs holding AEZS$0.52$0.37$2.83
863.Akorn (AKRX)$11.98 million-94%Akorn Inc. (Akorn), incorporated on January 20, 1971, together with its subsidiaries, is a specialty generic pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, as well ...See Company Profile ...Dividend History ...List of ETFs holding AKRX$0.09$0.02$5.4
864.Anchiano Therapeutics (ANCN)$11.58 million11.43%Anchiano Therapeutics Ltd, a clinical-stage biotechnology company, develops gene therapies to treat early-stage bladder cancer. It is primarily developing Inodiftagene that is in various clinical trials for the treatment of non-muscle-invasive bladder cancer. The company was formerly known as BioCancell Ltd. and changed its name Anchiano Therapeutics Ltd in July 2018. The company was founded in 2004 an...See Company Profile ...Dividend History ...List of ETFs holding ANCN$1.56$0.51$4.74
865.American Shared Hospital (AMS)$11.49 million-17.21%American Shared Hospital Services, incorporated on October 30, 1983, provides Gamma Knife stereotactic radiosurgery equipment and radiation therapy and related equipment to approximately 20 medical centers in approximately 20 states ...See Company Profile ...Dividend History ...List of ETFs holding AMS$2.02$1.16$3.58
866.Diversicare Healthcare (DVCR)$11.47 million-24.09%Diversicare Healthcare Services, Inc., incorporated on January 31, 1994, provides post-acute care services to nursing center patients and residents in approximately nine states, primarily in the Southeast and the Southwest ...See Company Profile ...Dividend History ...List of ETFs holding DVCR$1.67$1$3.95
867.Sonoma Pharma (SNOA)$11.32 million47.8%Sonoma Pharmaceuticals, Inc., formerly Oculus Innovative Sciences, Inc., incorporated on November 20, 2006, is a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and ...See Company Profile ...Dividend History ...List of ETFs holding SNOA$6.37$3.33$19.6
868.Cyclacel Pharma (CYCCP)$11.31 million19%Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's oncology development programs include sapaci...See Company Profile ...Dividend History ...List of ETFs holding CYCCP$5.95$3.87$8.07
869.Medigus (MDGS)$10.72 million-4.6%Medigus Ltd., a medical device company, develops, manufactures, and markets surgical endostaplers and direct vision systems for minimally invasive medical procedures or other commercial use in the United States...See Company Profile ...Dividend History ...List of ETFs holding MDGS$1.66$0.83$5.15
870.TRACON Pharma (TCON)$10.34 million-19.66%TRACON Pharmaceuticals, Inc., incorporated on October 28, 2004, is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics for cancer, wet age-related macular degeneration ...See Company Profile ...Dividend History ...List of ETFs holding TCON$1.88$0.95$6.28
871.Myomo (MYO)$10.33 million-59.31%Myomo, Inc., a commercial stage medical robotics company, designs, develops, and produces myoelectric braces or orthotics for people suffering with neuromuscular disorders in the United States. It offers MyoPro...See Company Profile ...Dividend History ...List of ETFs holding MYO$3.67$2.82$40
872.Phio Pharmaceuticals (PHIO)$10.26 million-76.17%Phio Pharmaceuticals Corp., a biotechnology company, focuses on discovering and developing immuno-oncology therapeutics to treat cancer. The company's lead product candidate is RXI-109, an sd-rxRNA that reduces...See Company Profile ...Dividend History ...List of ETFs holding PHIO$2.24$1.6$24.64
873.Viveve Medical (VIVE)$10.08 million-48.81%Viveve Medical, Inc., incorporated in March 1999, designs, develops, manufactures and markets a medical device, Geneveve, for the non-invasive treatment of vaginal laxity, for improved sexual function, and for vaginal ...See Company Profile ...Dividend History ...List of ETFs holding VIVE$0.65$0.53$47
874.Quorum Health (QHC)$10.02 million-68.29%Quorum Health Corporation is an operator and manager of general acute care hospitals and outpatient services in the United States. The Company operates in two segments: Hospital operations, which includes ...See Company Profile ...Dividend History ...List of ETFs holding QHC$0.3$0.22$1.87
875.Midatech Pharma (MTP)$9.88 million101.45%Midatech Pharma PLC, a specialty pharmaceutical company, focuses on developing and commercializing products in oncology and immunotherapy in the United States and the United Kingdom. The company operates throug...See Company Profile ...Dividend History ...List of ETFs holding MTP$1.39$0.86$13.6
876.Hancock Jaffe Laboratories (HJLI)$9.58 million-27.25%Hancock Jaffe Laboratories, Inc., a development stage medical device company, develops and sells biological tissue solutions to treat patients with coronary, vascular, end stage renal, and peripheral arterial d...See Company Profile ...Dividend History ...List of ETFs holding HJLI$0.4$0.21$1.2
877.Synthetic Biologics (SYN)$9.37 million0.59%Synthetic Biologics, Inc., incorporated on December 23, 2008, is a clinical-stage company. The Company is engaged in developing therapeutics to protect the gut microbiome while targeting pathogen-specific diseases. The Companys ...See Company Profile ...Dividend History ...List of ETFs holding SYN$0.51$0.25$0.64
878.Tenax Therapeutics (TENX)$8.75 million-32.69%Tenax Therapeutics, Inc., incorporated on April 17, 2008, is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing products for the critical care market. The Companys ...See Company Profile ...Dividend History ...List of ETFs holding TENX$0.95$0.25$2.68
879.DelMar Pharma (DMPI)$8 million1.45%DelMar Pharmaceuticals, Inc., incorporated on June 24, 2009, is a clinical-stage drug development company. The Company focuses on the treatment of cancer. The Company is engaged in conducting clinical trials ...See Company Profile ...Dividend History ...List of ETFs holding DMPI$0.7$0.38$2.66
880.XTL BioPharma (XTLB)$7.58 million10.22%XTL Biopharmaceuticals Ltd., incorporated on March 9, 1993, is a biopharmaceutical company. The Company focuses on the acquisition and development of pharmaceutical drugs for the treatment of medical needs. Its ...See Company Profile ...Dividend History ...List of ETFs holding XTLB$1.51$0.63$2.16
881.Novus Therapeutics (NVUS)$7.38 million-20.81%Novus Therapeutics, Inc., a pharmaceutical company, focuses on developing products for patients with disorders of ear, nose, and throat. Its lead product is (OP-02), a surfactant-based combination drug product ...See Company Profile ...Dividend History ...List of ETFs holding NVUS$0.46$0.25$1.45
882.NeuroMetrix (NURO)$7.26 million-51.4%NeuroMetrix, Inc., incorporated on April 25, 2001, is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. The Company ...See Company Profile ...Dividend History ...List of ETFs holding NURO$2.09$0.81$50
883.InVivo Therapeutics (NVIV)$7.18 million-78.22%InVivo Therapeutics Holdings Corp., formerly Design Source, Inc., incorporated on April 2, 2003, is a research and clinical-stage biomaterials and biotechnology company. The Company is engaged in developing and commercializing ...See Company Profile ...Dividend History ...List of ETFs holding NVIV$1.47$1.09$25.8
884.InspireMD (NSPR)$7.04 million-57.44%InspireMD, Inc., incorporated on February 29, 2008, is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment ...See Company Profile ...Dividend History ...List of ETFs holding NSPR$0.46$0.39$5.3
885.Cancer Genetics (CGIX)$6.58 million-51.17%Cancer Genetics, Inc., incorporated on April 8, 1999, is engaged in the field of personalized medicine, enabling precision medicine in the field of oncology through its diagnostic products and services ...See Company Profile ...Dividend History ...List of ETFs holding CGIX$2.91$1.92$9.5
886.Reliv' International (RELV)$6.38 million-3.95%Reliv International, Inc., incorporated on April 12, 1999, is a developer, manufacturer and marketer of a line of nutritional supplements addressing nutrition, specific wellness needs, weight management and sports nutrition. ...See Company Profile ...Dividend History ...List of ETFs holding RELV$3.65$2.6$7.75
887.Xenetic Biosciences (XBIO)$6.35 million-29.86%Xenetic Biosciences, Inc., incorporated on August 9, 2011, is a clinical-stage biopharmaceutical company. The Company is focused on the research and development of certain pharmaceutical products for use in humans ...See Company Profile ...Dividend History ...List of ETFs holding XBIO$1.01$0.44$13.68
888.Acura Pharma (ACUR)$6.34 million27.39%Acura Pharmaceuticals, Inc., incorporated on April 10, 1935, is a pharmaceutical company. The Company is engaged in the research, development and commercialization of technologies and products intended to address medication ...See Company Profile ...Dividend History ...List of ETFs holding ACUR$0.29$0.12$0.63
889.SunLink Health (SSY)$6.07 million-17.76%SunLink Health Systems, Inc., incorporated on June 9, 1959, through its subsidiaries, owns businesses, which provide healthcare services in various markets in the United States. The Companys segments include Healthcare ...See Company Profile ...Dividend History ...List of ETFs holding SSY$0.88$0.6$1.65
890.Endologix (ELGX)$5.95 million-80.37%Endologix, Inc., incorporated on June 2, 1993, is engaged in developing, manufacturing, marketing and selling medical devices for the treatment of aortic disorders. The Companys products are intended for the ...See Company Profile ...Dividend History ...List of ETFs holding ELGX$0.31$0.23$7.2
891.Obalon Therapeutics (OBLN)$5.36 million-63.53%Obalon Therapeutics, Inc. is a commercial-stage medical device company focused on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. The Companys product, Obalon ...See Company Profile ...Dividend History ...List of ETFs holding OBLN$0.69$0.62$10.5
892.Therapix Biosciences (TRPX)$4.47 million-71.7%Therapix Biosciences Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include THX-110 for the treatment of Tourette syndrome, Obstructive Sleep Apnea, and pain; THX-130 for the treatment of Mild Cognitive Impairment and Traumatic Brain Injury; THX-150 for the treatment of infectious diseases; ...See Company Profile ...Dividend History ...List of ETFs holding TRPX$0.32$0.25$4.69
893.Auris Medical Holding AG (EARS)$4.39 million-43.02%Auris Medical Holding AG, incorporated on April 15, 1998, is a holding and clinical-stage biopharmaceutical company focused on the development of products for the treatment of inner ear disorders. The ...See Company Profile ...Dividend History ...List of ETFs holding EARS$0.92$0.65$3.2
894.Micron Solutions (MICR)$4.27 million-38.49%Micron Solutions, Inc., through its subsidiary, Micron Products, Inc., operates as a contract manufacturing organization that produces medical device components requiring precision machining and injection moldi...See Company Profile ...Dividend History ...List of ETFs holding MICR$1.47$0.66$3.49
895.Zafgen (ZFGN)$3.09 million-10.81%Zafgen, Inc., incorporated on November 22, 2005, is a biopharmaceutical company. The Company is focused on improving the health and well-being of patients affected by obesity and complex metabolic disorders. ...See Company Profile ...Dividend History ...List of ETFs holding ZFGN$0.99$0.62$15.48
896.Regional Health Properties (RHE)$2.26 million-4.29%Regional Health Properties, Inc., through its subsidiaries, operates as a self-managed healthcare real estate investment company that invests primarily in real estate purposed for senior living and long-term healthcare through facility lease and sub-lease transaction. The company's facilities offer a range of health care and related services to patients and ...See Company Profile ...Dividend History ...List of ETFs holding RHE$1.34$0.75$3.12
897.Valeritas Holdings (VLRX)$2.14 million-54.95%Valeritas Holdings, Inc., a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with Type 2 diabetes in the United States and China. It offers V-Go, a wearable insulin delivery device for basal-bolus therapy. The company also develops h-Patch, a controlled delivery technology platform; ...See Company Profile ...Dividend History ...List of ETFs holding VLRX$0.26$0.02$7.66
898.Tocagen (TOCA)$2.01 million137.74%Tocagen Inc., a clinical-stage cancer-selective gene therapy company, focuses on developing and commercializing product candidates designed to activate a patient's immune system against their cancer. Its cancer...See Company Profile ...Dividend History ...List of ETFs holding TOCA$1.26$0.42$28.05
899.First Choice Healthcare (FCHS)$1.61 million-72.72%First Choice Healthcare Solutions, Inc., through its subsidiaries, provides healthcare services in the United States. Its network of non-physician-owned medical centers offer musculoskeletal and rehabilitative ...See Company Profile ...Dividend History ...List of ETFs holding FCHS$0.05$0.03$0.5
900.ImmunoCellular Therapeutics (IMUC)$1.26 million0%ImmunoCellular Therapeutics, Ltd., incorporated on March 20, 1987, is a clinical-stage biotechnology company. The Company is developing immune-based therapies for the treatment of cancers. The Companys cancer immunotherapies target cancer ...See Company Profile ...Dividend History ...List of ETFs holding IMUC$0.03$0.01$0.05

Top Performing Healthcare StocksAll Healthcare StocksAll Healthcare ETFsTop Dividend-paying Healthcare StocksTop Healthcare Stocks for Q3 2020

This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.

Other Popular Stocks Lists:

 ◐ List of Industrial Specialties Health Care Stocks

 ◐ List of Healthcare Reit Stocks

 ◐ List of Metal Fabrications Basic Industries Stocks

 ◐ List of Auto Manufacturing Stocks

 ◐ List of Miscellaneous Stocks

 ◐ List of Food & Beverage Stocks

 ◐ List of Steel Iron Basic Industries Stocks

 ◐ List of Internet Stocks

 ◐ List of Property Casualty Insurance Nec Stocks

 ◐ List of Railroads Stocks

 ◐ List of Specialty Chemicals Consumer Durables Stocks

 ◐ List of Electronics Distribution Stocks

 ◐ List of Telecommunications Equipment Consumer Non Durables Stocks

 ◐ List of Life Insurance Stocks

 ◐ List of Building Products Consumer Durables Stocks

 ◐ List of Cloud Computing Stocks

 ◐ List of Technology Services Stocks

 ◐ List of Publishing Stocks

 ◐ List of Dogs Of The Dow Stocks

 ◐ List of Business Services Miscellaneous Stocks

 ◐ List of Electric Utilities Public Utilities Stocks

 ◐ List of Office Equipment Supplies Services Miscellaneous Stocks

 ◐ List of Metal Fabrications Consumer Durables Stocks

 ◐ List of Bank Stocks

 ◐ List of Spirit Wine Stocks

 ◐ List of Consumer Durables Stocks

 ◐ List of Water Supply Stocks

 ◐ List of Real Estate Investment Trusts Stocks

 ◐ List of Paper Basic Industries Stocks

 ◐ List of Silver Stocks

 ◐ List of Marine Transportation Stocks

 ◐ List of Low Beta Stocks

 ◐ List of Investment Funds Stocks

 ◐ List of Nasdaq Stocks

 ◐ List of Industrial Specialties Capital Goods Stocks

 ◐ List of Books Stocks

 ◐ List of Educational Services Stocks

 ◐ List of Building Materials Capital Goods Stocks

 ◐ List of Consumer Specialties Consumer Durables Stocks

 ◐ List of Medical Dental Instruments Stocks

 ◐ List of Other Pharmaceuticals Stocks

 ◐ List of Engineering Construction Capital Goods Stocks

 ◐ List of Drug Manufacturer Stocks

 ◐ List of Amusement Recreation Stocks

 ◐ List of Metal Fabrications Capital Goods Stocks

 ◐ List of Consumer Specialties Consumer Services Stocks

 ◐ List of Auto Parts Oem Stocks

 ◐ List of Publishing Consumer Durables Stocks

 ◐ List of Robotics Stocks

 ◐ List of Home Furnishings Consumer Durables Stocks

 ◐ List of Telecommunications Equipment Technology Stocks

 ◐ List of Home Furnishings Consumer Services Stocks

 ◐ List of Investment Bankers Brokers Stocks

 ◐ List of Pollution Control Equipment Stocks

 ◐ List of Natural Gas Distribution Stocks

 ◐ List of Major Banks Stocks

 ◐ List of Other Specialty Stores Stocks

 ◐ List of Fluid Controls Stocks

 ◐ List of Property Insurance Stocks

 ◐ List of Advertising Consumer Services Stocks

 ◐ List of Multi Sector Companies Stocks

 ◐ List of Construction Agri Equipment Trucks Stocks

 ◐ List of Medical Electronics Stocks

 ◐ List of Meat Poultry Fish Stocks

 ◐ List of Environmental Services Public Utilities Stocks

 ◐ List of Industrial Machinery Components Miscellaneous Stocks

 ◐ List of Consumer Electronics Appliances Energy Stocks

 ◐ List of Textiles Basic Industries Stocks

 ◐ List of Office Equipment Supplies Services Consumer Services Stocks

 ◐ List of Oil Gas Production Energy Stocks

 ◐ List of Biotech Apparatus Stocks

 ◐ List of Farming Seeds Milling Stocks

 ◐ List of Professional Services Consumer Services Stocks

 ◐ List of Specialty Chemicals Basic Industries Stocks

 ◐ List of Property Casualty Insurers Stocks

 ◐ List of Catalog Specialty Distribution Stocks

 ◐ List of Biotech Instruments Stocks

 ◐ List of Gaming Stocks

 ◐ List of Biotech Stocks

 ◐ List of Building Materials Stocks

 ◐ List of Hospital Nursing Management Stocks

 ◐ List of Business Services Stocks

 ◐ List of Engineering Construction Stocks

 ◐ List of Aerospace Stocks

 ◐ List of Aluminum Stocks

 ◐ List of Banks Stocks

 ◐ List of Transportation Services Stocks

 ◐ List of Package Goods Cosmetics Basic Industries Stocks

 ◐ List of Private Equity Stocks

 ◐ List of Electronic Components Capital Goods Stocks

 ◐ List of Wholesale Distributors Stocks

 ◐ List of Precision Instruments Stocks

 ◐ List of Trading Mining Stocks

 ◐ List of Electrical Products Consumer Durables Stocks

 ◐ List of Aerospace Transportation Stocks

 ◐ List of Oil Gas Production Stocks

 ◐ List of Drilling Stocks

 ◐ List of Home Furnishings Basic Industries Stocks

 ◐ List of Publishing Miscellaneous Stocks

 ◐ List of Automotive Aftermarket Capital Goods Stocks

 ◐ List of Broadcasting Stocks

 ◐ List of Computer Software Programming Data Processing Stocks

 ◐ List of Television Services Stocks

 ◐ List of Most Diversified Stocks

 ◐ List of Tools Hardware Stocks

 ◐ List of Industrial Machinery Components Stocks

 ◐ List of Coffee Stocks

 ◐ List of Military Government Technical Consumer Services Stocks

 ◐ List of Containers Packaging Stocks

 ◐ List of 5g Stocks

 ◐ List of Small Dogs Of The Dow Stocks

 ◐ List of Health Care Equipment Services Stocks

 ◐ List of Motor Vehicles Consumer Non Durables Stocks

 ◐ List of Plastic Products Stocks

 ◐ List of Ordnance Accessories Stocks

 ◐ List of Industrial Specialties Stocks

 ◐ List of Farming Seeds Milling Consumer Services Stocks

 ◐ List of Homebuilding Stocks

 ◐ List of Restaurants Stocks

 ◐ List of Palladium Stocks

 ◐ List of Retail Building Materials Stocks

 ◐ List of Hotel Reit Stocks

 ◐ List of Rental Leasing Companies Stocks

 ◐ List of Technology Stocks

 ◐ List of Major Chemicals Stocks

 ◐ List of Movies Entertainment Stocks

 ◐ List of Apparel Stocks

 ◐ List of Textiles Consumer Non Durables Stocks

 ◐ List of Agricultural Chemicals Stocks

 ◐ List of Building Materials Consumer Services Stocks

 ◐ List of Package Goods Cosmetics Consumer Non Durables Stocks

 ◐ List of Advertising Stocks

 ◐ List of Reits Finance Stocks

 ◐ List of Office Equipment Supplies Services Stocks

 ◐ List of Telecommunications Equipment Consumer Durables Stocks

 ◐ List of Insurance Stocks

 ◐ List of Investment Managers Stocks

 ◐ List of Recreational Products Toys Consumer Services Stocks

 ◐ List of Engineering Construction Basic Industries Stocks

 ◐ List of Natural Gas Distribution Energy Stocks

 ◐ List of Greeting Cards Stocks

 ◐ List of Telecommunications Equipment Consumer Services Stocks

 ◐ List of Drug Delivery Stocks

 ◐ List of Office Reit Stocks

 ◐ List of Food Chains Consumer Services Stocks

 ◐ List of Military Government Technical Capital Goods Stocks

 ◐ List of Tobacco Stocks

 ◐ List of Containers Packaging Basic Industries Stocks

 ◐ List of Consumer Electronics Video Stocks

 ◐ List of Marine Transportation Capital Goods Stocks

 ◐ List of Advertising Technology Stocks

 ◐ List of Reit Stocks

 ◐ List of Food Distributors Stocks

 ◐ List of Finance Companies Stocks

 ◐ List of Industrial Specialties Consumer Durables Stocks

 ◐ List of Retail Reit Stocks

 ◐ List of Specialty Foods Stocks

 ◐ List of Other Consumer Services Stocks

 ◐ List of Blockchain Stocks

 ◐ List of Brazil Stocks

 ◐ List of Railroads Transportation Stocks

 ◐ List of Specialty Insurers Stocks

 ◐ List of Mining Quarrying Minerals Stocks

 ◐ List of Electric Utilities Stocks

 ◐ List of Railroads Capital Goods Stocks

 ◐ List of Telecom Stocks

 ◐ List of Environmental Services Basic Industries Stocks

 ◐ List of Building Products Capital Goods Stocks

 ◐ List of Automotive Aftermarket Stocks

 ◐ List of Transportation Stocks

 ◐ List of Recreational Products Stocks

 ◐ List of Professional Services Technology Stocks

 ◐ List of Computer Software Prepackaged Software Stocks

 ◐ List of Air Freight Stocks

 ◐ List of Shoe Manufacturing Stocks

 ◐ List of Electric Utilities Basic Industries Stocks

 ◐ List of Medical Specialities Capital Goods Stocks

 ◐ List of Military Government Technical Basic Industries Stocks

 ◐ List of Oil Gas Transmission Stocks

 ◐ List of Retail Stores Stocks

 ◐ List of Other Consumer Services Consumer Services Stocks

 ◐ List of Coal Mining Stocks

 ◐ List of Conglomerate Stocks

 ◐ List of Retail Computer Software Equipment Stocks

 ◐ List of Savings Institutions Stocks

 ◐ List of Electronic Components Technology Stocks

 ◐ List of Electrical Products Stocks

 ◐ List of Steel Iron Capital Goods Stocks

 ◐ List of Integrated Oil Companies Stocks

 ◐ List of Diversified Reit Stocks

 ◐ List of Water Waste Treatment Systems Stocks

 ◐ List of Commercial Banks Stocks

 ◐ List of Steel Iron Stocks

 ◐ List of Residential Reit Stocks

 ◐ List of Renewable Energy Stocks

 ◐ List of Diversified Electronic Products Stocks

 ◐ List of Biotech Products Stocks

 ◐ List of Iron Stocks

 ◐ List of Specialty Chemicals Capital Goods Stocks

 ◐ List of Automotive Aftermarket Consumer Services Stocks

 ◐ List of Biotech Research Stocks

 ◐ List of Marine Transportation Consumer Services Stocks

 ◐ List of Other Specialty Stores Basic Industries Stocks

 ◐ List of Industrial Reit Stocks

 ◐ List of Platinum Stocks

 ◐ List of Electronic Components Consumer Non Durables Stocks

 ◐ List of Farming Seeds Milling Consumer Non Durables Stocks

 ◐ List of Pharma Stocks

 ◐ List of Consumer Specialties Stocks

 ◐ List of Real Estate Finance Stocks

 ◐ List of Water Stocks

 ◐ List of Marine Transportation Transportation Stocks

 ◐ List of Health Care Stocks

 ◐ List of Containers Packaging Capital Goods Stocks

 ◐ List of Manufacturing Industries Stocks

 ◐ List of Finance Stocks

 ◐ List of Consumer Services Stocks

 ◐ List of Basic Industries Stocks

 ◐ List of Clothing Shoes Accessory Stocks

 ◐ List of Consumer Non Durables Stocks

 ◐ List of Transportation Services Transportation Stocks

 ◐ List of Fast Food Stocks

 ◐ List of Airlines Stocks

 ◐ List of Electronic Components Consumer Durables Stocks

 ◐ List of Aerospace Capital Goods Stocks

 ◐ List of Newspaper Stocks

 ◐ List of Consumer Electronics Appliances Stocks

 ◐ List of Miscellaneous Consumer Services Stocks

 ◐ List of Business Services Finance Stocks

 ◐ List of Oil Gas Stocks

 ◐ List of Diversified Commercial Services Consumer Services Stocks

 ◐ List of Transportation Services Consumer Services Stocks

 ◐ List of Water Supply Public Utilities Stocks

 ◐ List of Oil Refining Marketing Energy Stocks

 ◐ List of Building Contractors Nonresidential Stocks

 ◐ List of Office Equipment Supplies Services Consumer Durables Stocks

 ◐ List of Newspapers Magazines Stocks

 ◐ List of Telecommunications Equipment Basic Industries Stocks

 ◐ List of Medical Products Stocks

 ◐ List of Industrial Machinery Components Technology Stocks

 ◐ List of Paper Consumer Services Stocks

 ◐ List of Real Estate Consumer Services Stocks

 ◐ List of Mortgage Reits Stocks

 ◐ List of Package Goods Cosmetics Stocks

 ◐ List of Agriculture Stocks

 ◐ List of Food Chains Stocks

 ◐ List of Paints Coatings Stocks

 ◐ List of Commercial Reits Nec Stocks

 ◐ List of India Stocks

 ◐ List of Low Volatility Stocks

 ◐ List of Exhibition Conference Services Stocks

 ◐ List of Environmental Services Stocks

 ◐ List of Others Miscellaneous Stocks

 ◐ List of Motor Vehicles Consumer Services Stocks

 ◐ List of Consumer Finance Services Stocks

 ◐ List of Professional Services Stocks

 ◐ List of Consumer Lending Nec Stocks

 ◐ List of Oil Refining Marketing Stocks

 ◐ List of Dividend Aristocrats Stocks

 ◐ List of Food Chains Consumer Non Durables Stocks

 ◐ List of Oil Refining Marketing Transportation Stocks

 ◐ List of Electric Utilities Energy Stocks

 ◐ List of Automotive Aftermarket Consumer Durables Stocks

 ◐ List of Reits Consumer Services Stocks

 ◐ List of Containers Packaging Consumer Durables Stocks

 ◐ List of Biofuels Stocks

 ◐ List of Multiline Insurance Brokers Nec Stocks

 ◐ List of Natural Resources Stocks

 ◐ List of Computer Communications Equipment Stocks

 ◐ List of Gold Stocks

 ◐ List of High Beta Stocks

 ◐ List of Consumer Discretionary Stocks

 ◐ List of Telecommunications Equipment Stocks

 ◐ List of Other Consumer Services Miscellaneous Stocks

 ◐ List of Specialty Chemicals Stocks

 ◐ List of Meat Stocks

 ◐ List of Diversified Commercial Services Finance Stocks

 ◐ List of Medical Nursing Services Stocks

 ◐ List of Electrical Products Capital Goods Stocks

 ◐ List of Major Pharmaceuticals Stocks

 ◐ List of Homebuilding Consumer Services Stocks

 ◐ List of Other Transportation Stocks

 ◐ List of Esg Stocks

 ◐ List of Consumer Electronics Appliances Consumer Non Durables Stocks

 ◐ List of Power Generation Stocks

 ◐ List of Other Specialty Stores Consumer Services Stocks

 ◐ List of Healthcare Stocks

 ◐ List of Accident Health Insurance Stocks

 ◐ List of Homebuilding Basic Industries Stocks

 ◐ List of Building Operators Stocks

 ◐ List of Recreational Products Toys Stocks

 ◐ List of Oilfield Services Equipment Stocks

 ◐ List of Aerospace Defense Stocks

 ◐ List of Recreational Products Toys Consumer Non Durables Stocks

 ◐ List of Environmental Services Consumer Non Durables Stocks

 ◐ List of Office Reits Stocks

 ◐ List of Telecommunications Equipment Public Utilities Stocks

 ◐ List of China Stocks

 ◐ List of Electrical Products Technology Stocks

 ◐ List of Biotech Diagnostics Stocks

 ◐ List of Water Supply Basic Industries Stocks

 ◐ List of Dow Jones Stocks

 ◐ List of Radio Tv Broadcasting Stocks

 ◐ List of Capital Goods Stocks

 ◐ List of Homebuilding Consumer Non Durables Stocks

 ◐ List of Military Government Technical Stocks

 ◐ List of Cannabis Stocks

 ◐ List of Medical Specialities Stocks

 ◐ List of Medical Specialities Health Care Stocks

 ◐ List of Publishing Consumer Services Stocks

 ◐ List of Oil Stocks

 ◐ List of Miscellaneous Basic Industries Stocks

 ◐ List of Dowjones Stocks

 ◐ List of Consumer Electronics Appliances Consumer Durables Stocks

 ◐ List of Paper Stocks

 ◐ List of Energy Stocks

 ◐ List of Industrial Machinery Components Consumer Durables Stocks

 ◐ List of Natural Gas Distribution Public Utilities Stocks

 ◐ List of Packaged Foods Stocks

 ◐ List of Basic Materials Stocks

 ◐ List of Oil Gas Production Public Utilities Stocks

 ◐ List of Homebuilding Capital Goods Stocks

 ◐ List of Semiconductors Stocks

 ◐ List of Public Utilities Stocks

 ◐ List of Motor Vehicles Stocks

 ◐ List of Diversified Commercial Services Stocks

 ◐ List of Metal Fabrications Energy Stocks

 ◐ List of Business Services Technology Stocks

 ◐ List of Business Services Consumer Services Stocks

 ◐ List of Hotels Resorts Stocks

 ◐ List of Real Estate Stocks

 ◐ List of Steel Stocks

 ◐ List of Consumer Specialties Consumer Non Durables Stocks

 ◐ List of Oil Gas Exploration Stocks

 ◐ List of Diversified Financial Services Stocks

 ◐ List of Edp Services Stocks

 ◐ List of Drug Development Stocks

 ◐ List of Textiles Stocks

 ◐ List of Ophthalmic Goods Stocks

 ◐ List of Auto Accessories Stocks

 ◐ List of Electronic Components Stocks

 ◐ List of Building Products Stocks

 ◐ List of Specialized Reits Nec Stocks

 ◐ List of Computer Peripheral Equipment Stocks

 ◐ List of Precious Metals Stocks

 ◐ List of Forest Products Stocks

 ◐ List of Commercial Leasing Stocks

 ◐ List of Beverages Stocks

 ◐ List of Software Stocks

 ◐ List of Industrial Machinery Components Capital Goods Stocks

 ◐ List of Industrial Machinery Components Energy Stocks

 ◐ List of Trucking Freight Courier Services Stocks

 ◐ List of Investors Services Stocks

 ◐ List of Diversified Commercial Services Technology Stocks

 ◐ List of Metal Fabrications Stocks

 ◐ List of Russia Stocks

 ◐ List of Mexico Stocks

 ◐ List of Home Furnishings Stocks

 ◐ List of Computer Manufacturing Stocks

Stocks of Other Sectors

▶ Stock List of Sector

▶ Stock List of Basic Industries Sector

▶ Stock List of Basic Materials Sector

▶ Stock List of Capital Goods Sector

▶ Stock List of Communication Services Sector

▶ Stock List of Consumer Cyclical Sector

▶ Stock List of Consumer Defensive Sector

▶ Stock List of Consumer Discretionary Sector

▶ Stock List of Consumer Durables Sector

▶ Stock List of Consumer Non-Durables Sector

▶ Stock List of Consumer Services Sector

▶ Stock List of Energy Sector

▶ Stock List of Finance Sector

▶ Stock List of Financial Services Sector

▶ Stock List of Health Care Sector

▶ Stock List of Healthcare Sector

▶ Stock List of Industrials Sector

▶ Stock List of Miscellaneous Sector

▶ Stock List of Public Utilities Sector

▶ Stock List of Real Estate Sector

▶ Stock List of Services Sector

▶ Stock List of Technology Sector

▶ Stock List of Transportation Sector

▶ Stock List of Utilities Sector


 Search This Site